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Abstract 
 
In the modern world, one of the main issues that mankind tries to 
control and improve, concerning its well-being, is health. In the last decades, 
several progresses have been achieved in order to improve health and also to 
increase overall lifespan. However, modern lifestyle also brought changes that 
continuously threaten health. In an “industrial” world, environmental pollution 
increased largely, and its effects are reflected deeply in disease development 
rates and incidence percentages. 
Human exposure to pollutants can occur via various pathways, 
including inhalation of contaminated air and dust, ingestion of contaminated 
water and food, dermal exposure to chemical or contaminated products, or 
fetal exposure during pregnancy. Dibenzofuran (DBF) is a “dioxin-like” 
chemical that is known to be toxic. This pollutant has been identified in 
tobacco smoke and listed as a pollutant of concern due to its persistence in 
the environment and potential for bioaccumulation; its exposure has been 
reported to cause reproductive injury, endocrine disruption and respiratory 
damage. Nevertheless and although the lung is a primary site of exposure for 
many inhaled chemical contaminants, studies about pollutants-induced toxic 
effects in lung function are scarce. 
In this work we tested the toxic effects of DBF in vitro in isolated 
mitochondria, organelles that play a central role in cell life and death. 
Mitochondria were isolated from lung, primary target organ of exposure to 
pollutants through inhalation, and from the liver, the main organ responsible 
for accumulating and metabolize xenobiotics. In the lung mitochondria, DBF 
caused a decrease in the mitochondrial phosphorylative efficiency and 
interfered with the mitochondria permeability transition (MPT) induction. Liver 
mitochondrial function was also impaired by DBF, which caused increased 
phosphorylative lag phase, reduced mitochondrial state 3 respiration, as well 
as disturbance of the calcium loading capacity and MPT. Moreover, we 
identified an interaction of DBF with the adenine nucleotide translocase 
(ANT), a mitochondrial component that is involved in both the phosphorylative  
system and in MPT induction. 
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Exposure of lung epithelial cells A549 to the pollutant caused a 
reduction in cell proliferation, associated with a decreased mitochondrial 
activity (lower MTT reduction and reduced oxygen consumption rate) and 
impairment of ATP production. DBF exposure triggered autophagy in A549 
cells probably as a cytoprotective mechanism. 
In summary, our results indicate that mitochondria are probably a 
target in DBF-induced toxicity. A decrease in the mitochondrial 
phosphorylative efficiency elicited by Dibenzofuran, with subsequent decrease 
in ATP content, are damaging results from exposure to Dibenzofuran; also 
inhibition of lung cell proliferation and mitochondrial activity, as well as 
autophagy triggering seem to be critical events in DBF-induced function 
impairment. Yet, further studies focused on understanding the upstream 
molecular mechanisms, by which metabolic pathways are deregulated, may 
ultimately help to develop therapeutic strategies and to prevent diseases 
related to pollutants exposure. 
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Resumo 
 
No mundo moderno de hoje, um dos principais aspectos que o Homem 
tenta controlar e melhorar, no que respeita ao seu bem-estar, é a sua saúde. 
Nas últimas décadas, vários progressos foram feitos de forma a conseguir 
melhorar a saúde e também aumentar a esperança media de vida. No 
entanto, o estilo de vida moderno trouxe também algumas mudanças que 
constantemente ameaçam a saúde. Numa sociedade dita “industrial”, a 
poluição ambiental aumentou grandemente; em consequência disso os seus 
efeitos refletem-se largamente nas taxas de desenvolvimento de doenças e 
percentagens de incidência. 
A exposição humana a poluentes ambientais pode ocorrer por diversas 
vias, nomeadamente inalação de ar contaminado e de poeiras, ingestão de 
comida e água contaminadas, exposição por contacto dérmico com químicos 
ou produtos contaminados, ou ainda exposição fetal durante a gravidez. O 
Dibenzofurano (DBF) é um composto químico semelhante a dioxinas, 
conhecido por ser tóxico. Este poluente foi identificado no fumo de tabaco e 
listado como um poluente preocupante devido às suas características de 
persistência no ambiente e potencial para bioacumulação. Foi já reportado 
que a exposição a DBF prejudica a reprodução, causa disrupção endócrina e 
dano respiratório. Contudo, e apesar de o pulmão ser um órgão primário de 
exposição a vários contaminantes químicos inalados, são ainda escassos os 
estudos sobre os efeitos tóxicos induzidos por poluentes na função pulmonar.  
Neste trabalho foram testados os efeitos tóxicos do DBF in vitro, 
utilizando mitocôndrias isoladas, desempenhando estes organelos um papel 
central na vida e morte celular. As mitocôndrias foram isoladas a partir de 
pulmão, órgão alvo da exposição a poluentes por inalação, e a partir  de 
fígado, o principal órgão responsável por acumular e metabolizar compostos 
xenobióticos. Nas mitocôndrias de pulmão, a exposição a DBF causou uma 
redução na eficiência da fosforilação mitocondrial e interferiu com a indução 
de permeabilidade transitória mitocondrial (MPT). A função mitocondrial no 
fígado também foi inibida pela exposição a DBF, que causou um aumento da 
lag phase fosforilativa, redução do estado 3 da respiração mitocondrial, bem 
como um distúrbio na capacidade de retenção de cálcio pelas mitocôndrias e 
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na indução de MPT. Além destes efeitos, foi identificada uma interação do 
DBF com o translocator de nucleótidos de adenina (ANT), um componente 
mitocondrial que está envolvido tanto no sistema fosforilativo como na 
indução de MPT. 
A exposição de células epiteliais pulmonares (células A549) ao 
poluente causou uma redução da proliferação celular, associada a um 
decréscimo na atividade mitocondrial (diminuição na redução de MTT e na 
taxa de consumo de oxigénio) e a uma diminuição da produção de ATP. A 
exposição a DBF despoletou nas células A549 mecanismos de autofagia, 
provavelmente como um mecanismo de proteção celular em resposta ao 
dano causado. 
Em síntese, os resultados indicam que a mitocôndria é provavelmente 
um alvo envolvido na toxicidade causada pela exposição a DBF. Um 
decréscimo da eficiência fosforilativa mitocondrial causado pelo DBF, com 
consequente decréscimo na quantidade de ATP, são efeitos danosos da 
exposição a este poluente. Também a inibição da proliferação de células 
pulmonares e da atividade mitocondrial, assim como a indução de autofagia, 
parecem ser fenómenos causados pela exposição a DBF e consequente 
dano. Porém, estudos adicionais focados na compreensão dos mecanismos 
moleculares que levam à desregulação de vias metabólicas são necessários, 
podendo contribuir para o desenvolvimento de novas estratégias terapêuticas 
e para a prevenção de doenças relacionadas com a exposição a poluentes. 
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General introduction
   
Chapter 1 – General introduction 
 
In the modern world, one of the main issues that mankind tries to 
control and improve, concerning its well-being, is health. In the last decades, 
several progresses have been achieved in order to improve health and also to 
increase overall lifespan. However, modern lifestyle also brought changes that 
continuously threaten health. In an “industrial” world, environmental pollution 
increased largely, and its effects are reflected deeply in disease development 
rates and incidence percentages. 
Chemicals definitely became part of our daily lives. Moreover, they may 
cause diseases. One important question that decision-makers have to 
address, in order to prioritize efforts to protect us from the harmful effects of 
chemicals, is related to which fraction of the current disease burden are 
caused by chemical exposure, and also which are the chemicals of greatest 
concern. 
Unsurprisingly, chemicals exposure not only affects health but also 
economy, as modern societies spend more and more money trying to either 
cure people from diseases or prevent them from getting ill. 
 
1.1. Environmental pollution 
 
Chemicals, whether of natural origin or produced by human activities, 
are part of our environment. Their chemical, physical and toxicological 
properties vary greatly; while many are not hazardous or persistent, some are 
life-threatening on contact and some persist in the environment, accumulate 
in the food chain, travel large distances from where they are released, and are 
harmful to human health in small amounts (Prüss-Ustün et al., 2011). Human 
exposure can occur at different stages of the existence of a chemical in the 
environment, including through occupational exposure during manufacture, 
use and disposal, consumer exposure, exposure to contaminated products or 
environmental exposure to toxic waste. Exposure can occur via various 
pathways, including inhalation of contaminated air and dust, ingestion of 
contaminated water and food, dermal exposure to chemical or contaminated 
products, or fetal exposure during pregnancy (Table 1.1.1).
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Pollution implicates the insertion of contaminants into a natural environment 
that causes instability, disorder, harm or discomfort to the ecosystem (i.e. 
physical systems or living organisms). Pollution can take the form of chemical 
substances, noise, heat or light. Pollutants, the components of pollution, can 
be either foreign substances or naturally occurring contaminants. 
Air pollution has long been known to be detrimental to health, 
particularly that of the respiratory system, yet epidemiologic estimates of the 
respiratory effects of air pollution have suggested relatively small effects 
compared with those of other environmental exposures. However, effects 
estimated at a population level ignore individuals’ susceptibility to air pollution, 
which may be associated with genetic factors, together with non-genetic 
factors such as age, time spent outdoors, and level of physical exercise 
(Minelli et al., 2011). 
 
1.1.1. Toxicants exposure and disease 
 
Environmental pollution can lead to the development of several 
diseases or promote the exacerbation of conditions already prevailing. 
When one thinks about air pollution, it is mandatory to think of 
respiratory morbidity and respiratory diseases. Ambient air pollution is 
associated with a considerable burden of global disease (Figure 1.1.1). The 
World Health Organization estimated that exposure to fine particulate air 
pollution caused 800,000 deaths and 6.4 million lost years of healthy life in the 
world’s cities in 2000. The developing countries of Southeast Asia accounted 
for two-thirds of this burden (Cohen et al., 2005; Su et al., 2011). 
The effects of air pollutants continue to be at a high level of interest 
within the scientific, regulatory, and public communities. This is because of 
the need to address critical gaps in understanding how air pollution 
contributes to human health problems and how we can effectively attenuate 
them. A great deal of information exists concerning the effects of gaseous air 
pollutants but our current understanding of such effects, including the effects 
of mixed components on human mortality and morbidity, are limited. Also 
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limited is our understanding about the level of metabolic changes associated 
with changes in oxidative stress and how such changes modulate health. 
 
 
 
 
Figure 1.1.1 – Distribution of known burden of disease in DALYs - Disability-adjusted 
life years. Adapted from Prüss-Ustün et al., 2011. 
 
Several health problems have been associated with air pollution and 
oxidative stress, such as chronic obstructive pulmonary disease (COPD) 
(Chiba et al., 2012), cardiovascular diseases (Gentner and Weber, 2010; 
Nemmar et al., 2011; Jules et al., 2012; Martinelli et al., 2012), asthma 
(Lehmann et al., 2001; Lehmann et al., 2002), inflammation (Lehmann et al., 
2008) and lung cancer (Katanoda et al., 2011; Couraud et al., 2012). 
Particularly tobacco use is the oldest (Doll and Hill, 1950) and most well-
established (Khuder, 2001) risk factor for lung cancer, and lung cancer is the 
most common cause of cancer death (1.38 million, 18.2% of the total) (Ferlay 
et al., 2010; Jemal et al., 2011). The World Health Organization (WHO) 
estimates that 25% of lung cancer worldwide occurs in never smokers (Jemal 
et al., 2011). This percentage is probably closer to 10–15% in Western 
countries (Sun et al., 2007; Scagliotti et al., 2009). If considered as an 
independent entity, lung cancer in never smokers (LCINS) was already the 7th 
largest cause of cancer-related mortality in the world some years ago (Parkin 
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et al., 2005) and a top-ten cause of death in the United States (Thun et al., 
2006; Blair and Freeman, 2006). 
Apart from air pollution and respiratory diseases, many studies have 
also demonstrated that exposure to environmental chemicals has other 
severe adverse health effects, including neurotoxicity, immunotoxicity, 
developmental toxicity, hepatotoxicity, kidney toxicity and lymphomas (Bakke 
et al., 2007; Tabrez and Ahmad, 2009; Purdue et al., 2011). The liver is the 
major site of trichloroethylene (TCE) metabolism and TCE hepatotoxicity has 
been well documented in humans and experimental animal models (Yang et 
al., 2012). Occupational exposure to TCE has also been found to cause non-
cancer liver diseases, such as hepatic necrosis, fatty liver, and cirrhosis 
(Thiele et al., 1982; Pantucharoensri et al., 2004). TCE-associated 
hepatotoxicity involves increased oxidative stress and TCE treatment has also 
been found to cause genotoxic effects in HepG2 cells, which probably result 
from TCE-induced oxidative DNA damage (Hu et al., 2008). Moreover, human 
beings exposed to chromium, nickel or arsenic under environmental or 
occupational settings show increased risk of asthma, nasal septum and skin 
ulcerations, allergic and contact dermatitis, as well as respiratory cancers 
(Salnikow and Zhitkovich, 2008; Soudani et al., 2011). Experimental animals 
models exposed to chromium also exhibit acute tissue damage, including 
testicular lesions, kidney tubular necrosis, and liver damage (Pedraza-
Chaverri et al., 2005). The damage has been associated with the intracellular 
generation of toxic chromium intermediates, which are considered as strong 
oxidants; ROS generated in excess cause injury to cellular proteins, lipids and 
DNA, leading to oxidative stress (Soudani et al., 2011). Still, polychlorinated 
biphenyls (PCBs), lead, and mercury are common pollutants that have been 
associated with significant dose-dependent increase for ALT elevation not 
explained by viral hepatitis, hemochromatosis, or alcohol abuse, presenting a 
relationship between low-level environmental pollution and the development 
of liver disease and non-alcoholic fatty liver disease - NAFLD (Cave et al., 
2010). 
Table 1.1.2 presents a brief summary about diseases with suspected 
or already confirmed linkage to chemicals. 
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Based on recent estimations, the global burden of disease attributable 
to environmental exposure and management of selected chemicals sums to at 
least 4.9 million deaths (or 86 million DALYs - “Disability-adjusted life years”, 
a weighted measure of years of life lost due to premature death, and years 
lived with disability) per year (Prüss-Ustün et al., 2011). This represents 8.3% 
of the total deaths and 5.7% of the total burden of disease in DALYs 
worldwide. The share of the total disease burden is considerable, and 
supports the need for further public health considerations in this area. By far 
the largest disease burden is related to exposure to air pollution mixtures with 
70% of the total. These estimations include available information for 
chemicals in a broad sense, i.e. not only industrial and agricultural chemicals 
but also air pollutants and some naturally occurring chemicals. Available 
information for industrial and agricultural chemicals and acute poisonings only 
(i.e. without air pollution nor contaminated drinking-water) amounts to a global 
burden of disease of at least 1.2 million deaths (25 million DALYs), 
corresponding to 2.0% of the total deaths and 1.7% of the total burden of 
disease worldwide (Prüss-Ustün et al., 2011). 
Better insight on these diseases and linkage to toxicants exposure may 
direct means for more effective public health prevention and treatment of 
diseases associated with air pollution. 
 
1.1.2. Dioxins and Dibenzofurans 
 
Dibenzofuran is a heterocyclic organic compound with the chemical 
structure shown in Figure 1.1.2. It is an aromatic ether that has two benzene 
rings fused to one furan ring in the middle, having the chemical formula 
C12H8O. 
Dibenzofurans often inaccurately refer to polychlorinated dibenzofurans 
(PCDFs), a family of organic compounds with one or several of the hydrogens 
in the Dibenzofuran structure replaced by chlorines (Figure 1.1.3). For 
example, 2,3,7,8-tetrachlorodibenzofuran (TCDF) has chlorine atoms 
substituted for each of the hydrogens on the number 2, 3, 7, and 8 carbons. 
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Figure 1.1.2 – Chemical structure of Dibenzofuran. 
 
Polychlorinated dibenzofurans are structurally similar to polychlorinated 
dibenzodioxins (PCDDs) and these groups together are often inaccurately 
called “dioxins”, which represents a generic term used to denote a single 
compound or mixture of compounds derived from polychlorinated 
dibenzodioxins, with very similar structures and often found in association with 
them. 
The toxic potency of both PCDDs and PCDFs is a function of the 
number and positions of chlorine substituents. PCDDs and PCDFs with a 
decreased number of lateral chlorine atoms (positions 2, 3, 7 and 8) or 
increased non-lateral chlorine atoms are generally less toxic than TCDD 
(Safe, 1990). 
The mixture of dioxins and furans emitted from combustion sources are 
in both the gaseous and particulate phase, and the persistence of these 
substances may be a function of the phase into which they are emitted. The 
potency of dioxins and dibenzofurans is dependent on the chemical structure 
of the individual compound. Therefore, dibenzodioxin chlorinated in the 2, 3, 
7, and 8 positions has been demonstrated to be carcinogen, but other 
chlorinated dibenzodioxins, polychlorinated dibenzofurans and non-
chlorinated dibenzodioxins and dibenzofurans were evaluated as not 
classifiable as to their carcinogenicity to humans (McGregor et al., 1998) and 
the carcinogenic properties of these compounds remain unclear to the 
moment. 
Dibenzofuran (DBF) is a white crystal-like solid that is created from the 
production of coal tar, used as an insecticide and to make other chemicals. It 
has been found in coke dust, grate ash, fly ash, and flame soot. One can be 
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exposed to DBF by breathing contaminated air or by eating or drinking 
contaminated food or water. Since it has been found in tobacco smoke, you 
can be exposed if you smoke cigarettes or breathe cigarette smoke. In 
addition, you can be exposed to Dibenzofuran if you work in an industry that 
makes or uses coal tar. Moreover, it can also be absorbed into your body 
when it comes into contact with your skin. 
 
 
 
Figure 1.1.3 – General structures of PCDDs (left) and PCDFs (right). 
The PCDDs and PCDFs are two series of almost planar tricyclic aromatic 
compounds with very similar chemical properties. The number of chlorine atoms can 
vary between 1 and 8. The number of positional congeners is quite large; in all there 
are 75 PCDDs and 135 PCDFs. 
 
Little information is available on the effects of DBF exposure to our 
health. However, the information that does exist shows that short-term 
exposure to DBF can cause skin, eye, nose, and throat irritation. 
Dibenzofurans, coplanar PCBs and other dioxin-like chemicals were shown to 
be anti-estrogenic in oviduct porcine epithelial cell line (Hombach-Klonisch et 
al., 2006), reported to act as endocrine disruptors (Aoki, 2001) and to prompt 
menstrual effects in DBF-poisoned women (Yang et al., 2011), and testified to 
cause reduced fertility and alterations in pregnancy in women exposed to 
PCB/PCDF-contaminated cooking oil (Yang et al., 2008). 
 
1.1.3. Molecular targets of exposure and toxicity 
 
Many toxic agents such as dioxins, dibenzofurans, benzo[a]pyrene 
(B[a]P), cigarette smoke toxicants, PCBs, and other related organochlorine 
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compounds have been proven to cause harmful effects. Several studies have 
demonstrated the association between air pollution and respiratory and 
cardiovascular diseases (Brunekreef and Forsberg, 2005), namely changes in 
blood homeostasis, alterations in heart rate and atherosclerosis (Sun et al., 
2010), asthma and COPD (Perez et al., 2010). These sort of chemicals can 
also regulate several immunological responses. Indeed, some authors have 
reported upregulation of the production of proinflammatory cytokines in airway 
epithelial cells due to cigarette smoke (Baginski et al., 2006). Cigarette smoke 
has also been proved a potent Th17 adjuvant and IL-17RA signaling is 
required for chemokine expression necessary for MMP12 induction and tissue 
emphysema in mice exposed to cigarette smoke (Chen et al., 2011). Studies 
with mice have also reported the inhibition of the antigen-presenting activity of 
alveolar macrophages and a decrease in interleukin-1beta mRNA expression, 
as well as a significant increase in DNA damage and ROS generation in 
alveolar macrophages (Ishida et al., 2009). Furthermore, some volatile 
organic compounds (VOCs) widely distributed in the environment were shown 
to markedly increase the expression level of cyclooxygenase-2 (COX-2), the 
rate-limiting enzyme of the prostaglandin pathway, in human lung cells (Mögel 
et al., 2011). Additionally, prostaglandin E2 (PGE2) and prostaglandin F2α 
(PGF2α), major products of the COX enzyme, were found to be upregulated in 
response to the same aromatic compounds, which exposure caused 
activation of p38 MAPK (Mögel et al., 2011). However, a complete 
understanding of inflammatory interactions is far from clear. 
Concerning air pollution, increased concentrations of particulate matter 
with an aerodynamic diameter of less than 10μg/m3 (PM10) have been linked 
to an acute increase in emergency room visits, hospital admissions, 
respiratory symptoms, mortality rate due to respiratory and cardiovascular 
disease and restricted activity days due to morbidity (Pelucchi et al., 2009). 
Regarding chemical toxicants, one of the most toxic dioxins, 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), induces the production of tumor 
necrotizing factor-α (TNF-α) in THP-1, a human promonocytic leukemia cell 
line (Cheon et al., 2007). TNF-α is known as a primary mediator of an acute 
inflammatory response, and its over-production plays a key role in many 
pathologic processes (Vassalli, 1992), including TCDD associated mortality, 
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hypersensitivity to endotoxin, an enhanced peritoneal inflammatory response, 
cachexia, and endometriosis (Clark et al., 1991). This compound has also 
been reported to increase the expression of transforming growth factor-α 
(TGF-α) mRNA in MCF-10A, a human mammary epithelial cell line (Davis et 
al., 2003). Furthermore, noxious agents such as TCDD mimic the epithelial 
growth factor receptor (EGFR) signaling pathway, leading to tyrosine kinase 
phosphorylation and its physical association with EGFR (Sewall et al., 1995). 
On the other hand, TCDD also blocks cell differentiation through EGFR 
signaling in human epidermal keratinocytes (Sutter et al., 2009). EGFR exists 
on the cell surface and is activated by binding of its specific ligands, including 
epidermal growth factor (EGF) and TGFα. Upon activation, EGFR undergoes 
a transition from an inactive monomeric form to an active homodimer (Yarden 
and Schlessinger, 1987), resulting in downstream activation and signaling 
transduction cascades, essentially the mitogen-activated protein kinase 
(MAPK), Akt (v-akt murine thymoma viral oncogene homolog; also known as 
PKB - protein kinase B) and c-Jun N-terminal kinase (JNK) pathways, leading 
to DNA synthesis and cell proliferation (Oda et al., 2005). Activation of EGFR 
is important for the innate immune response in human skin (Roupé et al., 
2010). Though, it has been shown that TCDD inhibited EGF withdrawal-
induced apoptosis in the human mammary epithelial cell line MCF-10A and 
that the ability of TCDD to overcome EGF withdrawal-induced apoptosis likely 
requires the induction of TGF-α (Davis et al., 2003), thus reporting the 
inhibition of apoptosis upon TCDD exposure as a potentially important 
mechanism of tumor promotion. 
Currently it is known that the biological effects of these dioxin-like 
compounds are mainly mediated through binding to the arylhydrocarbon 
receptor (AhR). The AhR is a ligand-activated transcription factor ubiquitously 
distributed in the body, and after ligation of aromatic compounds (such as 
dioxins and dibenzofurans) to the AhR, the receptor translocates from the 
cytosol to the nucleus, heterodimerizes with the AhR nuclear translocator 
(ARNT), and binds to an enhancer sequence, called a xenobiotic response 
element (XRE), of several drug metabolizing enzymes, such as cytochrome 
P450 1A1 (CYP1A1) (Mimura and Fujii-Kuriyama, 2003; Gendy et al., 2012). 
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The effects of toxicants exerted through AhR binding are often related 
to increased reactive oxygen species (ROS) production through downstream 
enzymes such as cytochrome P450 (Kopf and Walker, 2010; Chiba et al., 
2012). It is well established that superoxide anion and H2O2 are common by-
products of the P450 catalytic cycle, resulting from inefficient coupling of 
NADPH consumption to substrate oxidation (Zangar et al., 2004), and this 
may represent one potential mechanism by which ROS can be produced 
downstream of CYP1A1 induction (Kopf and Walker, 2010). CYP1A1 is a 
phase I xenobiotic metabolizing enzyme that bioactivates several polycyclic 
aromatic hydrocarbons (PAHs) and other hydrophobic environmental 
procarcinogens into their ultimate carcinogenic forms (Shimada and Fujii-
Kuriyama, 2004), reactive intermediates that form DNA adducts, which lead to 
mutagenesis and carcinogenesis. Several lines of evidence demonstrate a 
strong correlation between the activity of CYP1A1 and the increased risk of 
different human cancers such as colon, rectal and lung cancers (Slattery et 
al., 2004; Shah et al., 2009). Likewise, the inhibition of AhR activity and its 
regulated gene, CYP1A1, could result in the prevention of the toxic effects 
caused by the AhR ligands, including carcinogenicity (Puppala et al., 2008). In 
the lung, it has also been shown that Clara cells, in bronchiolar epithelium, are 
the most sensitive to AhR stimulation (Tritscher et al., 2000). Besides, 
significant progress in identifying other molecular targets for PAHs-induced 
toxicity has also occurred. Misregulation of AhR downstream pathways, such 
as conversion of arachidonic acid to prostanoids via cyclooxygenase-2 (COX-
2), and altered Wnt/β-catenin signaling downregulating transcription factor 
Sox9, and signaling by receptors for inflammatory cytokines, have been 
implicated in tissue-specific endpoints of dioxin toxicity (Yoshioka et al., 
2011), shedding some more light on molecular events associated with 
developmental defects and diseases linked to pollutants exposure. 
Furthermore, it has been reported that several pollutants induce the 
formation of DNA adducts in different tissues. The DNA damage and DNA 
adducts, when unrepaired, can then cause mutations in vital genes including 
tumor suppressors or oncogenes, dysregulation of which may lead to cancer 
initiation and progression (Halappanavar et al., 2011). Halappanavar and 
colleagues reported the formation of DNA adducts in the liver and lungs of 
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mice exposed to benzo[a]pyrene (B[a]P) by oral gavage (Halappanavar et al., 
2011); other authors have shown that cigarette smoke-associated chemicals 
induce DNA damage, namely DNA double strand breaks (DSBs), in a human 
pulmonary epithelial cell model (A549 cells) (Toyooka and Ibuki, 2009), which 
is related to genomic instability and carcinogenesis and therefore 
demonstrates the strong genotoxicity of passive smoking. More recently, it 
has been reported an increase in the frequency of mitochondrial DNA 
(mtDNA) somatic mutations in lung tissues of fruit growers which had been 
exposed to pesticides multiple times by inhalation (Wang and Zhao, 2012). 
The mitochondrial genome is particularly prone to DNA damage, because of 
the limited DNA repair capabilities, the lack of protective histone proteins and 
the tolerance of damaged DNA (Wang and Zhao, 2012). Moreover, 
mitochondria are known to be the major source of reactive oxygen in most 
mammalian cell types, as well as a major target organelle for oxidative 
damage (Chomyn and Attardi, 2003). Mitochondrial superoxide and H2O2 can 
cause direct damage to mitochondrial proteins, result in nuclear and 
mitochondrial genotoxicity (Shen et al., 2005), and initiate apoptosis (Polster 
and Fiskum, 2004). It has been reported that dioxin causes sustained 
oxidative stress and damage in liver mitochondria from mice exposed to 
TCDD and in hepatocytes incubated with the same pollutant (Senft et al., 
2002; Aly and Domènech, 2009); thus, mitochondria has also been reported 
as a direct target for dioxin-induced toxicity. 
 
1.2. Mitochondria: general view 
 
Mitochondria are cellular organelles delimited by two membranes that 
embrace about one tenth of the cell’s proteins. These organelles, on a weight 
basis proportion, are able to convert between 10 000 and 50 000 times more 
energy per second than the sun. 
Almost a century after the first descriptions of mitochondria, the 
acquirement of the ability to isolate them and the discovery that mitochondria 
contain a respiratory system and the enzymes of the tricarboxylic acid cycle 
and fatty acid oxidation marked the start of the bioenergetics era. This period 
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culminated with Peter Mitchell’s chemiosmotic theory, that deserved him the 
Nobel Prize for chemistry in 1978. 
The mitochondrion consists of four main structures or compartments: 
two membranes, the intermembrane space and the matrix within the inner 
membrane. The mitochondrial outer membrane (MOM) separates the cytosol 
from the intermembrane space. The MOM is responsible for interfacing with 
the cytosol and its interactions with cytoskeletal elements, which are important 
for the movement of mitochondria within a cell. This mobility is essential for 
the distribution of mitochondria during cell division and differentiation. The 
mitochondrial inner membrane (MIM) separates the intermembrane space 
from the matrix. The folding of the MIM (cristae) serves to increase the 
surface area of this membrane (Figure 1.2.1). Mitochondria also move along 
intermediate actin filaments, using kinesin and dynein proteins. 
The MIM hosts the most important redox reactions converting the 
energy of nutrients into ATP. These reactions are catalyzed by the 
mitochondrial electron transport chain (ETC), which transports electrons from 
several substrates to oxygen, in the complex multistep process termed 
mitochondrial respiration. According to the chemiosmotic theory, 
mitochondrial respiration generates a transmembrane potential (ΔΨm) across 
the inner membrane, which is used by ATP synthase to phosphorylate ADP. 
The MIM is normally impermeable to protons and other ions, and this 
solute barrier function of the MIM is critical for energy transduction. 
Permeabilization of the MIM dissipates ΔΨm and thereby uncouples the 
process of respiration from ATP synthase, halting mitochondrial ATP 
production (Kushnareva and Newmeyer, 2010). Hence, the free energy of 
respiration is used to pump protons from the matrix to the intermembrane 
space (IMS), establishing an electrochemical gradient. Since the MIM displays 
an extremely low passive permeability to protons, an electrochemical gradient 
(∆μH+) is built across the membrane. The electrochemical gradient is the sum 
of two components: the proton concentration difference and the electrical 
potential difference across the membrane. The estimated magnitude of the 
proton electrochemical gradient is about -220 mV (negative inside) and under 
physiological conditions most of the gradient is in the form of electrical 
potential difference. The proton gradient is converted in ATP, by the F1F0-
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ATP synthase. F1F0-ATP synthase couples the transport of the protons back 
to the matrix with the phosphorylation of ADP to ATP. 
 
 
 
Figure 1.2.1 – Mitochondrial morphology. 
Mitochondria are double membrane-bound organelles with characteristic inner 
membrane folds, termed cristae. 
Upper left: The schematic shows the structure of mitochondria. 
Bottom left: A transmission electron microscopy image of mitochondria in ultrathin 
sections of human fibroblast cells is also shown. 
Right: In many cell types, mitochondria appear as long, tubular and sometimes 
branched structures that spread throughout the entire cytoplasm. Mitochondria 
(green) were stained in human osteosarcoma cells (U2OS) by indirect 
immunofluorescence using antibodies against the outer membrane protein TOM20. 
Nuclei (blue) were stained with DAPI (4′,6-diamidino-2-phenylindole). Cells were 
analyzed by confocal microscopy. From Westermann, 2010. 
 
In addition to the process of ATP formation, mitochondria are highly 
dynamic organelles that have been implicated in the regulation of a great and 
increasing number of physiological processes. Mitochondrial function is a key 
to cell life and death, and the deregulation of mitochondrial metabolism is 
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critical to the pathogenesis of disease (Figure 1.2.2). Cells need energy not 
only to support their vital functions but also to die gracefully, through 
programmed cell death, or apoptosis (Kushnareva and Newmeyer, 2010). 
Execution of an apoptotic program includes energy-dependent steps, 
including kinase signaling, formation of the apoptosome, and effector caspase 
activation. Furthermore, mitochondrial regulation is also present beyond cell 
death mechanisms. Indeed, besides oxidative ATP production, mitochondria 
assume other functions such as heme synthesis, β-oxidation of free fatty 
acids, metabolism of certain amino acids, production of free radical species, 
formation and export of Fe/S clusters, iron metabolism, and play a crucial role 
in calcium homeostasis (Duchen, 2004b; Michel et al., 2012). In addition, 
firstly described as a key checkpoint of intrinsic programmed cell death, 
accumulating data point mitochondria as a central platform involved in many 
cellular pathways, such as those recently highlighted participating to innate 
immune response (West et al., 2011) or its lipidic contribution to 
autophagosomal membrane genesis during starvation-induced autophagy 
(Hailey et al., 2010). Still, the regulatory roles of mitochondria over normal 
physiology include the transduction pathway that underlies the secretion of 
insulin in response to glucose by β-cells and in the sensing of oxygen tension 
necessary for oxygen sensing in the carotid body and the pulmonary 
vasculature. Mitochondria also house key enzyme systems quite distinct from 
those required for intermediary metabolism - the rate-limiting enzymes in 
steroid biosynthesis, and even the carbonic anhydrase required for acid 
secretion in the stomach (Duchen, 2004a). By accumulating calcium when 
cytosolic calcium levels are high, mitochondria play subtle roles in 
coordinating the complexities of intracellular calcium-signaling pathways, at 
least in some cell types, in which their contribution may be extremely 
important in the finer aspects of cell regulation. The physiological “uncoupling” 
of mitochondria plays a central role as a heat-generating mechanism in non-
shivering thermogenesis in young mammals. It has also been suggested that 
the production of free radical species by mitochondria may play a key role as 
a signaling mechanism, for example, in the regulation of ion-channel activities 
and also in initiating cytoprotective mechanisms in stressed cells (Michel et 
al., 2012). 
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Figure 1.2.2 – Main features of mitochondrial metabolism relevant to the 
pathogenesis of disease. 
(1) Energy production by OXPHOS, (2) ROS generation as a toxic by-product of 
OXPHOS, and (3) regulation of apoptosis through activation of the mitochondrial 
permeability transition pore (mPTP). I, II, III, IV, and V = OXPHOS complexes I–V; 
ADP or ATP = adenosine di- or tri-phosphate; ANT = adenine nucleotide translocase, 
cyt c = cytochrome c; GPx = glutathione peroxidase-1; LDH = lactate 
dehydrogenase; MnSOD = manganese superoxide dismutase or SOD2; NADH = 
reduced nicotinamide adenine dinucleotide; TCA = tricarboxylic acid cycle; VDAC = 
voltage dependent anion channel. From Wallace, 2005. 
 
1.2.1. Respiratory chain, OXPHOS and energy 
production 
 
Oxidative phosphorylation (OXPHOS) produces more than 95% of a 
cell's energy in the form of ATP under normal physiological conditions. This 
process involves five different protein complexes, Complex I-V, localized in 
the mitochondrial inner membrane. 
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The respiratory chain or electron transport chain (ETC; Complexes I–
IV) in the MIM is associated with electron transfer components – coenzyme Q 
and cytochrome c (Figure 1.2.3). In the matrix, pyruvate oxidation, β-oxidation 
of fatty acids, and the TCA cycle pathways are associated. 
The five protein complexes constituting the OXPHOS system are: 
Complex I: NADH dehydrogenase-ubiquinone oxidase, Complex II: succinate 
dehydrogenase-ubiquinone oxidoreductase, Complex III: ubiquinone 
cytochrome c oxidoreductase, Complex IV: cytochrome c oxidase, Complex 
V: ATP synthase (Figure 1.2.3). Mobile components of the ETC are 
cytochrome c and coenzyme Q10. Coenzyme Q can occur in oxidized form 
(ubiquinone – Q), reduced form (ubiquinol – QH2) and radical form (Q.), 
called “Q-Cycle”. 
The total number of polypeptides involved directly in OXPHOS is 91 
when cytochrome c is included. Of these proteins, some are nuclear-encoded, 
and some are mitochondrial-encoded in the mtDNA. MtDNA in mammals 
consists of ~16,5 Kb circular double-stranded DNA that encodes for only 13 
subunits of the OXPHOS complexes, plus 2 rRNAs (12S rRNA and 16S 
rRNA), and 22 tRNAs (Attardi and Schatz, 1988). The mitochondrial genome 
encodes for essential proteins for the complex I, III, IV and V of the ETC, but 
curiously complex II subunits are all encoded by the nuclear genome. 
Because of its limited coding capacity mtDNA relies on nuclear genes for 
structural components and biological functions. Besides, nuclear-encoded 
genes also regulate mitochondrial transcription, translation, and mtDNA 
replication, thus the precise cooperation of nuclear and mtDNA expression is 
essential to regulate OXPHOS capacity in response to different physiological 
demands and disease states (Scarpulla, 2008; Peralta et al., 2011). 
Dysregulated mtDNA expression has been associated with human 
mitochondrial diseases (Shoubridge, 2001; Smeitink et al., 2006) and is also 
observed in normal aging process (Krishnan et al., 2007; Larsson, 2010). 
Moreover, there are also additional proteins required for efficient OXPHOS 
including those for stability, replication and transcription of mtDNA and 
multiple proteins acting in assembly of each of the complexes. In all, close to 
300 proteins are needed for efficient OXPHOS activity. The overall process of 
oxidative phosphorylation is tightly controlled by transcriptional regulation at 
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Figure 1.2.3 - Schematic representation of mitochondrial 
compartmentalization. Mitochondria are divided in four compartments: the outer 
mitochondrial membrane (OMM or MOM), the intermembrane space (IMS), the inner 
mitochondrial membrane (IMM or MIM), and the matrix. The respiratory chain is 
localized at the IMM whereas the mitochondrial DNA (mtDNA) is located in the 
matrix. The citric acid cycle (or Krebs cycle or TCA cycle) takes place within the 
mitochondrial matrix. Asterisk indicates mitochondrial cristae. The respiratory chain, 
also known as the electron transport chain (ETC) or oxidative phosphorylation 
system (OXPHOS), is composed of approximately 100 proteins, 13 of which are 
encoded by the mtDNA. The remaining components are encoded by the nuclear 
DNA and imported into the mitochondria. It consists of five protein complexes; 
complex I (NADH dehydrogenase) and complex II (succinate dehydrogenase) 
receive electrons (e-) from intermediary metabolism, which are then transferred to 
coenzyme Q and subsequently delivered to complex III (cytochrome c reductase). 
The electron shuttling protein cytochrome c then transfers the electrons to complex 
IV (cytochrome c oxidase), which constitutes the final step in the ETC in which 
molecular oxygen is reduced to water. The electron transport is coupled to proton 
(H+) pumping across the IMM by complexes I, III, and IV. The resulting proton 
gradient drives ATP synthesis through complex V (ATP synthase). Reactive oxygen 
species (ROS), in the form of superoxide, can be generated by the exit of electrons 
at the level of complex I and III. C, cytochrome c; Q, coenzyme Q. From Perier and 
Vila, 2012. 
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the level of DNA, translational effects via RNA levels and stability, by 
substrate feedback inhibition, and by post-translational modifications including 
phosphorylation and acetylation. 
The first four complexes of the ETC receive electrons from the 
catabolism of carbohydrates, fats, and proteins and generate a proton 
gradient across the inner mitochondrial membrane. Electrons enter the chain 
through oxidation of either NADH at Complex I or FADH2 at Complex II and 
then flow to Complex IV to reduce O2 to H2O. Complex I and Complex II 
collect these electrons, transfer them to coenzyme Q10, Complex III and 
Complex IV. Complex I, III and IV utilize the energy in electron transfer to 
pump protons across the inner mitochondrial membrane, producing a proton 
gradient, which is used by Complex V for ATP production from ADP and 
inorganic phosphate (Figure 1.2.4). The produced ATP is translocated from 
the mitochondria into the cytoplasm by adenine nucleotide translocase (ANT). 
The inner and outer mitochondrial membranes have numerous contact sites. 
Both of them contain a large assortment of integral and peripheral proteins as 
well as numerous phospholipids. 
Inefficient electron transfer through complexes I-IV causes human 
disease in part because of loss of energy metabolism but also because insults 
to the various enzymes (particularly Complexes I, II and III) induce production 
of toxic reactive oxygen species. Defects of complex V are also a cause of 
mitochondrial dysfunction (Schapira, 2006; Wu et al., 2010; Abramov et al., 
2011). It has also been reported that the deterioration of mitochondrial 
function underlies common metabolic-related diseases (Rolo and Palmeira, 
2006; Palmeira et al., 2007; Turner and Heilbronn, 2008), and several studies 
have identified compromised oxidative metabolism, altered mitochondrial 
structure and dynamics, and impaired biogenesis and gene expression in 
insulin resistance or type 2 diabetes (T2DM) models (Cheng et al., 2010; Rolo 
et al., 2011; Gomes et al., 2012). 
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Figure 1.2.4 - Mitochondrial energy production in the ETC. 
Electron transport between complexes I to IV is coupled to extrusion of protons from 
complexes I, III and IV into the intermembrane space, creating an electrochemical 
gradient across the inner mitochondrial membrane (Δψm). Protons then flow through 
complex V (ATP synthase), which utilizes the energy to produce ATP from ADP. 
Some common mitochondrial respiratory chain inhibitors are shown. C, cytochrome 
c; Q, ubiquinone. From Bayir and Kagan, 2008. 
 
1.2.2. Generation of reactive oxygen species 
 
Oxidative stress is among the major causes of toxicity due to 
interaction of ROS with cellular macromolecules and structures and 
interference with signal transduction pathways (Lenaz, 2012). ROS are 
thought to be byproducts of aerobic respiration with damaging effects on 
DNA, protein, and lipid. The mitochondrial respiratory chain, specially from 
Complexes I and III, is considered the main origin of ROS (Figure 1.2.5), 
particularly under conditions of high membrane potential, but several other 
sources may be important for ROS generation, such as mitochondrial 66-
kilodalton isoform of the growth factor adapter Shc (p66Shc), monoamine 
oxidase, α-ketoglutarate dehydrogenase, enzymatic activation of cytochrome 
p450, and NADPH oxidases, further suggesting involvement in a complex 
array of cellular processes (Bae et al., 2011; Lenaz, 2012). A growing body of 
evidence indicates that ROS are involved in the maintenance of redox 
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homeostasis and various cellular signaling pathways (Bae et al., 2011), as 
depicted in Figure 1.2.6. 
Oxidative stress is at the basis of ageing and many pathological 
disorders, such as ischemic diseases, neurodegenerative diseases, diabetes, 
and cancer, although the underlying mechanisms are not always completely 
understood (Lenaz, 2012). Concerning environmental pollutants, it is 
recognized that the production of toxic ROS is one of the major effects 
responsible for a variety of toxicity phenotypes caused by environmental 
pollutants, leading to adverse health effects and diseases (Valavanidis et al., 
2006; Yoshioka et al., 2011). 
 
 
 
Figure 1.2.5 - Mitochondrial oxidative stress. 
In the mitochondria, superoxide can be produced by respiratory complexes. Complex 
I in the brain and complex III in the heart and lung seem to be the primary sources of 
mitochondrial superoxide production. Superoxide is detoxified by manganese 
superoxide dismutase (MnSOD) to hydrogen peroxide (H2O2) in the mitochondria. 
Glutathione peroxidases (GPxs) convert hydrogen peroxide to water. Nitric oxide 
(NO) generated from (mitochondrial) nitric oxide synthase (mt)NOS can compete 
with MnSOD and form peroxynitrite (ONOO-). Peroxynitrite in turn initiates thiol 
oxidation or nitrosylation and tyrosine nitration. C, cytochrome c; O2-, superoxide; Q, 
ubiquinone. From Bayir and Kagan, 2008. 
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Almost all O2 consumed in mitochondria is reduced to water at 
Complex IV. Nevertheless, reactive oxygen species (ROS) are produced as 
an inevitable byproduct of respiration in mitochondria, and also but in lesser 
amounts at other sites in a cell. The major reactive oxygen species (ROS) are 
the superoxide radical (O2·−), hydrogen peroxide (H2O2), and the hydroxyl 
radical (OH·). When protonated, the superoxide radical becomes a 
hydroperoxyl radical. In fact, the only very reactive species among them is the 
hydroxyl radical, which is believed to be responsible for most of the actual 
damage done to biological macromolecules. The risk posed by the other two 
species comes primarily from their spread and subsequent reactions, which 
ultimately lead to the formation of the hydroxyl radical. 
Oxygen is a true substrate of complex IV of the mitochondrial electron 
transport chain, and it may be assumed that is the site in a cell where oxygen 
can be activated to the superoxide radical. Instead, it is widely accepted that 
electrons “leaking” from the electron transport chain to oxygen at high 
potential upstream sites are responsible for the majority of ROS produced in 
mitochondria. Thus, complexes I and III, and more recently complex II, have 
been implicated in the generation of ROS. The proposed mechanism has 
mutated over the years. In consideration of the small size and zero charge of 
the oxygen molecule, it can potentially penetrate deeply into protein domains 
of these complexes. The leaking electrons may come from the free radical 
semiquinone intermediate of ubiquinone (coenzyme Q) and the free radical 
intermediates formed by the flavin moieties in complex I (and II). Alternatively, 
it has been proposed that electrons may escape from the reduced [Fe–S] 
center N2. It is quite likely that a semiquinone intermediate of the Q cycle is 
the source of electrons in ROS production by complex III. Recent experiments 
and arguments in favor of complex I as a major source of ROS tend to favor 
the flavin intermediate as the donor. 
The superoxide radical is also generated “accidentally” by reactions of 
oxygen at microsomal cytochromes P450, as well as by less well defined or 
understood reactions (auto-oxidation reactions) involving catecholamines, 
ascorbic acid, and reduced flavins, often with the participation of a metal ion. 
The toxicity of such compounds has been exploited in some physiologically 
useful reactions. The best-known example is the generation of superoxide,  
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Figure 1.2.6 - Overview of mitochondrial ROS production. 
ROS production by mitochondria can lead to oxidative damage to mitochondrial 
proteins, membranes and DNA, impairing the ability of mitochondria to synthesize 
ATP and to carry out their wide range of metabolic functions. Mitochondrial oxidative 
damage can also increase the tendency of mitochondria to release intermembrane 
space proteins such as cytochrome c (cyt c) to the cytosol by mitochondrial outer 
membrane permeabilization (MOMP) and thereby activate the cell’s apoptotic 
machinery. In addition, mitochondrial ROS production leads to induction of the 
mitochondrial permeability transition pore (PTP), which renders the inner membrane 
permeable to small molecules in situations such as ischaemia/reperfusion injury. 
Consequently, it is unsurprising that mitochondrial oxidative damage contributes to a 
wide range of pathologies. In addition, mitochondrial ROS may act as a modulatable 
redox signal, reversibly affecting the activity of a range of functions in the 
mitochondria, cytosol and nucleus. From Murphy, 2009. 
 
Chapter 1 – General Introduction 

radicals, hydrogen peroxide, and HOCl by activated macrophages, 
presumably to kill their target cells (bacteria, fungi, etc.) before phagocytosis. 
Several peroxisomal oxidases generate hydrogen peroxide — for example, d-
amino acid oxidase, xanthine oxidase, and the dehydrogenase in the first step 
of very long chain fatty acid oxidation. In some systems the superoxide radical 
has been proposed as an intercellular signal. In a more indirect way, the O2·− 
ion can remove nitric oxide, another free radical, and an intercellular 
messenger in neurotransmission, in the immune response, and in the 
regulation of smooth muscle contraction. 
ROS are able to oxidatively modify lipids, proteins, carbohydrates and 
nucleic acids in mitochondria and to activate/inactivate signaling pathways by 
oxidative modification of redox-active factors. Cells are endowed with several 
defense mechanisms including repair or removal of damaged molecules, and 
antioxidant systems, either enzymatic or non-enzymatic (Lenaz, 2012). 
Reactive oxygen species have also been assigned a central role in the 
mechanisms of apoptosis, still with some uncertainties about whether they are 
responsible for signaling and cell killing or whether their increased generation 
is the consequence of another damaging event affecting mitochondria. 
 
1.2.3. Mitochondrial permeability transition (MPT) 
 
The mitochondrial permeability transition (MPT) was originally defined 
as sudden increase in the inner membrane permeability to solutes of 
molecular mass less than 1500 Da. An increase in mitochondrial membrane 
permeability is one of the key events in apoptotic and necrotic death, although 
the details of the mechanisms involved remain to be fully elucidated. Unlike 
the resting potentials of neurons and cardiomyocytes, which are largely 
governed by basal K+ conductance of their plasma membranes, the value of 
the mitochondrial resting potential is controlled by the very high resistance of 
the inner membrane, i.e., low permeability to all ions. While the inner 
membrane contains several channels (Figure 1.2.7), their opening is tightly 
regulated in order to prevent dissipation of the membrane potential and proton 
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gradient that is the electrochemical energy reservoir for ATP-synthesis and 
transport (Kinnally et al., 2011). 
 
 
 
Figure 1.2.7 - Mitochondrial ion channels in apoptosis and necrosis. 
Left, apoptotic stimuli induce relocation of Bax from the cytosol into the mitochondrial 
outer membrane (MOM). Bax, Bak, and possibly other unidentified protein(s) 
oligomerize and form mitochondrial apoptosis-induced channels (MAC) to release 
cytochrome c. VDAC oligomerization upon apoptotic stimuli was also reported to be 
involved in cytochrome c release. Right, necrotic stimuli lead to exacerbated calcium 
uptake and reactive oxygen species (ROS) generation by mitochondria. High levels 
of calcium and ROS induce a cyclophilin-D (CypD)-sensitive opening of mPTP that 
leads to swelling of the matrix and release of calcium. Swelling disrupts the outer 
membrane, while released calcium activates proteases, phosphatases, and 
nucleases that lead to necrotic degradation. TIM23/22, translocases of the inner 
membrane; mRyR, mitochondrial ryanodine receptor; TOM, translocase of the outer 
membrane; MCU, mitochondrial calcium uniporter; MIM, mitochondrial inner 
membrane. From Kinnally et al., 2011. 
 
The mitochondrial permeability is now believed to be due to the 
opening of a voltage- and Ca2+-dependent, cyclosporine A (CsA)-sensitive, 
high-conductance channel, which is referred to as the mitochondrial 
permeability transition pore (mPTP) (Bernardi et al., 1992; Bernardi, 1992; Di 
Lisa and Bernardi, 2009). The mPTP is the most notorious of all the inner 
membrane channels; it has not only been linked to a rupture of mitochondrial 
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outer membrane during cell death (Figure 1.2.7) but also to a myriad of 
pathologies, including neurodegenerative disorders such as Alzheimer’s 
disease and multiple sclerosis (Singh et al., 2009; Su et al., 2009; Kinnally et 
al., 2011) and ischemia/reperfusion injury (Halestrap and Pasdois, 2009; 
Varela et al., 2010; Pasdois et al., 2011). mPTP is considered to be a channel 
with a large conductance that is activated by Ca2+ overloading and other 
factors including oxidative stress (Zoratti and Szabò, 1995; Bernardi, 1999; 
Chinopoulos and Adam-Vizi, 2012) and to be regulated by the 
transmembrane voltage (Bernardi et al., 1992; Bernardi, 1992). 
A variety of potential functions are credited to mPTP, which may not be 
exclusive: (1) a voltage sensor, (2) a matrix pH sensor, (3) a divalent cation 
sensor (role in calcium homeostasis), (4) a sensor of adenine nucleotide 
concentrations, (5) a sensor of the redox state of the pyridine nucleotide pool, 
and (6) a thiol sensor (redox status of glutathione). However, it has received 
the most particular attention because pore opening has been implicated in the 
regulation of apoptosis and necrosis (Zorov et al., 2009; Rasola et al., 2010a; 
Rasola et al., 2010b). 
 
1.2.3.1. Molecular composition of the mitochondrial 
permeability transition pore (mPTP) 
 
Although the molecular identity of the mPTP remains unclear, several 
proteins have been implicated in either its structure or regulation. The original 
model for the pore based upon biochemical and pharmacological studies had 
three components: the voltage-dependent anion channel (VDAC) in the outer 
membrane, the adenine nucleotide translocase (ANT) in the inner membrane, 
plus cyclophilin D (CypD) in the matrix (Figure 1.2.8). 
Currently, this model is discussed and other proteins are suggested as 
mPTP components or regulators, such as mitochondrial creatine kinase (CK), 
cytosolic hexokinase (HK), the inner membrane phospholipid cardiolipin (CL), 
adenylate cyclase in the intermembrane space and the peripheral 
benzodiazepine receptor protein of the MIM. HK, VDAC and ANT all occur as 
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isoforms and it remains to be determined whether there is specificity of these 
different forms for the mPTP. 
 
Voltage-dependent anion channel (VDAC) 
VDAC, also known as mitochondrial porin, is the most abundant protein 
of the MOM and the major channel for the exchange of metabolites and ions 
between the mitochondria and other cellular compartments (Lee et al., 1996; 
Rostovtseva et al., 2002). The VDAC family of proteins consists of three 
isoforms from three separate genes (VDAC1, VDAC2, and VDAC3) 
(McCommis and Baines, 2012). 
As a consequence of its location at the boundary between 
mitochondria and cytosol, VDAC is also a binding partner for proteins that 
mediate and regulate the integration of mitochondrial functions with other 
cellular activities. Notably, VDAC has been reported to bind pro- and anti-
apoptotic proteins of the Bcl-2 family that regulate the permeability of the 
outer membrane (Azoulay-Zohar et al., 2004); it may interact with 
mitochondrial proteins that form contact sites between the inner and outer 
membranes (Brdiczka et al., 1998) and that may generate the mPTP complex 
(Crompton et al., 2002); and it binds to cytosolic proteins, such as hexokinase 
I and hexokinase II (Pedersen et al., 2002) which influences not only its 
metabolic function, but also its capacity to respond to Bcl-2 family proteins 
and its role in apoptosis (Pastorino and Hoek, 2003; Pastorino and Hoek, 
2008). 
Although VDAC has long been considered a key component of the 
mPTP, the evidence supporting its involvement is largely circumstantial. Initial 
support for a role for VDAC in MPT came from Crompton's laboratory, which 
demonstrated that a GST–CypD fusion protein was able to pull down VDAC 
along with the adenine nucleotide translocase (ANT), another putative mPTP 
component from mitochondrial lysates (Crompton et al., 1998). Additional 
supporting evidence for VDAC's involvement in MPT came from experiments 
using putative VDAC inhibitors and anti-VDAC antibodies. Monoclonal 
antibodies purported to block VDAC's channel activity were reported to 
prevent MPT in isolated mitochondria (Shimizu et al., 2001; Zheng et al., 
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2004). Yet the specificity of these antibodies for VDAC has been cast into 
doubt (Rostovtseva et al., 2005). 
Conversely, several studies have been made demonstrating that VDAC 
is not an essential component of the MPT. In this regard, an intact MPT 
response was reported in isolated mouse mitochondria and cells essentially 
deficient for all three VDAC isoforms, suggesting that VDACs are dispensable 
for MPT and are not an essential component of the mPTP (Baines et al., 
2007). Other group has also reported a maintained MPT response in 
VDAC1−/− (Krauskopf et al., 2006) and VDAC1/3−/− mitochondria (Chiara et 
al., 2008). Thus, in light of both the nonspecific VDAC “blocking” agents used 
in previous studies and the more recent findings of maintained MPT 
responses in VDAC-deficient null mitochondria, we must conclude that VDAC 
is not an essential component of the mPTP. We found that mitochondria and 
cells lacking VDAC have an exacerbated MPT and death response (Baines et 
al., 2007), suggesting that, if anything, VDAC appears to protect against 
rather than contribute to MPT (McCommis and Baines, 2012). 
 
Adenine nucleotide translocase (ANT) 
ANT is a reversible transporter of ATP and ADP. During oxidative 
phosphorylation (OXPHOS) the protein exchanges ATP out for ADP in; 
however, in the absence of OXPHOS ANT works in reverse to maintain 
mitochondrial membrane potential. Patients with heart-related diseases have 
been shown to harbor mutations in the ANT gene or to develop an 
autoimmune reaction against the protein. The ANT is the most abundant 
protein in mitochondria. The ANT family mediates the exchange of ATP and 
ADP across the inner mitochondrial membrane. There are three isoforms of 
ANT: ANT1, ANT2 and ANT3, being ANT1 the most abundant protein in the 
MIM. 
A former general agreement indicated that the ANT was a participant in 
channel formation, perhaps by forming complexes with outer membrane 
proteins to create contact sites and hence to stabilize and/or enlarge the 
channel. Some evidences suggest that ANT1 or ANT3 is a component of the 
mPTP. ANT functions as a pore between two extreme conformations, in which 
the binding sites of the substrate are on cytosolic side of the inner membrane 
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- c conformation - or on the matrix side - m conformation. The conformation c 
is likely to change with the binding of Ca2+, thus inducing MPT; while this does 
not apply for the conformation m of ANT. 
Classically, the ANT was suggested to be the membrane component of 
the MPT and to exert its pore-forming function by interacting with VDAC at 
mitochondrial contact sites, a scheme originally proposed by the group of 
Halestrap (Halestrap and Davidson, 1990). However, this model has come 
under doubt as a result of studies demonstrating that cyclosporin-sensitive 
mPTP formation could occur in the absence of ANT (Bauer et al., 1999). The 
ANT has been ruled out as an assembling component of the pore (Kokoszka 
et al., 2004); using mice in which ANT is not expressed, it has been shown 
that it does not significantly alter MPT, thus raising doubts about ANT's 
identity and if it is a necessary component of the mPTP. However, the same 
group has demonstrated that even though ANT1 might not be a component of 
the mPTP per se, it can control susceptibility to MPT induction. Nevertheless, 
the ANT2 isoform has been shown to be expressed in cancer cells that 
display enhanced glycolysis and in such cells a large proportion of hexokinase 
II is bound to the mitochondria (Chevrollier et al., 2005). A hypothesis that 
could account for these effects proposes that CypD stabilizes the interaction 
between ANT and the oligomeric form of VDAC that is enhanced by 
hexokinase II binding (Pastorino and Hoek, 2008). 
Attention to ANT and its implication in MPT has been renewed due to 
recent and unrelated findings: i) the polyclonal antibody used to identify a 
protein that binds CypD was originally deemed as ANT1, but in fact was the 
phosphate carrier (Leung et al., 2008; Leung and Halestrap, 2008), and ii) the 
ANT of the embryos of a crustacean in which mitochondrial mPTP is absent, 
is refractory to bongkrekic acid (Konràd et al., 2011), a well-established ANT 
inhibitor, also known to suppress PTP (Klingenberg, 2008). Regardless of the 
fact that liver mitochondria isolated from mice lacking ANT1 and ANT2 
isoforms still exhibited the mPTP (Kokoszka et al., 2004), evidence that the 
ANT may be regulating mPTP opening through interactions with the 
phosphate carrier and perhaps the F0–F1-ATP synthase, are likely to emerge 
(Chinopoulos and Adam-Vizi, 2012). 
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Cyclophilin D (CypD) 
Cyclophilins are a family of proteins that catalyze the cis/trans 
isomerization of peptidic bonds. CypD is a water-soluble protein (18kDa) that 
is ubiquitously located predominantly in the mitochondrial matrix. Its 
association facilitates a conformational change in the ANT, probably 
promoting MPT. Indeed, CypD is a known activator of the mPTP as its 
inhibition by CsA leads to closure of the pore (Broekemeier and Pfeiffer, 1989; 
Broekemeier et al., 1992). Therefore, it is classically assumed that 
suppression of the ANT-CypD interaction may contribute to the elevation of 
the threshold for MPT induction. 
Nevertheless, CypD has already been shown dispensable for mPTP 
assembly (Baines et al., 2005; Nakagawa et al., 2005; Schinzel et al., 2005; 
Basso et al., 2005), but is involved in open/closed mPTP probability (Giorgio 
et al., 2010; Azzolin et al., 2010; Doczi et al., 2011). CypD is a member of the 
cyclophilins family encoded by the ppif gene (Wang and Heitman, 2005), that 
exhibit peptidyl-prolyl cis/trans isomerase activity. Inhibition of cypD by 
cyclosporin A (CsA), or genetic ablation of the ppif gene (Baines et al., 2005; 
Nakagawa et al., 2005; Schinzel et al., 2005; Basso et al., 2005; Basso et al., 
2008) negatively affect mPTP opening probability. However, it is not clear if 
the cis/trans peptidyl prolyl isomerase activity is a prerequisite for promoting 
MPT (Lin and Lechleiter, 2002). Furthermore, CypD knockout mice do not 
exhibit a severe phenotype; instead, these mice exhibit enhanced anxiety, 
facilitation of avoidance behavior, occurrence of adult-onset obesity (Luvisetto 
et al., 2008) and a defect in platelet activation and thrombosis (Jobe et al., 
2008). These mice also exhibit limited metabolic flexibilities in the heart, due 
to alterations in mPTP-mediated Ca2+ efflux mechanisms during 
cardiovascular stress (Elrod et al., 2010).  
Cyclophilin-D-depleted mitochondria still undergo a calcium-induced 
permeability transition, but this phenomenon requires higher calcium 
concentrations and is insensitive to CsA (Basso et al., 2005). These 
observations reinforce the notion that CypD is an important regulator of the 
mPTP but also refute the notion that this protein might be a structural 
component of the pore (Kinnally et al., 2011). 
Yet it was recently postulated that CypD favors the open conformation 
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of mPTP by masking a specific site for inorganic phosphate (Pi); the 
occupancy of this site by Pi leads to a desensitization of the mPTP to calcium 
(Basso et al., 2008). In the absence of CypD, the mPTP still forms and opens 
in response to some challenges, but is not responsive to Ca2+ or inhibition by 
CsA. Additionally, the effects of knockout of CypD established that opening of 
the mPTP was essential for mitochondrial injury in necrotic cell death but 
dispensable for mitochondrial mediation of apoptosis (Pastorino and Hoek, 
2008). 
 
 
 
Figure 1.2.8 – Molecular models for the mitochondrial permeability transition 
pore (mPTP). 
Left, The original model for the mPTP, consisting of the voltage-dependent anion 
channel (VDAC) in the mitochondrial outer membrane (MOM), the adenine 
nucleotide translocase (ANT) in the mitochondrial inner membrane (MIM), and 
cyclophilin-D (CypD) in the matrix. Right, Revised models in light of recent findings in 
gene-targeted mice. VDAC is no longer part of the model and it appears that an outer 
membrane component may not even be necessary for this process. ANT now 
appears to be more of a regulatory protein, and only CypD remains as an established 
component. In contrast, the mitochondrial phosphate carrier (PiC) has been added to 
model as a potential candidate for the pore-forming unit of the MPT pore. From 
Baines, 2009. 
 
Mitochondrial phosphate carrier (PiC) 
More recently, the phosphate carrier was proposed to play a central 
role in the MIM pore of mPTP (Halestrap, 2009). 
Functional support was provided to the role of PiC as a MTP 
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component by demonstrating that agents able to inhibit mitochondrial Pi 
transport activity also blocked MPT in isolated mitochondria. It has also been 
shown that the mitochondrial phosphate transporter forms a complex with 
CypD. MPT-inducing agents enhance PiC–CypD interaction, whereas MPT-
blocking compounds reduce it. Halestrap’s group proposed a new MPT model 
consisting of PiC and ANT, of which Ca2+ sensitivity is regulated by CypD 
binding to PiC and by oxidant stress-induced dithiol cross-links within PiC and 
ANT molecules. 
While intriguing, the role of the PiC in the elusive mPTP awaits more 
conclusive molecular studies in which the effects of eliminating the various 
isoforms of this carrier on the mPTP characteristics are determined. 
 
1.2.3.2. Regulation of mPTP 
 
Studies from different groups have questioned the molecular identity of 
the mPTP. A number of genetic studies have excluded VDAC (Baines et al., 
2007) and ANT (Kokoszka et al., 2004) as essential structural components of 
the mPTP complex. As portrayed above, a new model of the mPTP consisting 
of phosphate carrier and ANT has been proposed where Ca2+ sensitivity of 
the pore is regulated by CypD binding to a phosphate carrier (Leung et al., 
2008) (Figure 1.2.9). Many studies have provided strong evidence that CypD 
plays a major regulatory role in mPTP formation (Basso et al., 2005; Baines et 
al., 2005; Nakagawa et al., 2005). Although cytoplasmic cyclophilins such as 
CypA are involved in cell signaling and protein folding as chaperones (Min et 
al., 2005), the role of mitochondrial CypD under normal conditions remains 
unclear. One of the functions of CypD may be formation of the mPTP with a 
low conductance to regulate the ion homeostasis in the mitochondrial matrix 
under physiological conditions. Mitochondria isolated from CypD knockout 
mice were desensitized to onset of the MPT, and required much higher 
concentrations of Ca2+ to induce pore opening compared to wild type animals, 
which is consistent with the role of CypD to regulate Ca2+-mPTP interactions. 
High matrix phosphate levels that compete for the nucleotide-binding site of 
ANT favor pore opening. The conformational state of the ANT is affected by 
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specific ligands of the exchanger such as carboxyatractyloside (CAT) and 
bongkrekic acid (BKA), that respectively decrease and increase matrix ADP 
binding affinity, thereby leading to the opening and closing of the mPTP. 
mPTP opening is inhibited by H+ and divalent cations (Mg2+, Mn2+, Sr2+) that 
antagonize Ca2+ binding to ANT (Bernardi et al., 1992). The conformational 
state and pore forming activity of mPTP compounds are also regulated by 
hexokinase (HK), the peripheral benzodiazepine receptor (PBR) and Bcl2 
proteins on the MOM where they bind to VDAC, and creatine kinase (CK) in 
the intermembrane space interacting with ANT (Azarashvili et al., 2010; 
Ricchelli et al., 2011; Javadov et al., 2011; Sileikytė et al., 2011; Bernardi and 
Stockum, 2012). 
 
 
 
Figure 1.2.9 – Working model for mPTP opening modulation. 
A scheme representing how the PiC, ANT and CypD may interact to form the mPTP 
and account for the effects of Ca2+, oxidative stress and ligands of the ANT on mPTP 
opening. From Halestrap, 2009. 
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1.2.3.3. Physiological role of mPTP 
 
It is clear that a prolonged opening of a number of pores, or the 
simultaneous opening of many pores, would deenergize and inactivate 
mitochondria rapidly, and it may be that such an event is associated with the 
irreversible breakdown of ΔΨm observed in the course of apoptosis (Figure 
1.2.10). However, at this time it is still a matter of much speculation as to 
whether the MPT makes a significant contribution to mitochondrial activities 
under physiological conditions and the precise metabolic role of mPTP 
formation is still being debated. It could be imagined as a safety valve under 
stressful conditions (Lemasters et al., 2009); for example the low-conductance 
state of the pore allows fine dissipation of mitochondrial membrane potential, 
preventing mitochondrial ROS generation that is due to mitochondrial 
hyperpolarization. However, the lack of specificity for any small-molecular-
weight solute prohibits any fine-tuning for specific ions or solutes. 
While there is no consensus on the physiological role of the MPT, a 
number of feasible suggestions have been made. Among these are that the 
MPT provides a way of clearing the mitochondrial matrix of damaged or 
unneeded molecules (Gunter and Pfeiffer, 1990), that the MPT provides an 
important pathway for inducing apoptosis in cells in which certain types of 
damage have occurred (Kroemer et al., 1997), and that the MPT provides a 
way of getting rid of damaged mitochondria (Lemasters et al., 2002). MPT is 
also likely to contribute to regulation of mitochondrial matrix volume pH and 
redox reactions (Di Lisa and Bernardi, 2009), and to provide a pathway for the 
rapid exchange of pyridine nucleotides (PN) across the MIM (Bernardi et al., 
1994). Through this pathway PN synthesized in the cytosol would be rapidly 
available for intramitochondrial steroidogenesis (Pfeiffer and Tchen, 1975), 
while the efflux of PN stored in the matrix would provide the necessary 
substrates to poly-ADP ribose polymerase for DNA repair (Di Lisa and Ziegler, 
2001). In addition, it might operate as a regulator of mitochondrial Ca2+; low 
conductive MPT-induced matrix swelling and increased mitochondrial Ca2+ 
can regulate ATP synthesis through the tricarboxylic acid cycle, electron 
transport chain and oxidative phosphorylation (Javadov et al., 2011). 
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Induction of MPT in response to pathological stresses can also be 
regulated with the signaling protein kinases PKA, PKC and GSK-3β which 
interact with VDAC (Baines et al., 2003; Javadov et al., 2009). Expression of 
the major components (ANT, VDAC, CypD) and regulatory proteins (HK, 
PBR, Bcl2, CK) of the mPTP complex are presumed to play, along with 
metabolic and signaling factors, a key role under continuous pathological 
conditions such as carcinogenesis. Furthermore, unlike cardiac I/R, induction 
of MPT can differ among various cancer diseases in a tissue/organ/cell-
specific manner (Javadov et al., 2011). 
Undoubtedly, in the cardiovascular field the major focus has been 
mPTP involvement in myocardial I/R injury, a topic that has been covered by 
numerous studies (Halestrap et al., 2004; Baines et al., 2005; Di Lisa and 
Bernardi, 2006; Murphy and Steenbergen, 2008). The mPTP is now generally 
considered as the common target of different pathways set in motion by 
insufficient oxygen availability. In particular, the intracellular milieu created by 
post-ischemic reperfusion appears optimal for mPTP opening, especially 
because of intracellular [Ca2+] elevation concomitant with accumulation of 
ROS (Halestrap et al., 2007; Di Lisa et al., 2007). These notions were 
established based upon direct evidence of mPTP opening in isolated cells and 
intact hearts (Griffiths and Halestrap, 1995; Petronilli et al., 1999; Di Lisa et 
al., 2001). In addition, pharmacological and genetic approaches were 
successfully exploited to demonstrate that mPTP inhibition results in 
cardioprotection (Hausenloy and Yellon, 2003; Piot et al., 2008; Di Lisa and 
Bernardi, 2009). Decreased susceptibility to mPTP opening appears to be 
also involved in endogenous mechanisms of cardioprotection, such as those 
elicited by ischemic pre- and post-conditioning (Hausenloy et al., 2004; 
Argaud et al., 2005; Meier et al., 2005). Of note, so far mPTP-dependent 
cardioprotection has been obtained exclusively by targeting CypD (Basso et 
al., 2005; Bernardi et al., 2006). Given that the modulatory power of CypD 
(and therefore of CsA) is limited; and that the mPTP can open in the presence 
of CsA (and in the absence of CypD), it is likely that further insights into the 
role of mPTP in myocardial I/R injury will be provided when direct inhibitors of 
the mPTP will become available. Yet, and most importantly, mPTP 
desensitization by CsA has been reported to afford cardioprotection in clinical 
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settings (Piot et al., 2008; Gomez et al., 2009). Not only do these reports 
highlight the relevance of mPTP as a therapeutic target; they also provide 
clinical demonstration of the cardioprotective efficacy of pharmacological 
interventions aimed at preventing mitochondrial dysfunction caused by I/R. 
 
 
 
Figure 1.2.10 – Scheme of mitochondrial alterations following mitochondrial 
membrane permeabilization (MMP). 
In response to the opening of the mPTP (green and red ellipses, corresponding to 
ANT and VDAC respectively in this model), swollen mitochondria exhibit an increase 
in volume, a more translucide matrix with less cristae and a permeabilized outer 
membrane. Cytochrome c and apoptosis-inducing factor (AIF) (blue circles and 
yellow squares), normally confined into the intermembrane space, are released 
trough ruptures in the outer membrane. The transmembrane inner potential (ΔΨm) is 
dissipated in response to the arrest of the function of the respiratory complexes, 
which contributes to an inhibition of ATP biosynthesis. Altogether, these alterations 
are lethal, irreversible and lead to cell death. From Martel et al., 2012. 
 
1.2.4. Calcium homeostasis 
 
Ca2+ has long been recognized as a fundamental second messenger 
involved in learning, memory, fertilization, proliferation, development, muscle 
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contraction and secretion. Its concentration in the cytosol varies dynamically 
under the tight control of coordinated homeostatic mechanisms and complex 
interactions among pumps, channels, exchangers and binding proteins, and 
relatively small and/or local changes in its concentration modulate a wide 
range of intracellular actions.  
The main driving force for Ca2+ accumulation across the inner 
mitochondrial membrane is the electrochemical gradient established and 
maintained by the respiratory chain. Indeed, respiring mitochondria maintain a 
membrane potential which constitutes a strong driving force for Ca2+ influx into 
the matrix. Applying the Nernst equation, thermodynamic equilibrium for Ca2+ 
(ΔμCa = 0) would be reached at Ca2+ concentrations 106 higher than in the 
cytoplasm. Conversely, experimental evidence demonstrates that, in resting 
conditions, [Ca2+]m is similar to [Ca2+]c, reinforcing the idea that mitochondria 
do not act as a Ca2+ store, and that Ca2+ distribution is modulated by kinetic 
rather than simply thermodynamic parameters. In other words, Ca2+ 
concentrations in the mitochondrial matrix are controlled by low affinity uptake 
pathways and by efflux mechanisms that re-extrude Ca2+, at the cost of a 
significant futile cycle across the inner membrane. Influx is mainly supported 
by a Ca2+ electrophoretic mechanism (“uniporter”) whereas the Na+– Ca2+ and 
Na+–H+ exchangers are responsible for Ca2+ efflux. While the activities of the 
exchangers tend to saturate when [Ca2+]m increases, the uniport is a channel 
and does not saturate. A direct consequence of this transport system is that, 
when [Ca2+]m increases above a certain threshold, mitochondria have to cope 
with the risk of Ca2+ overload. Avoiding mitochondrial Ca2+ overload is 
energetically demanding for the cell, which has evolved a number of transport 
mechanisms to rationalize the system and adapt it to varying conditions of 
energy expenditure (Figure 1.2.11). 
The mitochondrial Ca2+ uniporter (MCU) is a channel, which transports 
Ca2+, Sr2+, but not Mg2+ with different selectivity and very low affinity. Several 
modulators of the MCU have been identified, including ruthenium red, an 
allosteric inhibitor, and divalent cations that do not permeate through the 
channel, such as Mn2+, Ba2+ and lanthanides. Several estrogen receptors 
ligands have also been shown to modulate the activity of the uniporter. The 
molecular structure of this transporter remains elusive but various hypotheses 
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have been proposed over the years, starting in the 1970′s when purification 
was first attempted. A highly selective Ca2+ channel activity with kinetic and 
pharmacological characteristics of the mitochondrial uniporter has been 
identified and characterized from the electrophysiological point of view and 
recent studies have also showed an important role of UCP2 and UCP3 in 
mitochondrial Ca2+ uptake. 
 
 
 
Figure 1.2.11 – Mitochondrial physiology and mitochondrial Ca2+ handling. 
Ca2+ enters in the mitochondrial matrix via a low affinity uniporter (MCU) and through 
a high electronegative potential. Extrusion of Ca2+ takes two major routes, one driven 
by the Na+/Ca2+ exchanger, and another pathway which involves the H+-Ca2+ 
exchanger. In the matrix, Ca2+ stimulates the activity of three Ca2+-sensitive 
dehydrogenases of the Krebs cycle. VDAC: voltage-dependent anion channel, ANT: 
adenine nucleotide translocase, HK: hexokinase, CD: cyclophilin D, CK: creatine 
kinase, BR: benzodiazepine receptor, PTP: permeability transition pore. From Giorgi 
et al., 2012. 
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1.3. Mitochondria and cell death 
 
Mitochondria play a pivotal role in the process of cell death. It has been 
generally accepted that cells die by necrosis when ATP is not sufficient, or 
they die by the process of apoptosis when sufficient ATP is available. 
Apoptosis (programed cells death) is a process coordinated by a family of 
proteases – the caspases, which participate in the molecular control of 
apoptosis as triggers of cell death and as regulatory elements within this 
process. Excessive accumulation of Ca2+ leads to the formation of reactive 
oxygen species (ROS) and to opening of the mitochondrial permeability 
transition pore (mPTP), which depolarizes the mitochondria and leads to 
mitochondrial swelling. This may also provide a mechanism for the release of 
cytochrome c from the intermembrane space into the cytoplasm. Cytochrome 
c normally functions as a part of the respiratory chain, but when released into 
the cytosol it becomes a critical component of the apoptosis execution 
machinery, where it activates caspases and causes apoptotic cell death. 
Apoptosis may be triggered by extracellular signals (extrinsic pathway) or by 
intracellular processes (intrinsic pathway) (Figure 1.3.1). An increased 
mitochondrial formation of ROS triggers the intrinsic pathway by opening 
permeability transmission pores with increased permeability of the outer 
mitochondrial membrane. 
 
1.3.1. Mitochondria in apoptosis 
 
Two main features characterize mitochondrial involvement in 
apoptosis: the release of effector proteins from the IMS and the initiation of a 
programme of mitochondrial dysfunction, that includes loss of mitochondrial 
membrane potential (∆Ψm) (Bernardi et al., 2001). Underlying molecular 
mechanisms and a putative crosstalk between these two events are still under 
investigation. 
A reservoir of proteins involved in amplification of apoptosis localizes to 
the IMS of mitochondria. Among them, SMAC/ DIABLO and OMI/HTRA2 
enhance caspase activation through the neutralization of proteins that inhibit  
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Figure 1.3.1 – Mitochondrial-dependent apoptosis. 
Apoptosis can result from the activation of two distinct molecular cascades, known as 
the extrinsic (or death receptor) and the intrinsic (or mitochondrial) pathways. Both 
pathways, which can converge at the level of mitochondria, involve the activation of 
initiator caspases (caspase-8 and -9, respectively) that catalyze the proteolytic 
maturation of downstream executioner caspases, such as caspase-3, which are the 
final effectors of cell death. Mitochondrial outer membrane permeabilization (MOMP) 
represents the point-of-no-return in the mitochondrial apoptotic pathway. Following 
MOMP, mitochondrial apoptogenic factors such as cytochrome c, Smac/Diablo, 
endonuclease G, or apoptosis-inducing factor (AIF) are released to the cytosol. Once 
into the cytosol, these factors can initiate cell death in a caspase-dependent or a 
caspase-independent manner. MOMP is highly regulated by anti-apoptotic (e.g., Bcl-
2 and Bcl-xL) and pro-apoptotic (e.g., Bax and Bak) protein members of the Bcl-2 
family. AIF, apoptosis-inducing factor; Casp-9, caspase-9; CL, cardiolipin; OPA1, 
optic atrophy type 1; Cyt. c, cytochrome c; EndoG, endonuclease G; IAP, inhibitor of 
apoptosis; tBid, truncated Bid. From Perier and Vila, 2012. 
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caspases (Du et al., 2000; Verhagen et al., 2000); and Endonuclease G (Li et 
al., 2001; van Loo et al., 2001) and apoptosis-inducing factor (AIF) (Susin et 
al., 1999) have been proposed to play a role in caspase-independent cell 
death. A central player in caspase activation released by mitochondria upon 
an apoptotic stimulus is cytochrome c (Liu et al., 1996). The MOM was shown 
to be impermeable to cytochrome c (Wojtczak et al., 1972); thus, in order to 
release cytochrome c, the MOM must change its permeability properties. This 
process is named MOM permeabilization and could explain the egress of 
cytochrome c from mitochondria. Although the precise mechanism of this 
event is still a matter of debate, it appears clear that Bcl2 family proteins are 
critical regulators. In addition to MOM permeabilization, complete release of 
cytochrome c during apoptosis requires cristae remodeling (Scorrano, 2009). 
Once released, cytosolic cytochrome c in a complex together with 
APAF1, dATP and ADP forms the apoptosome, which recruits procaspase-9, 
facilitating its auto-activation. Caspase-9 activates downstream executioner 
caspases (Zou et al., 1997; Thornberry and Lazebnik, 1998) that cleave other 
intracellular substrates leading to the characteristic morphological changes in 
apoptosis such as chromatin condensation, nucleosomal DNA fragmentation, 
nuclear membrane breakdown, externalization of phosphatidylserine (PS) and 
formation of apoptotic bodies (Hengartner, 2000). 
 
1.4. Mitochondrial shape and dynamics 
 
Mitochondrial shape is very heterogeneous, ranging from small 
spheres to interconnected tubules (Bereiter-Hahn and Vöth, 1994). For 
example, the mitochondria of rat cardiac muscle and diaphragm skeletal 
muscle appear as isolated ellipses or tubules in embryonic stages but then 
reorganize into reticular networks in the adult (Bakeeva et al., 1978). The 
name of the organelle, “mitochondrion”, reflects their heterogeneous 
morphology, a combination of the Greek words for “thread” and “grain”. During 
cell life, mitochondria undergo continuous cycles of fusion and fission (Figure 
1.4.1). Therefore, mitochondria are now recognized as highly dynamic 
organelles that move throughout a cell and constantly fuse and divide (Chen 
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and Chan, 2010). Studies over the last several years indicate that these 
membrane remodeling processes promote homogenization of the 
mitochondrial population by content mixing and thereby preserve 
mitochondrial function (Detmer and Chan, 2007; Chen and Chan, 2009). 
Mitochondrial fusion is clearly an important physiological activity; mutations in 
fusion genes in humans cause neurodegenerative diseases, and mice with 
reduced mitochondrial fusion show severe defects in multiple cell types (Chen 
and Chan, 2009; Chen and Chan, 2010). 
 
 
 
Figure 1.4.1 – Mitochondrial dynamics. 
(A) Mitochondrial fusion and fission control mitochondrial number and size. Fission is 
mediated by dynamin-related protein 1 (Drp1) and mitochondrial fission-1 protein 
(Fis1). Mitofusins (Mnf) 1 and 2 are involved in the fusion of the MOM, whereas 
protein optic atrophy type 1 (OPA1) regulates the fusion of the MIM. (B) In neurons, 
mitochondria are recruited to subcellular compartments distant from the cell body, 
such axons and dendrites, by active transport along microtubules and actin filaments. 
Distinct molecular motors transport the mitochondria in anterograde or retrograde 
directions. From Perier and Vila, 2012. 
 
Real-time imaging reveals that individual mitochondrial tubules 
continually move back and forth along their long axes on radial tracks. 
Occasionally, two mitochondrial tubules encounter each other and fuse (Chen 
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et al., 2003). On the other hand, these tubules can also undergo fission 
events, giving rise to two or more mitochondrial units. It was reported, in 
pancreatic β-cells, that fusion and fission events are paired. Fusion triggers 
fission, but fission has no effect on the following fusion event (Twig et al., 
2008) 
In addition to complete fusion, a transient form of fusion was recently 
identified in which two mitochondria come into close apposition, exchange 
soluble IMS and matrix proteins, and separate, maintaining the original 
morphology. Transient fusion, called “kiss-and-run”, has been shown to 
support mitochondrial motility and metabolism; the phenomenon of transient 
fusion provides an efficient recharging mechanism by allowing rapid 
equilibration of the soluble IMS and matrix proteins and probably, smaller 
molecules including mRNA between the organelles. Since a short-term 
decrease in the ∆Ψm does not seem to prevent transient or complete fusion, 
these processes may provide a means to rescue the function of organelles 
that ran short in some components (Liu et al., 2009). 
Research on mitochondrial fusion and fission (collectively termed 
mitochondrial dynamics) gained much attention in recent years, as it is 
important for our understanding of many biological processes, including the 
maintenance of mitochondrial functions, apoptosis and ageing (Detmer and 
Chan, 2007; Westermann, 2010) (Figure 1.4.2). Being the mitochondria 
bordered by two membranes, any mechanism of fusion and fission must take 
into account that the coordinate fusion/ division of four lipid bilayers is 
required. Thus, mitochondrial fusion and fission are complicated processes 
that are controlled by a growing number of mitochondrial-shaping proteins. 
The core components of the fusion machinery in mammals are mitofusin 1 
and mitofusin 2 (MFN1 and MFN2), responsible for outer membrane fusion 
(Koshiba et al., 2004; Meeusen et al., 2004), and also optic atrophy protein 1 
(OPA1), involved in inner membrane fusion (Olichon et al., 2003; Landes et 
al., 2010). Regarding mitochondrial fission machinery, the core components 
are dynamin-related protein 1 (DRP1/DLP1), involved in outer membrane 
division (Smirnova et al., 1998; Westermann, 2010), and mitochondrial fission 
1 (Fis1), the outer membrane receptor for recruitment of DRP1 (James et al., 
2003; Zhang and Chan, 2007). Mutations in two of the mitochondria shaping  
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Figure 1.4.2 – Biological functions of mitochondrial dynamics. 
a - The mitochondrial life cycle starts with growth and division of pre-existing 
organelles (biogenesis) and ends with degradation of impaired or surplus organelles 
by mitophagy (turnover). In between, mitochondria undergo frequent cycles of fusion 
and fission that allow the cell to generate multiple heterogeneous mitochondria or 
interconnected mitochondrial networks, depending on the physiological conditions. 
b - Fusion and fission of mitochondria are important for many biological functions. 
Division is required for inheritance and partitioning of organelles during cell division, 
for the release of pro-apoptotic factors from the intermembrane space, for 
intracellular distribution by cytoskeleton-mediated transport and for turnover of 
damaged organelles by mitophagy. Fused mitochondrial networks are important for 
the dissipation of metabolic energy through transmission of membrane potential 
along mitochondrial filaments and for the complementation of mtDNA gene products 
in heteroplasmic cells to counteract decline of respiratory functions in ageing (X and 
Y depict alleles of different mitochondrial genes). Westermann, 2010. 
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proteins have been causally linked to familial neurodegenerative diseases. 
Whereas autosomal-dominant MFN2 mutations pathogenically underlie 
Charcot-Marie- Tooth Disease type 2A (CMT2A) (Züchner et al., 2004; 
Oettinghaus et al., 2011), a peripheral axonal neuropathy, OPA1 mutations 
lead to autosomal-dominant optic atrophy (ADOA) (Alexander et al., 2000; 
Delettre et al., 2000). In addition, the mitochondrial fission protein Drp1 can 
sporadically be affected by mutations in humans, as exemplified by the report 
of a lethal syndromic birth defect attributable to a heterozygous Drp1 mutation 
(Waterham et al., 2007). The dysregulation of mitochondrial dynamics (fusion 
and fission) has also been linked to other neurodegenerative conditions, 
including Alzheimer’s, Huntington’s and Parkinson’s disease, as well as 
ischemic brain damage (Westermann, 2010; Reddy et al., 2011; Oettinghaus 
et al., 2011). 
 
1.5. Autophagy 
 
Autophagy, deriving from the Greek meaning “self-eating”, was first 
described by Christian de Duve in 1963 as a lysosome-mediated degradation 
process for non-essential or damaged cellular constituents (de Duve, 1963; 
de Duve and Wattiaux, 1966). It was mainly based on ultrastructural changes 
observed in rat liver after injection with glucagon. Glucagon results in an 
increase in cAMP levels, and, consequently, activation of PKA, that triggers 
autophagy in liver cells by a mechanism that is not yet fully understood. 
Physiologically, autophagy serves to preserve the balance between 
organelle biogenesis, protein synthesis and their clearance. Autophagy is 
emerging as an important mediator of pathological responses and engages in 
cross-talk with ROS (reactive oxygen species) and RNS (reactive nitrogen 
species) in both cell signaling and protein damage (Lee et al., 2012). 
Autophagy, a catabolic process conserved from lower to higher 
eukaryotes, is essential for recycling energy sources when cells have to deal 
with demanding conditions, as nutrient depletion and hypoxia, or during 
development. Cells increase the level of autophagy in response to other 
Chapter 1 – General Introduction 

environmental stresses, such as toxicants exposure, oxidative stress, 
pathogen infection, radiation or anticancer drug treatment. Additionally, a 
basal, constitutive level of autophagy plays a key role in the quality control 
maintenance inside the cell, being essential for the degradation of superfluous 
or damaged/old organelles as well as long-lived proteins and protein 
aggregates. Impaired mitochondrial function, oxidative stress, accumulation of 
protein aggregates and autophagic stress are common in many pathologies, 
including neurodegenerative diseases (Shacka et al., 2008; Schapira and 
Gegg, 2011). 
Autophagy refers to any process of degradation of cytosolic 
components at the lysosome, embracing diverse pathways. Three autophagic 
pathways have been characterized based on the apparent differences 
observed in cargo delivery to the lysosome – macroautophagy, 
microautophagy and chaperone-mediated autophagy (CMA) (Figure 1.5.1). 
Summarily, during macroautophagy, a phagophore forms in the cytosol and 
expands into a double-membrane, engulfing cytosolic components, including 
proteins, lipid droplets, ribosomes and organelles and giving rise to the 
autophagosome. The external membrane of the autophagosome fuses with 
the lysosomal membrane, being the inner vesicle together with its cargo 
degraded. Resulting nutrients are recycled back to the cytosol, through 
membrane permeases. 
Microautophagy differs from macroautophagy since cytosolic 
components are directly sequestered by the lysosome through an invagination 
of the lysosomal membrane. Degradation of soluble proteins and entire 
organelles by microautophagy has been described in yeast, where a group of 
proteins involved in microautophagy have been identified, some of which are 
in common with macroautophagy. On the other hand, our understanding of 
microautophagy in mammalian cells is poor. 
CMA, a form of autophagy just described in mammals, mediates the 
translocation of soluble proteins from the cytosol to the lysosome, across a 
translocon-like complex in the lysosomal membrane. Proteins to be degraded 
by CMA are recognized by a chaperone of the HSP70 family in the cytosol. 
The complex chaperone-substrate binds to a receptor protein in the lysosomal 
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membrane, which moves the substrate into the translocation complex. Once 
in the lysosomal lumen, the substrates are rapidly degraded. 
 
 
 
 
Figure 1.5.1 – Different types of autophagy. 
Microautophagy refers to the sequestration of cytosolic components directly by 
lysosomes through invaginations in their limiting membrane. In the case of 
macroautophagy, the cargoes are sequestered within a unique double-membrane 
cytosolic vesicle, an autophagosome. Sequestration can be either nonspecific, 
involving the engulfment of bulk cytoplasm, or selective, targeting specific cargoes 
such as organelles or invasive microbes. Fusion of the autophagosome with a 
lysosome provides hydrolases. Lysis of the autophagosome inner membrane and 
breakdown of the contents occurs in the autolysosome, and the resulting 
macromolecules are released back into the cytosol through membrane permeases. 
CMA involves direct translocation of unfolded substrate proteins across the lysosome 
membrane through the action of a cytosolic and lysosomal chaperone hsc70, and the 
integral membrane receptor LAMP-2A (lysosome-associated membrane protein type 
2A). From Mizushima et al., 2008. 
 
Defining the stages of autophagy and its progress in a tissue or cell is 
important for understanding its function and regulation (Figure 1.5.2). 
Ultrastructural analysis by EM (electron microscopy) of autophagosomes at 
different stages of maturation has been the classic approach for confirming 
autophagic activities. EM can distinguish early autophagosomes or 
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phagopores, and amphisomes, from autolysosomes generated by fusion of 
amphisomes or autophagosomes fusing lysosomes (de Duve and Wattiaux, 
1966). 
 
 
 
Figure 1.5.2 – The autophagic pathway. 
The production of PtIns3P by the Beclin 1 complex is an early event in 
autophagosome formation that is necessary for the recruitment of certain Atg 
proteins to the phagophore or isolation membrane. Subsequently, the sequential 
recruitment of Atg12-Atg5 complex and Atg8-LC3 protein to the phagophore takes 
place. The cytosolic form of LC3, LC3-I, is covalently bound to 
phosphatidylethanolamine (PE), generating LC3-II, which binds to the 
autophagosomal membrane. The phagophore, a cup-shaped structure, encapsulates 
cytosolic proteins and organelles, forming a double-membraned structure termed 
autophagosome. At this point, most of the Atg proteins, except LC3-II, are recycled 
from the autophagosome membrane back to the cytosol. Then, the autophagosome 
can fuse with endosomal compartments, generating the amphisome. The 
sequestered material is finally degraded by fusion of the amphisome with the 
lysosomal compartment, forming the autolysosome. Fusion of autophagosomes and 
amphisomes with the lysosomal compartment depends on an active Rab7. From 
Fader and Colombo, 2009. 
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Measuring the long-lived protein degradation rate by pulse–chase methods is 
also a commonly used complementary approach (Klionsky et al., 2008). 
These two methods have helped to determine autophagic pathways and time 
lapses during autophagy. 
Another widely used tool for measuring autophagy is based on 
Atg8/LC3. Generation of the pre-autophagosomal structure requires the 
beclin-1–class III PI3K (phosphoinositide 3-kinase) complex, as well as 
generation and insertion of LC3 (light chain 3)-II into the autophagosomal 
membrane (Chen and Klionsky, 2011). Atg8/LC3 is a ubiquitin-like protein and 
it undergoes post-translational modifications when LC3-I becomes LC3-II 
(Kabeya et al., 2004; Tanida et al., 2004); this allows to discriminate the 
proteins by their difference in mobility on gel electrophoresis. LC3-II insertion 
into the autophagosomal membrane is a consistent key step in 
autophagosomal formation, and its level reflects the relative amount of 
autophagosomes in the cell. LC3-II protein can also be visualized by 
immunocytochemistry as vesicular puncta when associated with 
autophagosomes (Tanida et al., 2008). 
 
1.5.1. Physiological functions of autophagy / Autophagy 
and disease 
 
Autophagy is crucial for cell life. Indeed, autophagy is essential to 
maintain tissue homeostasis, due to its role in defending against metabolic 
stress, like, for instances, growth factor depletion, nutrient deprivation, 
hypoxia, ER stress and microbial infections. 
In mammals, autophagy is indispensable for development and 
differentiation, at least at three different steps – pre-implantation development, 
survival to neonatal starvation and differentiation of erythrocytes, lymphocytes 
and adipocytes. Indeed, mouse models knockout for core Atg genes revealed 
embryonic or perinatal lethality. 
A defect in autophagy can be retrieved in diverse pathological 
conditions (Figure 1.5.3). In particular, impairment of the autophagic activity 
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has been reported in neurodegenerative diseases, like Parkinson’s disease, 
Huntington’s disease and Alzheimer’s disease. Decreased autophagic activity 
results in accumulation of aggregates formed by the mutated toxic proteins, a 
key feature of these diseases. Indeed, activation of autophagy was proven to 
be beneficial in animal models of Huntington’s disease. In addition, defective 
activation of the autophagic programme has been recently reported to be 
pathogenic also in congenital muscular dystrophies linked to collagen VI 
deficiency. Again, forced activation of autophagy improved the dystrophic 
phenotype. 
In addition, autophagy plays an important role in innate and adaptive 
immunity, probably having a major role in degradation of pathogens, for 
subsequent antigen presentation. 
 
Autophagy and differentiation 
Autophagy may help the cell to rapidly and efficiently change its 
cytosolic composition, accelerating routine protein and organelle turnover and 
modifying the cell’s appearance in terms of exposed receptors, transcriptional 
factors present in the nucleus, and cytoskeletal dynamics. Likewise, 
autophagy can significantly influence cell-autonomous and/or regulated 
differentiation (Cecconi and Levine, 2008). 
In the case of becn1-/- mutant embryos, visceral endoderm 
development occurs, although cells seem to have an abnormal morphology 
and development is blocked after visceral endoderm formation (Yue et al., 
2003). In specific stage of embryogenesis, the autophagosomes may 
selectively destroy subcellular structures or clusters of proteins, allowing a 
fast replacement by the protein synthesis apparatus that involves translation 
or translational control of mature mRNAs (Cecconi and Levine, 2008). 
Similarly, the brain patterning of Ambra1 mutant embryos is dysregulated 
during neural tube differentiation at e10.5 (Fimia et al., 2007), with the 
morphogen sonic hedgehog (Shh) diffused in the area of the neural tube floor 
plate rather than concentrated in the notochord, which is related to impaired 
autophagosome formation mediated by Ambra1. 
Autophagy genes could also play a role in the specification of the left-
right axis. In vertebrates, left-right symmetry is determined in part by a flow of 
Chapter 1 – General introduction 
 
Shh in the left cells of the node during gastrulation, inducing left-gene 
expression in the left part of the primitive streak. Interestingly, the factor 
UVRAG (another component of the dynamic Beclin 1/Vps34 complex) is 
mutated in a human case of abnormal left-right axis formation, resulting in 
heterotaxy and multiple malformations (Iida et al., 2000). This phenotype 
could also be related to an impairment of Shh distribution in the node, caused 
by a decreased rate of autophagosome formation and a defective cell 
makeover in those cells (Cecconi and Levine, 2008). 
 
Autophagy and neurodegenerative disease 
Early reports demonstrating that autophagosomes accumulate in the 
brains of patients with diverse neurodegenerative diseases, including 
Alzheimer’s disease, transmissible spongiform encephalopathies, Parkinson’s 
disease, and Huntington’s disease (Rubinsztein et al., 2007; Levine and 
Kroemer, 2008), led to the initial hypothesis that autophagy contributed to the 
pathogenesis of these disorders. In mice with cerebellar degeneration due to 
mutations in glutamate receptor, autophagy was also postulated to be a 
mechanism of non-apoptotic cell death (Yue et al., 2002). In contrast, other 
studies provide compelling evidence that at least in model organisms 
autophagy protects against diverse neurodegenerative diseases and that the 
accumulation of autophagosomes primarily represents the activation of 
autophagy as a beneficial physiological response or, in the case of 
Alzheimer’s disease, the consequence of a defect in autophagosomal 
maturation (Martinez-Vicente and Cuervo, 2007; Rubinsztein et al., 2007). 
The development of neurodegenerative disease in patients with 
proteinopathies implies that the autophagy may reach a saturation point in 
which its capacity to degrade the mutant aggregate-prone proteins is 
exceeded, or that concurrent defects may occur in the autophagy pathway. 
Acquired defects in autophagosome formation may result from the 
sequestration of autophagy proteins in aggregates formed by mutant proteins, 
the age-related decline that occurs in Beclin 1 and potentially other autophagy 
protein expression in human brain, and other unidentified factors (Shibata et 
al., 2006). In addition to defects that result in decreased autophagic activity, 
genetic or functional alterations may occur that impair delivery of 
Chapter 1 – General Introduction 

autophagosomes to the lysosome. For example, mutations that affect the 
dynein motor machinery impair autophagosome-lysosome fusion, leading to 
decreased autophagic clearance of aggregate proteins and enhanced toxicity 
of the huntingtin mutant protein in Drosophila and mouse models (Ravikumar 
et al., 2005). Of long-term interest, both for the treatment of 
neurodegenerative diseases and, potentially, the prevention of aging, would 
be drugs that can reverse age-dependent declines that occur in CNS 
autophagy protein expression and lysosomal clearance of autophagosomes 
(Levine and Kroemer, 2008). 
 
 
Figure 1.5.3 - The role of autophagy in human disease. 
Degradation, in particular through autophagy and the proteasome, is important in 
cellular physiology. Autophagy can act as a cytoprotective mechanism to prevent 
various diseases, and dysfunctional autophagy leads to pathology. In some cases, 
however, autophagy can be deleterious; for example, some microbes subvert 
autophagy for replication, and the cytoprotective action can allow cancer cells to 
resist anti-cancer treatments. From Mizushima et al., 2008. 
Chapter 1 – General introduction 
 
 
Autophagy and Liver Disease 
Tissue-specific knockout studies in mice indicate an important role for 
basal hepatocyte autophagy in intracellular protein and organelle quality 
control. The protein quality-control function may be important in the 
pathogenesis of the most common genetic cause of human liver disease, α-1-
antitrypsin deficiency, which is associated with chronic inflammation and 
carcinogenesis (Perlmutter, 2006). Perhaps, similar to neurodegenerative 
disorders caused by aggregate-prone proteins, pharmacological activation of 
autophagy may be helpful in these conditions. A toxic gain-of-function point 
mutation in α-1-antitrypsin Z (α-1-ATZ) impairs proper protein folding and 
renders a normally secreted hepatic protein prone to form aggregated 
polymers within the hepatocyte ER. Whereas wild-type α-1-antitrypsin is 
degraded primarily by the proteasome, mutant α-1-ATZ is thought to be 
degraded primarily by autophagy (Yorimitsu and Klionsky, 2007). In cell lines 
depleted of atg5, there is decreased degradation of the mutant α-1-ATZ, 
especially insoluble forms, and increased accumulation of cytoplasmic 
inclusion bodies (Kamimoto et al., 2006). A broader question of biomedical 
relevance is whether the protein quality-control function of autophagy plays a 
more general role in protecting the liver against alcohol and other hepatotoxic 
agents. 
 
Autophagy and Muscle Disease 
Similar to neurodegenerative diseases, the pathogenesis of 
myodegenerative diseases may involve either the failure of autophagosomes 
to fuse with lysosomes or the aggregation of misfolded proteins that exceed 
the autophagic clearance capacity of the myocyte. Danon disease, a genetic 
disease characterized by cardiomyopathy, myopathy, and variable mental 
retardation, results from a mutation in the lysosomal protein LAMP-2 and is 
associated with extensive accumulation of autophagosomes in the muscles of 
LAMP-2-deficient mice and patients (Levine and Kroemer, 2008). The concept 
that failure of lysosomes to fuse with autophagosomes contributes to 
myopathy is further supported by evidence that pharmacological inhibition of 
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this fusion step (e.g., with chloroquine or hydroxy-chloroquine) causes severe 
vacuolar myopathies in rats and humans (Bolaños-Meade et al., 2005). 
There are several other histologically related diseases, such as X-
linked myopathy with excessive autophagy, infantile autophagic vacuolar 
myopathy, adult-onset vacuolar myopathy with multiorgan involvement, and 
X-linked congenital autophagic vacuolar myopathy (Nishino, 2006); the 
prediction is that these disorders may be due, at least in part, to an 
impairment in autophagosome-lysosome fusion. Thus, a general theme 
seems to be emerging in diseases associated with aggregate-prone proteins 
not only in the brain but also in the liver and muscle; the autophagy pathway 
plays a central role in the clearance of such proteins, and pharmacologic 
upregulation of autophagy may protect against aggregate accumulation. 
 
Autophagy and Cardiac Disease 
Defective autophagy (due to impaired autophagosome-lysosome 
fusion) may play a role in relatively rare forms of inherited diseases of the 
heart (e.g., Danon disease, Pompe disease) (Levine and Kroemer, 2008). Of 
greater medical significance is the possibility that autophagy may constitute 
an important physiological or pathophysiological response to cardiac stresses 
such as ischemia or pressure overload, which are frequently encountered in 
patients with coronary artery disease, hypertension, aortic valvular disease, 
and congestive heart failure. The accumulation of autophagosomes has been 
noted in cardiac biopsy tissues of patients with these disorders, rodent models 
of these cardiac diseases, and isolated stressed cardiomyocytes (Terman and 
Brunk, 2005). Prior to genetic studies, it was largely assumed that autophagy 
invariably contributed to myocyte degeneration in such settings. However, 
more recent data challenge this view; the cytoprotective effects of autophagy 
(either via ATP production, protein and organelle quality control, or other 
mechanisms) may predominate in certain settings. 
The cardiomyocyte, similar to the neuron, is a postmitotic cell in which 
basal autophagy may be important in protein and organelle quality control. 
Heart-specific knockout of atg5 in adult mice results in cardiac hypertrophy 
and contractile dysfunction that is accompanied by increased levels of 
ubiquitinated proteins and ultrastructural evidence of sarcomere and 
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mitochondrial structural abnormalities (Levine and Kroemer, 2008). Beyond 
this need for autophagy under basal conditions, the heart may uniquely rely 
on stress- induced upregulation of autophagy to ensure the availability of 
energy substrates and to promote cellular remodeling. 
 
Autophagy and Cancer 
Several genetic links have emerged between autophagy defects and 
cancer, providing increasing support for the concept that autophagy is a bona 
fide tumor suppressor pathway (Mathew et al., 2007). The regulation of 
autophagy overlaps closely with signaling pathways that regulate 
tumorigenesis. Several tumor suppressor genes involved in the upstream 
inhibition of TOR signaling, including PTEN, TSC1, and TSC2, stimulate 
autophagy and, conversely, TOR-activating oncogene products such as class 
I PI3K and Akt inhibit autophagy (Levine and Kroemer, 2008). P53, the most 
commonly mutated tumor suppressor gene in human cancers, positively 
regulates autophagy in DNA-damaged cells, perhaps through AMPK 
activation of the TSC1/TSC2 complex and subsequent TOR inhibition or 
perhaps via upregulation of DRAM (damage-regulated autophagy modulator), 
a lysosomal protein that may induce autophagy (Feng et al., 2005; Crighton et 
al., 2006). The death-associated protein kinase (DAPk) also induces 
autophagy and apoptosis, is commonly silenced in human cancers by 
methylation, and has tumor and metastasis suppressor properties (Gozuacik 
and Kimchi, 2006). The cellular proto-oncoproteins, Bcl-2 and Bcl-XL, which 
are often overexpressed in human cancers, are generally thought to mediate 
oncogenesis by suppressing mitochondrial membrane permeabilization, one 
of the rate-limiting steps of apoptosis. In addition, ER-localized Bcl-2 and Bcl-
XL inhibit autophagy by binding to the Beclin 1 autophagy protein (Maiuri et 
al., 2007). Thus, there is a strong correlation between molecules that are 
involved in autophagy induction and tumor suppression and between 
molecules that are involved in autophagy inhibition and oncogenesis. 
Although it is presently unclear whether cell survival/cell death effects 
are relevant to the tumor suppressor role of autophagy, such effects are likely 
important in cancer therapeutics. A large series of clinically approved and 
experimental anticancer therapies induce the accumulation of 
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autophagosomes in tumor cell lines in vitro (Maiuri et al., 2007). For many 
years, it was thought that these therapies kill cells through autophagy (i.e., 
induce “autophagic cell death”). However, specific inhibition of autophagy with 
siRNAs targeted against ATG genes usually accelerates, rather than 
prevents, cell death in these settings, indicating that autophagy activation 
represents a cellular attempt to cope with stress induced by cytotoxic agents. 
This suggests that inhibition of autophagy (rather than stimulation of 
autophagy) might be beneficial in cancer treatment. 
 
1.5.2. Selective autophagy 
 
Initially, autophagy was believed to be a non-selective process, 
meaning that cytosolic components would be randomly surrounded by the 
autophagosome and broken down. However, it was observed in different 
studies that, under specific conditions, certain macromolecular components 
were preferentially delivered to the lysosome. Along the years, several 
examples of selective degradation have been revealed, as specific breakdown 
of aggregated proteins (Ravikumar et al., 2002), selective removal of 
superfluous or damaged organelles – like mitochondria (mitophagy) (Elmore 
et al., 2001), peroxisomes (pexophagy) (Sakai et al., 2006) and endoplasmic 
reticulum (ER-phagy) (Bernales et al., 2006) - and specific degradation of 
invading bacteria (Zheng et al., 2009). 
Molecular mechanisms of selective autophagy have just started to be 
unveiled. Generally, a receptor protein, that is part or binds the cargo to be 
engulfed, interacts also with the autophagosomal membrane protein Atg8/ 
LC3 and/ or an adaptor protein, as Atg11 in yeast, mediating the selective 
targeting of the cargo to the autophagosome. Receptor proteins for different 
cargoes have been revealed – for instances, Atg19, which acts as a receptor 
protein for the yeast Cvt pathway; Atg32, which functions as a receptor in 
yeast mitochondria; PpAtg30, in yeast peroxisomes; NIX, in mammalian 
mitochondria and p62, NBR1, two mammalian proteins that bind ubiquitinated 
substrates (Komatsu and Ichimura, 2010). 
 
Chapter 1 – General introduction 
 
1.5.2.1. Mitophagy - Selective degradation of 
mitochondria 
 
The term “mitophagy” was first introduced in 2005 (Lemasters, 2005), 
even if the first descriptions of mitochondria inside lysosomes date from about 
40 years before. Engulfment of mitochondria together with other organelles by 
lysosomes in rat hepatocytes exposed to glucagon have been described in 
1962 (Ashford and Porter, 1962). 
Concomitant with energy production through oxidative phosphorylation 
in the mitochondria, this organelle generates ROS, causing protein, lipid and 
DNA oxidation and often inducing cell death. Therefore, quality control of 
mitochondria is essential for cellular homeostasis, and it is thought that such 
process is achieved through autophagy based on occasional identification of 
mitochondria surrounded by autophagosome and the presence of deformed 
mitochondria in autophagy-deficient cells. 
Being crucial organelles for energy production, regulation of cell 
signaling and amplification of apoptosis (Rizzuto et al., 2000; Green and 
Kroemer, 2004), and simultaneously the major source of reactive oxygen 
species (ROS), that may cause oxidative damage to their own lipids, proteins 
and DNA (Scherz-Shouval and Elazar, 2011), mitochondrial quality control is 
crucial for the fitness of the cell. Mitophagy is believed to play a key role, 
being the prime mechanism to eliminate superfluous or damaged 
mitochondria (Michel et al., 2012). The critical role that autophagy plays in the 
maintenance of a “healthy” cohort of mitochondria was showed both in yeast 
(Zhang et al., 2007) and mammals (Twig et al., 2008). Yeast strains with ATG 
(autophagy-related) genes deletions are unable to degrade mitochondria 
during stationary phase, present growth defects in a non-fermentable carbon 
source and accumulate dysfunctional mitochondria. In accordance, ATG 
mutants present lower oxygen consumption rates, decreased mitochondrial 
membrane potential and higher ROS levels (Zhang et al., 2007). Similarly, 
mammalian cells deficient for ATG5 or treated with an inhibitor of autophagy – 
3-MA – presented a reduction in maximal respiration (Twig et al., 2008). 
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In the last few years, mitophagy has been intensively studied. The 
accumulating evidences indicate that mitochondria can be selectively 
removed by autophagy and the signals that specifically target mitochondria to 
autophagy have started to be unraveled (Figure 1.5.4). 
 
 
 
 
Figure 1.5.4 – A working model of Atg32-mediated mitophagy. 
(A) Mitochondria in growing cells contain low levels of Atg32 and ROS, and 
mitophagy is hardly seen. (B) When cells accumulate high levels of ROS, Atg32 is 
strongly expressed in the cytosol, targeted to mitochondria, and inserted into the 
outer membrane. (C) Atg32 recruits Atg8 and Atg11 to the mitochondrial surface. 
Atg11 acts as a scaffold to facilitate assembly of core Atg proteins essential for 
autophagosome formation. Atg8, Atg11, and the assembled core Atg proteins 
cooperatively generate isolation membranes/phagophores enclosing mitochondria. 
From Okamoto et al., 2009. 
 
1.6. Mitochondrial biogenesis and mitophagy: quality 
control and mitochondrial abundance regulation 
 
The definition of ‘‘mitochondrial biogenesis’’ refers to both the formation 
of mitochondria during the cell cycle, the genesis of the organelle for normal 
turnover, as well as the phylogenesis and ontogenesis of mitochondria 
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(Michel et al., 2012). Some authors have classified the proposed theories on 
the biogenesis of mitochondria into three categories: (i) de novo synthesis of 
the organelle from sub-microscopic precursors present in the cytoplasm; (ii) 
formation from other membranous structures of the cell; (iii) growth and 
division of pre-existing mitochondria. The bulk of experimental evidences 
performed on mitochondrial biogenesis process is in favor of the concept that 
pre-existing mitochondria may grow and divide. However, the other two 
possibilities have not been ruled out conclusively yet. 
When dealing with the biogenesis of mitochondria, at least three 
coordinated aspects related to the composition, structure, and function of the 
organelle require special attention: (i) the transcription, the import, targeting, 
and potential assembly of nuclear genes-encoded proteins within 
mitochondria; (ii) the maintenance, replication, and the transcription of 
mitochondrial genome; and (iii) the biogenesis of mitochondrial membranes. 
To be coordinated, all these aspects need to be tightly orchestrated at the 
transcriptional level in response to various external stimuli and downstream 
signaling pathways. 
The abundance of mitochondrial population in cells does not only result 
from the biogenesis of the organelle but is also dependent on its turnover that 
involves the degradation of internal mitochondrial components as well as the 
autophagic digestion of the entire organelle by mitophagy (Figure 1.6.1). 
The basal turnover of mitochondria can gradually be enhanced in 
response to different stresses of various intensities such as the accumulation 
of unfolded or aggregated proteins that induce a specific and adaptive 
mitochondrial unfolded protein response (mtUPR) (Haynes and Ron, 2010). 
However, severe mitochondrial dysfunction such as activity impairment 
caused by defective oxidative phosphorylation will lead to the entire organelle 
degradation. The response to increasing mitochondrial stress is crucial in a 
cell attempt to recover proper mitochondrial homeostasis, which, if not, would 
lead to cell dysfunction or even cell death by apoptosis (Tatsuta and Langer, 
2008; Luce et al., 2010). 
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Figure 1.6.1 – The mitochondrial life cycle. 
Fission and fusion are two opposing processes that control mitochondrial number, 
size, shape, and distribution. In addition, these events allow mitochondria to shuttle 
between two distinct states — “individual state” and “network state”. Additional 
processes that define the life of mitochondria are biogenesis (birth) and degradation 
(death). Since mitochondria cannot be synthesized de novo, they must be 
proliferated from pre-existing ones. Their biogenesis seems to be regulated through 
multiple processes including protein and lipid import, oxidative phosphorylation, and 
mtDNA replication. From Okamoto and Kondo-Okamoto, 2012. 
 
 
1.7. Aims / Objectives 
 
It is recognized that the effects caused by environmental toxicants are 
mainly mediated through the binding of noxious agents to the AhR. All major 
human cell types express AhR, including pulmonary tissue. The liver, adipose 
tissue, and skin are the major storage sites of AhR ligands in humans. These 
AhR ligands are also concentrated in bronchial epithelial cells, suggesting that 
the respiratory system is very sensitive to AhR ligands. However, the 
mitochondria are crucial organelles in cell homeostasis and in cell life/death. 
Direct effects of chemical toxicants on mitochondria, causing its dysfunction, 
could be the cause to further cellular damage induced by pollutants and to the 
development of pollutants-associated diseases. 
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In this work we aim to explore the effects of Dibenzofuran on isolated 
mitochondria. Since DBF is an environmental pollutant to which we are 
exposed mainly through air (inhalation), we aim to evaluate lung mitochondrial 
function upon exposure to DBF. Nevertheless, we will also assess 
mitochondrial function using isolated mitochondria from liver, the main 
detoxifying organ and the organ that accumulates the most of the xenobiotics 
in the organism. Furthermore, we aim to evaluate the effects of DBF on lung 
cells. Mitochondrial damage can further induce cellular damage, yet cells 
have more complex rescue mechanisms, such as autophagy. We aim to 
evaluate DBF-induced damage in lung cells and the triggering of autophagy. 
The triggering and the enhancement of the defense/rescue mechanisms of 
the cell can help to prevent some of the damage and, ultimately, some of the 
diseases caused by the exposure to environmental pollutants.
 
 
 
 
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2.1   Materials 
Except when noted, all compounds were purchased from Sigma-
Aldrich (St. Louis, MO). Dibenzofuran was purchased from Supelco, USA (4-
0261). 
All reagents and chemicals used were of the highest grade of purity 
commercially available. 
 
2.2   List of antibodies used 
Antibody Specie Dilution Supplier Reference 
Actin Mouse 1 : 5000 Sigma A5441 
ANT Mouse 1 : 500 Mitosciences MSA02 
CypD Mouse 1 : 1000 Mitosciences MSA04 
Cyt c Mouse 1 : 1000 BD Pharmingen 556433 
LC3 Mouse 1 : 500 NanoTools 0260-
100/2G6 
p-62 Guinea-pig 1 : 10000 Progen GP62-C 
VDAC rabbit 1 : 5000 AbCam Ab3434 
 
Goat anti-rabbit immunoglobulin G (IgG)-AP conjugated was 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA) (sc-2007); goat 
anti-mouse IgG + IgM-AP conjugated antibody from Amersham Biosciences 
(NIF 1316); HRP-conjugated rabbit anti-guinea-pig antibody from Zymed (61-
4620). ECF Western blotting reagent was purchased from Amersham 
Biosciences (Piscataway, NJ) (RPN 3685). 
 
2.3   Animals 
Pig lungs were used to obtain isolated mitochondria. Lungs were 
obtained from a local supplier, collected each day of experiments immediately 
after animals sacrifice and kept on ice during transport and isolation 
procedure. 
For liver mitochondria isolation, Wistar male rats were used, obtained 
from Charles River (France). Upon arrival, animals were allowed 7 days to 
acclimatize (room temperature was 22-24º C) and housed under controlled 
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light (12h-light cycle) and humidity (moisture 50-60%) conditions with free 
access to food and water (pH 4.5). All animals received care according to 
institutional guidelines. 
 
2.4   Isolation of mitochondria 
Mitochondria were isolated from lung or liver by conventional methods 
with slight modifications, as previously described (Gomes et al., 2012; Rolo et 
al., 2009). All isolation material was kept on ice during the isolation procedure. 
The lung or the liver tissue was finely minced in an ice-cold homogenization 
medium (250mM sucrose, 0.5mM EGTA, 0.5% bovine serum albumin (BSA) 
and 10 mM HEPES, pH 7.4) and the minced blood-free tissue was then 
homogenized with a ‘‘Potter-Elvejhem’’ type glass homogenizer and a Teflon 
piston. The homogenate was then centrifuged in a refrigerated centrifuge 
(Sorvall, Thermo Scientific), at 800x g. Supernatant was collected and 
centrifuged at 10.000x g to pellet mitochondria, which were resuspended in 
washing medium (250mM sucrose and 10 mM HEPES, pH 7.4). When using 
lung tissue, an additional centrifugation at 800x g was performed; supernatant 
was again collected and centrifuged at 10.000x g to pellet mitochondria. The 
pellet was resuspended and finally centrifuged at 10.000x g. Mitochondria in 
the pellet were resuspended in a final washing medium and immediately 
used. 
Protein content was determined by the biuret method (Gornall et al., 
1949), calibrated with BSA. 
 
2.5   Mitochondrial transmembrane potential (∆Ψm) measurements 
The mitochondrial transmembrane potential (∆Ψm) was estimated using 
an ion-selective electrode to measure the distribution of 
tetraphenylphosphonium (TPP+) according to previously established methods 
(Kamo et al., 1979; Palmeira et al., 1994). The reference electrode was 
Ag/AgCl2 (model MI 402, Microelectrodes Inc, Bedford, NH). Both electrodes 
were connected to an adequate potentiometer (Jenway pH meter 3305); the 
signal was delivered to a Kipp and Zonen recorder (model BD 121, Kipp & 
Zonen B.V.) via a manufactured potential compensatory box (Madeira, 1975). 
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Mitochondria (lung: 2mg; liver: 1mg) were suspended with constant stirring, at 
25ºC, in 1 ml of standard respiratory medium (130mM sucrose, 50mM KCl, 
5mM MgCl2, 5mM KH2PO4, 50µM EDTA, 5mM HEPES, pH 7,4) 
supplemented with 3μM TPP+ and 3μM rotenone, and were energized with 
10mM succinate. A matrix volume of 1.1µl/mg protein was assumed (Masini 
et al., 1984). Control assays were done in order to exclude the possibility of 
interference with the electrode. 
 
2.6   Mitochondrial respiration / Oxygen consumption 
Oxygen consumption of isolated mitochondria was polarographically 
determined with a Clark oxygen electrode (Estabrook, 1967; Rolo et al., 2009) 
connected to a suitable recorder, through an oxygen electrode control system. 
Mitochondria (lung: 2mg; liver: 1mg) were suspended under constant stirring, 
at 25ºC, in 1 ml of standard respiratory medium described above with 
rotenone (3µM) as inhibitor of complex I, and energized by adding succinate 
to a final concentration of 10mM. ADP (50, 100 or 250 nmol) was added to 
induce state 3 respiration. The respiration control ratio (RCR) was calculated 
taking into account oxygen consumption rates during state 3 (following ADP 
phosphorylation) and subsequent state 4 respiration. The ADP/O ratio was 
calculated as the nmol of ADP phosphorylated by natoms oxygen consumed 
(Chance and Williams, 1956). 
 
2.7   ATPase activity 
ATPase activity was determined spectrophotometrically at 660 nm, in 
association with ATP hydrolysis (Madeira et al., 1974). The reaction was 
carried out at 37ºC, in 2ml reaction medium (100 mM NaCl, 25 mM KCl, 5 mM 
MgCl2, and 50 mM HEPES, pH 7,4). After the addition of freeze–thawed 
mitochondria (0,25 mg), DBF was added and allowed to incubate for 3 min 
before the initiation of the reaction by adding 2mM Mg2+-ATP, in the presence 
or absence of oligomycin (1µg/mg protein). After 10 minutes, the reaction was 
stopped by adding 1ml of 40% trichloroacetic acid and the samples 
centrifuged (5min, 3.000x g). 2ml of ammonium molybdate (1%) plus 2ml of 
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deionized H2O were then added to 1ml of supernatant and reacted for 5min at 
room temperature. ATPase activity was calculated as the difference in total 
absorbance and absorbance in the presence of oligomycin. 
 
2.8   Cytochrome c oxidase (COX) activity 
COX activity was polarographically determined with a Clark oxygen 
electrode, as previously described (Brautigan et al., 1978; Varela et al., 2008). 
The reaction was carried out at 25 °C in 1.4 ml of standard respiratory 
medium (as in mitochondrial respiration) supplemented with 2μM rotenone, 
10μM oxidized cytochrome c and 0.3 mg Triton X-100. After the addition of 
freeze–thawed mitochondria (0.5 mg), DBF was added and allowed to 
incubate for 3 min before the initiation of the reaction by adding 5mM 
ascorbate plus 0.25mM tetramethylphenylene-diamine (TMPD). 
 
2.9   Mitochondrial permeability transition (MPT) 
MPT was assessed estimating mitochondrial swelling through changes 
in light scattering as monitored spectrophotometrically (Jasco V-560 
spectrophotometer) at 540 nm (Palmeira and Wallace, 1997; Teodoro et al., 
2011). The experiments were started by the addition of 1 mg of mitochondria 
to a final volume of 2 ml of the standard incubation medium (200mM sucrose, 
10mM HEPES (pH 7,4), 1mM KH2PO4 and 10µM EGTA), supplemented with 
3µM rotenone and 5mM succinate. The medium was stirred continuously and 
temperature maintained at 25ºC. After a brief incubation period to establish a 
baseline absorbance, different calcium (CaCl2) concentrations were added as 
indicated by the arrows in the figures, to induce permeability transition. In 
selected assays, cyclosporine A (a known MPT inhibitor) or, in lung 
mitochondria experiments, ADP (100µM) plus oligomycin (1µM), were used 
as a negative control to prevent MPT (Palmeira and Wallace, 1997). 
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2.10   Measurement of mitochondrial calcium fluxes / calcium retention 
capacity 
The accumulation and release of calcium by isolated mitochondria was 
determined using a calcium-sensitive fluorescent dye, Calcium Green-5N, as 
previously described (Varela et al., 2010). Briefly, the reactions were carried 
out at 25 °C in 2 ml of the MPT buffer (as above), supplemented with 
rotenone (3 µM), oligomycin (0.5 μg/ml) and Calcium Green-5N (200nM). 
Mitochondria (1 mg) were loaded and fluorescence was recorded 
continuously using a Victor3 plate reader (Perkin–Elmer), with excitation and 
emission wavelengths of 485 and 535nm, respectively. Energization was 
obtained with 5 mM succinate. Calcium fluxes are expressed as relative 
fluorescence units (RFUs). 
 
2.11   Immunoprecipitation of ANT and western blot detection of 
cyclophilin D 
ANT was immunocaptured from mitochondrial extracts using 
monoclonal antibodies to ANT crosslinked to agarose beads (MitoSciences 
Cat#MSA01). Mitochondria (1mg) collected after calcium-induced MPT were 
resuspended in 300μl of the extraction buffer for immunoprecipitation (250mM 
sucrose, 20mM MOPS, 10mM Tris, 0.5% Triton, protease Inhibitor cocktail, 
pH 7.2) and frozen in liquid nitrogen. Samples were incubated overnight at 
4ºC with the antibody/agarose beads. Beads were washed four times with ice-
cold buffer. Elution of immunocomplexes with Laemmli sample buffer and 
heat-denaturation were performed immediately prior to one-dimensional gel 
electrophoresis. Proteins were separated on 15% SDS-polyacrylamide gels 
and electroblotted onto PVDF membranes. The western blots were then 
probed with antibodies against ANT and CypD. Western blot membranes 
were blocked with 5% nonfat milk and incubated with antibodies anti-ANT or 
anti-CypD overnight at 4ºC. Immunodetection was performed with 
WesternDot 625 (Invitrogen) goat anti-mouse western blot kits and the 
membranes were imaged using a Gel Doc instrument (Biorad). 
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2.12   Carboxyatractyloside (CAT) titration 
CAT is a highly selective inhibitor of cytosolic side-specific ANT that 
causes stabilization of the c conformation of ANT leading to MPT induction 
and loss of mitochondrial membrane potential. 
 The mitochondrial transmembrane potential was estimated as 
described before. Energized mitochondria were titrated with 0.02 nmol CAT. 
Successive additions of CAT aliquots before ADP addition, progressively 
block a higher number of ANT units contributing to the observed decreased 
number of phosphorylation cycles induced by successive ADP additions. 
 
2.13   Western blotting analysis with lung mitochondria 
Mitochondrial pellets were obtained after mitochondrial permeability 
induction experiments described above and kept frozen. After thawing pellets 
were homogenized in lysis buffer (1M urea, 10mM Tris, 2% SDS, pH 7.5, 
60°C). Aliquots were fractionated in 8–15% polyacrylamyde gels, transferred 
to polyvinylidene difluoride (PVDF) membranes, and blotted with anti-
cytochrome c or anti-VDAC antibodies. The immunoreactive proteins were 
visualized with goat anti-mouse and anti-rabbit antibodies, membranes were 
reacted with the ECF detection system and read with the Versa Doc imaging 
system (series 1300, Bio-Rad). VDAC content was used as mitochondrial 
loading control for the total protein content. 
 
2.14   Cell line 
A549 human lung carcinoma cell line was purchased from American 
Type Culture Collection, USA (ATCC catalog no. CCL-185). 
 
2.15   Cell culture 
A549 cells were cultured in Minimum Essential Medium (MEM) Eagle 
(with 1.5 g/l sodium bicarbonate and 0.11 g/l pyruvate), containing 10% foetal 
bovine serum (FBS). Cells were maintained in a humidified CO2 (5%) 
incubator at 37ºC, and passaged and harvested for experiments by 
detachment with a recombinant enzyme trypsin, TrypLE Express (Invitrogen, 
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Cat. No. 12605). ~80% confluent cells were used for DBF treatment. Control 
cells received an equivalent amount of vehicle (ethanol 0.1%). 
 
2.16   Cell death/viability 
For analysis of cell death 2.5 × 104 A549 cells were grown in 12-well 
plates and treated as indicated 24h after seeding. When indicated, cells were 
collected and stained with propidium iodide and annexin-V-FLUOS 
(BenderMedSystems) according to the manufacturer’s protocol. Cell viability 
was then measured by flow cytometry (FACSCalibur, BD Biosciences) as the 
percentage of annexin-V- and propidium iodide-negative events. 
 
2.17   LDH leakage 
Cell viability and membrane integrity was evaluated by measuring the 
amount of cytoplasmic Lactate Dehydrogenase released into the medium, 
using an assay based on the reduction of NAD by the action of LDH. LDH 
based kit (TOX-7) was purchased from Sigma. The resulting reduced NAD 
(NADH) is utilized in the stoichiometric conversion of a tetrazolium dye. The 
resulting coloured compound is measured spectrophotometrically at 490nm. 
A549 cells were seeded in 12-well plates at 1.25 × 104 cells/ml and allowed to 
attach and recover for 1 day prior to drug treatment. Medium from each well 
(each experimental sample) was centrifuged to pellet cells and aliquots were 
transferred to clean flat-bottom plate to proceed with enzymatic analysis 
accordingly to the in vitro toxicology assay kit. 
 
2.18   Cell proliferation 
Cell proliferation and in vitro cytotoxicity were measured with 
Sulforhodamine B method (Skehan et al., 1990). Sulforhodamine B (TOX-6) 
was purchased from Sigma. The cells were seeded in 12-well plates at 1.25 × 
104 cells/ml (in a total medium volume of 2ml per well) and allowed to attach 
and recover for 1 day prior to drug treatment. After addition of DBF cells were 
cultured for up 2 days (24h and 48h). After the treatment, cells were briefly 
washed, fixed and stained with the dye. The incorporated dye was then 
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liberated from the cells in a Tris-base solution. Absorbance of the solubilized 
dye was measured at 540 nm in a Victor3 plate reader (Perkin–Elmer), 
indicating the degree of cytotoxicity caused by test compound. 
 
2.19   MTT reduction assay 
Mitochondrial dehydrogenases activity was evaluated my measuring 
the amount of formazan formed after cleavage of the 3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyl tetrazolium bromide (MTT) ring. MTT assay kit (TOX-1) was 
purchased from Sigma. A549 cells were seeded in 12-well plates at 1.25 × 
104 cells/ml (final volume of 2ml) and allowed to attach and recover for 1 day 
prior to drug treatment. After addition of DBF, cells were cultured for up 2 
days (24h and 48h). At the end of the treatment, 1mg of MTT (from a recently 
prepared stock of 5 mg/ml in PBS) was added to each well and the plates 
returned to the incubator for 3h to allow MTT reduction. After the incubation 
media was dumped off and purple formazan crystals were dissolved in 1ml 
isopropanol during 30 minutes on a shaking table. The resulting purple 
solution was spectrophotometrically measured at 540nm. 
 
2.20   Adenine nucleotides content 
A549 cells were cultured in flasks and treated for 24 and 48h with DBF 
150µM and 250µM. At the end of the treatment cells were harvested by 
detachment with trypsin; adenine nucleotides were extracted using an acid 
extraction (HClO4) procedure, final pH 7 achieved with aliquots from stock 
2.5M KOH in 1.5M K2HPO4, maintaining samples on ice. Adenine nucleotides 
were separated by reverse-phase high-performance liquid chromatography, 
HPLC (Stocchi et al., 1985). The chromatographic apparatus was a Beckman-
System Gold, consisting of a 126 Binary Pump Model and a 166 Variable UV 
detector, controlled by a computer. The detection wavelength was 254 nm, 
and the column was a 5-m Lichrospher 100RP-18 from Merck (Darmstadt, 
Germany). An isocratic elution with 100mM phosphate buffer (KH2PO4, pH 
6.5) and 1.2% methanol was performed with a flow rate of 1 ml/min. The time 
required for each analysis was 5 minutes. 
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2.21   Measurement of mitochondrial membrane potential (ΔΨm) in A549 
cells 
ΔΨm in A549 cells was measured with a fluorescent probe, 
tetramethylrhodamine methyl ester (TMRM), as described before (Rolo et al., 
2003) with slight modifications. TMRM was purchased from Invitrogen (T668). 
Briefly, to monitor mitochondrial ΔΨ, cells grown in 12-well plates were loaded 
with 6.6 µM TMRM for 15 min at 37 ºC. Cells were then washed and culture 
medium without FBS or phenol red was added. TMRM is a cell-permeant, 
cationic fluorescent dye that is readily sequestered by active mitochondria, 
accumulating electrophoretically in proportion to their ΔΨ (Ehrenberg et al., 
1988). Fluorescence was measured using excitation and emission 
wavelengths of 485 and 590 nm, respectively. After recording basal 
fluorescence, mitochondrial ΔΨ was estimated taking into account the 
complete depolarization caused by 2,4-dinitrophenol (DNP), normalizing the 
data to potein content in each well. 
 
2.22   Oxygen consumption in A549 cells 
Cells were cultured as described before and exposed to DBF. Cells 
were then harvested by trypsinization and washed with PBS. The whole cell 
pellets were then suspended in DMEM and 0.2 x 106 cells were added to 
individual wells of a 96-well BD Oxygen Biosensor System plate (BD 
Biosciences), followed by cell culture medium (without phenol red) to a final 
volume of 200 μl per well. The plates were then maintained for 30min at 37 °C 
in a humidified incubator with 5% CO2. Plates were scanned in a 
temperature-controlled (37°C) plate reader (Perkin-Elmer Victor3) with an 
excitation wavelength of 485nm and an emission wavelength of 630 nm. 
Measurements were taken 1 min apart for a total of 40 min and the time 
profiles of fluorescence intensity in each well were analyzed using Excel 
software (Microsoft). The fluorescence traces in each well were normalized to 
the signal in air-saturated buffer. Slopes of fluorescence signal were 
calculated in the dynamic range of the measurements to compare respiratory 
rates of different samples. 
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2.23   Measurement of ROS production 
ROS production was determined fluorometrically, as described before 
(Palmeira et al., 2007). 2′,7′-Dichlorodihydrofluorescin diacetate (H2DCF-DA) 
(D6883) was purchased from Sigma. Briefly, cells were collected by 
trypsinization and centrifugation, and resuspended at 1×106 cells per ml in 
culture medium without FBS or phenol red. Cells were loaded with 50 μM 
H2DCF-DA for 30 min at 37 °C, washed and 200 μl containing 2x105 cells 
were loaded into a 96-well plate. The fluorescence coming from the formation 
of oxidized derivatives was monitored at an excitation wavelength 485 nm and 
an emission wavelength 538 nm, for 30 min, to calculate the rate of ROS 
formation. 
  
2.24   Nuclear morphology (apoptosis) 
Cells were seeded on glass cover slips in 6-well plates at 1.25 × 104 
cells/ml, as previously described (in a total medium volume of 5ml per well). 
At 24h or 48h treatment (250µM DBF), plates were rinsed twice with PBS. 
Cover slips were fixed in solution (1ml) of paraformaldehyde 4% and sucrose 
4% during 15min at room temperature. Cells were then washed two times with 
PBS. The cells were stained with 5µg/ml Hoechst 33342 in PBS during 10 
minutes to evaluate nuclear morphology. Hoechst 33342 (H1399) was 
purchased from Invitrogen. Cover slips were mounted in a fluorescent 
mounting medium (Dako) and images were recorded using a Zeiss Axioskop 
2 Plus fluorescence microscope (Carl Zeiss) with a Zeiss AxioCam MRC (Carl 
Zeiss). Apoptotic cells were identified as those whose nuclei exhibited brightly 
staining condensed chromatin, nuclear fragmentation or apoptotic bodies. 
 
2.25   Lysotracker accumulation 
Cells were seeded on glass cover slips in 6-well plates as described 
above. After DBF treatment they were gently washed with PBS and incubated 
for 30 minutes with LysoTracker Red 100nM in culture medium without phenol 
red. LysoTracker Red DND-99 (L7528) was purchased from Invitrogen. Cells 
were then inspected and photographed using a Zeiss Axioskop 2 Plus 
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fluorescence microscope (Carl Zeiss) with a Zeiss AxioCam MRC (Carl 
Zeiss). 
 
2.26   LC3 subcellular distribution 
A549 cells were seeded on glass cover slips in 6-well plates as 
described above, and transfected with YFP-LC3 plasmid (kindly provided by 
Dr. M. Sandri in the Venetian Institute of Molecular Medicine, Padua, Italy) 
using Lipofectamine 2000 Transfection Reagent (Invitrogen) accordingly to 
manufacturer’s instructions. Cells were allowed to express the protein and 
incubated with DBF 24h after transfection. As a positive control for autophagy 
induction cells were incubated in “starvation” medium (Hank’s Balanced Salt 
Solution supplemented with 10mM Hepes, ph 7.4). After treatment cells were 
fixed with formaldehyde 3,7% and images recorded using a Zeiss Axioskop 2 
Plus fluorescence microscope (Carl Zeiss) with a Zeiss AxioCam MRC (Carl 
Zeiss). Cells were blindly classified as autophagy-negative cells (presenting a 
predominantly diffuse YFP-LC3 fluorescence) or autophagy-positive cells 
(cells with a punctuate YFP-LC3 pattern). 
 
2.27   Western blotting analysis with A549 cell extracts 
A549 cells were collected from culture flasks after exposure to DBF, 
homogenized in lysis buffer (1M urea, 10mM Tris, 2% SDS, pH 7.5, 60°C) 
and cell lysates aliquots were fractionated in 8–15% polyacrylamyde gels, 
transferred to PVDF membranes, and probed with anti-LC3 antibody, anti-β-
actin antibody, anti-p62 antibody, anti-mouse antibody (dilution 1:10000) or 
anti-guinea-pig antibody (dilution 1:5000). Membranes were reacted with the 
ECF or ECL Plus (GE Healthcare) detection system. The fraction prepared 
from starved cells was used as a positive control. b-actin content was used as 
loading control for the total protein content and showed no differences 
between groups. 
 
2.28   DNA isolation and real-time qPCR 
DNA was isolated from control and DBF-treated samples with resource 
to a specialized kit (Qiagen GmbH). Total DNA yield was quantified in a 
Materials and methods

Nanodrop instrument (Thermo Scientific). Mitochondrial copy number was 
assessed using real-time PCR, by quantifying the number of DNA copies of a 
mitochondrial encoded mitochondrial gene (Cytochrome B) normalized 
against a nuclear encoded mitochondrial gene (Pyruvate kinase). For 
mitochondrial copy number assays, the values represent the cycle at witch the 
gene’s Ct was obtained; thus, a lower value represents a higher content of the 
same gene. Gene expression was evaluated by real-time qPCR, in a 
MiniOpticon equipment (Bio-Rad). Primers used were the following: 
Cyt B human antisense: 5’ TGT TGT TTG GAT ATA TGG AGG ATG 3’ 
Cyt B human sense: 5’ TGA TAT TTC CTA TTC GCC TAC ACA 3’ 
Pyruvate kinase human antisense: 5’ CTC CTA GTT TTC ACC CTC ATT TTC 
3’ 
Pyruvate kinase human sense: 5’ GTC GAT CCA GGA GAA CAT ATC AT 3’ 
 
2.29   Statistical analysis 
Results are presented as means ± S.E.M. of the number of different 
experiments (3-5 independent experiments). Solvent controls were included 
within each experimental determination. Statistical significance was 
determined using the two-tailed Student’s t test. A P value < 0.05 was 
considered statistically significant. 
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3.1 – Introduction 
 
In humans, exposure to dioxins and dioxin-like pollutants, such as fuel 
constituents, is associated with chronic obstructive pulmonary disease 
development and with lung cancer (Patel and Homnick, 2000; Matsumoto et 
al., 2007; Billet et al., 2008). Moreover, chronic respiratory diseases are one 
of the major problems concerning public health subjects. Dibenzofuran (DBF) 
is an aromatic ether with properties and chemical structure similar to dioxins. 
Potential exposure to DBF may occur through inhalation and dermal contact, 
particularly at sites engaged in combustion/carbonization processes (coal tar 
and coal gasification) where DBF is released to the ambient air (Aristizábal et 
al., 2008; Hu et al., 2009; Chang et al., 2010).  This pollutant has also been 
identified in tobacco smoke and listed as a pollutant of concern due to its 
persistence in the environment, potential for bioaccumulation and toxicity to 
humans and the environment (Mennear and Lee, 1994; Iida et al., 2007; 
Nadal et al., 2009; Li et al., 2010). Nevertheless and although the lung is a 
primary site of exposure for many inhaled chemical contaminants, studies 
about pollutants-induced toxic effects in lung function are scarce. 
Mitochondria play a central role in cell life and cell death (Kushnareva 
and Newmeyer, 2010). Mitochondria are the energy suppliers for eukaryotic 
cells and a proper mitochondrial function is therefore essential in the fulfilment 
of the tissues energy-demand. Therefore, alterations of mitochondrial 
bioenergetic features by toxicants reduce energetic charge and may result in 
cell death. Previous studies have identified mitochondrial targets of 
environmental pollutants, namely ROS production and decreased ATP 
content (Senft et al., 2002; Shertzer et al., 2006). Consequently, maintenance 
of cell function is strictly dependent on the existence of a healthy population of 
mitochondria. 
The main objectives of this work concerned DBF effects on lung 
mitochondrial function. Due to the central role of mitochondria in cell function, 
isolated pig lung mitochondria were used to analyse effects of DBF at the 
level of mitochondrial function (membrane potential, respiration, MPT 
induction and cytochrome c release). Clarifying the role of pollutants in some 
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mechanisms of toxicity, such as unbalance of bioenergetics status or cell 
death induction, may help explain the progressive and chronic evolution of 
lung diseases. 
 
3.2 – Results 
 
3.2.1 – Mitochondrial transmembrane potential 
 
Transmembrane potential (ΔΨm) sustained by mitochondria upon 
energization is essential for mitochondrial function. Since this parameter 
reflects the differences on electric potential and represents the greater 
component of the electrochemical gradient of protons in the membrane, 
contributing for the majority of the energy used in the oxidative 
phosphorylation, mitochondrial transmembrane potential was evaluated after 
incubation with DBF. Mitochondria transmembrane potential was not 
significantly altered upon exposure to DBF, when compared to control, as well 
as repolarization potential (Table 3.2.1; Figure 3.2.1). 
 
Table 3.2.1 – Effects of DBF in mitochondrial transmembrane potential (ΔΨm) 
and lag phase. 
Mitochondria were incubated with DBF prior to succinate energization and ∆Ψ was 
evaluated using a TPP+-electrode as described in Chapter 2. 
 Control 
DBF 
50 μM 
DBF 
100 μM 
DBF 
150 μM 
DBF 
250 μM 
Initial potential ∆Ψ 
(-mV) 
186.60 ± 
2.56 
190.50 ± 
2.61 
189.80 ± 
2.79 
183.80 ± 
6.42 
185.10 ± 
0.20 
∆Ψ Depolarization 
(-mV) 
17.50 ± 
0.26 
17.13 ± 
0.32 
18.47 ± 
0.26 
17.03 ± 
0.70 
14.27 ± 
1.50 
∆Ψ Repolarization 
(-mV) 
177.80 ± 
2.72 
180.90 ± 
3.69 
178.60 ± 
3.22 
173.30 ± 
7.00 
175.70 ± 
1.27 
Lag phase (s) 
27.00 ± 
5.20 
34.00 ± 
7.21 
41.00 ± 
6.08 
82.00 ± 
17.78  * 
73.50 ± 
16.50  * 
Data are means ± SEM of different experiments. * indicates statistically significant difference 
versus control (P < 0.05). 
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Depolarization induced by the addition of ADP didn’t show statistical 
significant variations in lung mitochondria exposed to DBF when compared to 
control, despite the slight decrease tendency in depolarization of mitochondria 
incubated with the highest concentration of DBF (Table 3.2.1; Figure 3.2.1).  






Figure 3.2.1 - Mitochondrial transmembrane potential (ΔΨm) and lag phase. 
Transmembrane potential measurements were performed with the TPP+-electrode
using freshly isolated mitochondria (2mg), as described in Chapter 2. DBF was 
added to mitochondria 3min prior to energization with succinate. The traces are 
representative of different experiments performed with independent mitochondrial 
preparations. 
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Conversely, the lag phase that occurs before repolarization was 
significantly increased in lung mitochondria incubated with DBF at 
concentrations of 150 and 250 μM (Table 3.2.1; Figures 3.2.1 and 3.2.2). 
 
 
 
 
Figure 3.2.2 – Effects of DBF in the lag phase preceding the mitochondrial 
repolarization. 
Measurements were performed with the TPP+-electrode as described in Chapter 2. 
Data are means ± SEM of different experiments. * indicates statistically significant 
difference versus control (P < 0.05). 
 
 
3.2.2 – Mitochondrial respiration / oxygen consumption 
 
Oxidative phosphorylation and respiratory chain competence of lung 
mitochondria was investigated by following oxygen consumption after 
succinate oxidation, upon exposure to DBF. The results showed no 
significant variation for all of the parameters evaluated in mitochondria 
exposed to DBF as compared with control: state 3 and state 4 respiration; 
respiratory control ratio (RCR); and oxidative phosphorylation efficiency, 
expressed as ADP/O ratio (Table 3.2.2). 
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Table 3.2.2 – Oxygen consumption measurements. 
Mitochondria were incubated with DBF and O2 consumption was evaluated with use 
of a Clark-type electrode, as described in Chapter 2. 
    Control 
DBF 
50 μM 
DBF 
100 μM 
DBF 
150 μM 
DBF 
250 μM 
State 3 
(natoms O/min/mg protein) 
31,68 ± 
10,56 
38,35 ± 
4,1 
32,52 ± 
3,04 
33,99 ± 
5,12 
32,52  ± 
10,56 
State 4 
(natoms O/min/mg protein) 
19,43 ± 
8,45 
23,65  ± 
2,74 
22,39 ± 
3,91 
24,99 ± 
3,4 
20,28 ± 
8,45 
R.C.R. 1,72 ± 0,2 
1,44 ± 
0,13 
1,35 ± 
0,13 
1,36 ± 
0,08 
1,68 ± 
0,18 
ADP/O 0,63 ± 0,055 
0,62 ± 
0,086 
0,63 ± 
0,05 
0,5 ± 
0,046 
0,8 ± 
0,06 
Data are means ± SEM of different experiments. No statistically significant differences were 
found (P < 0.05). 
 
 
3.2.3 – ATPase activity 
 
The enlarged lag phase in mitochondria exposed to DBF suggested 
that exposure to the pollutant could affect mitochondrial phosphorylative 
system. In order to clarify this alteration, mitochondrial ATPase 
(ATPsynthase) activity, one of the components of the mitochondrial 
phosphorylative sub-system, was evaluated through phosphate (Pi) 
production from ATP hydrolysis. No significant differences were found 
between lung mitochondria incubated with DBF and control (Figure 3.2.3), 
showing that the decreased performance of phosphorylation in lung 
mitochondria upon DBF exposure (as reflected by an increased lag phase) 
was not clearly correlated with a less efficient ATPase. 
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Fig. 3.2.3 – ATPase activity in lung mitochondria. 
Mitochondria were incubated with different concentrations of DBF and ATPase 
activity was measured spectrophotometrically (660nm) in association with ATP 
hydrolysis, as described in Chapter 2. Data are presented as means ± S.E.M. No 
statistically significant differences were found (P<0.05). 
 
3.2.4 – Mitochondrial permeability transition 
 
Mitochondria show a finite capacity of accumulating calcium before 
undergoing the calcium-dependent MPT. Mitochondrial swelling induced by 
calcium was used as an indicator of lung mitochondria susceptibility to MPT 
induction (Figure 3.2.4). Lung mitochondria exposed to DBF showed greater 
capacity of calcium accumulation before undergoing permeability transition. 
ADP and oligomycin together were used as inhibitors of MPT induction, 
allowing lung mitochondria to accumulate and keep hold of added calcium for 
a longer period.  
 
3.2.5 – Cytochrome c content 
 
Mitochondrial content in cytochrome c was assessed in lung mitochondria 
after MPT induction (Figure 3.2.5), in order to estimate cytochrome c release 
from mitochondria undergoing MPT. 
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Figure 3.2.4 – Susceptibility to mitochondrial permeability transition induction. 
Mitochondria were incubated with DBF and MPT was induced with the addition of 
Ca2+. MPT was evaluated spectrophotometrically (540nm) as described in Chapter 2. 
The traces are representative of different independent experiments. 
 
Cytochrome c content was more preserved in mitochondria incubated 
with DBF, after calcium addition, in comparison to mitochondria incubated 
only with calcium (Figure 3.2.5). This indicates that DBF may slightly prevent 
mitochondria from undergoing mitochondrial permeability transition, 
consequently showing minor cytochrome c release than mitochondria 
exposed only to calcium.  
 
 
 
Figure 3.2.5 – Cytochrome c content in lung mitochondria exposed to DBF.  
Western blot evaluations were conducted as described in Chapter 2, using 
mitochondrial samples collected after MPT induction experiments. Images are 
representative bands of protein content. 
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Again, as in mitochondrial swelling, mitochondria incubated with ADP 
and oligomycin together, showed cytochrome c content similar to that in 
control (Figure 3.2.5). 
 
3.3 – Discussion 
 
Exposure to dioxins and other environmental pollutants, such as fuel 
constituents and incineration products, is associated in humans with 
obstructive pulmonary disease and lung cancer (Boffetta, 2006). DBF is a 
widespread environmental contaminant that results from chemical and 
combustion processes, and exposure to it brings out several dreadful effects. 
Although some work has been conducted on pollutants-induced liver toxicity 
using liver cells in culture and animal models (Bunger et al., 2003; Niittynen et 
al., 2008; Weinstein et al., 2008), the evaluation of lung cell function after 
exposure to this kind of toxicants is scarce. In this study we report that DBF 
affects mitochondria isolated from lungs. 
Previous studies on mitochondrial dysfunction induced by exposure to 
pollutants, such as TCDD or arsenic, have been carried out in liver 
(Mildaziene et al., 2002; Lee and Sokol, 2007), blood cells (Banerjee et al., 
2008) or in brain (Coburn et al., 2008). In both hepatic mitochondria isolated 
from TCDD-treated mice and mitochondria incubated in vitro with TCDD, a 
number of functional alterations have been observed, including a defect in 
ATP synthesis and increased ROS production (Senft et al., 2002; Shen et al., 
2005; Shertzer et al., 2006). Experiments with isolated mitochondria from 
lungs showed that the generation of mitochondrial membrane potential was 
not compromised by exposure to DBF. Nevertheless, the time that elapses 
from ADP-induced depolarization until total repolarization – lag phase – was 
significantly enlarged in mitochondria exposed to DBF, suggesting that DBF 
may impair mitochondrial phosphorylative efficiency. No significant differences 
were observed on mitochondrial respiration, unlike the effects of other 
pollutants in hepatic mitochondrial respiratory chain function (Shertzer et al., 
2006). Additionally, Shertzer and collaborators have also shown a decrease in 
hepatic ATP levels related to a defect in the mitochondrial ATP synthase in 
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rats treated with TCDD for 1 week. Thus, the mitochondrial phosphorylative 
system is probably a target for pollutant-induced mitochondrial dysfunction. 
MPT induction is associated with pathological conditions and is 
triggered by high Ca2+, oxidative stress, ATP depletion, high inorganic 
phosphate and mitochondrial depolarization. In this work, MTP induction in 
mitochondria incubated with DBF was evaluated. Results show that this 
pollutant seems to slightly prevent MPT induction. In one week TCDD-
exposed mice, it has been shown that TCDD induces an increase in 
mitochondrial ROS and membrane potential though a mechanism involving an 
elevated reduction state of glutathione, which then prevents MPT induction 
(Shen et al., 2005). Thus, although the impairment of ATP synthesis induced 
by pollutants in both lung and hepatic mitochondria, data suggest that dioxins 
and DBF in a certain extent inhibit induction of the MPT.  
Although we have reported a limited toxicity of DBF affecting isolated 
mitochondria function, which could be due to very short time exposure of 
mitochondria to the pollutant in vitro, our results indicate that mitochondria are 
probably a target in DBF-induced lung toxicity. A decrease in the 
mitochondrial phosphorylative efficiency elicited by DBF is a damaging result 
from exposure to this toxicant and further studies are needed to better 
evaluate DBF-induced impairment of pulmonary function. 
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4.1 – Introduction 
 
Environmental pollution has been challenging human health and 
healthcare practitioners more and more in the last decades. As a 
consequence of a wide range of industrial applications, several toxic 
compounds are produced, environmental release occurs and exposure 
becomes inevitable. Moreover, several diseases and clinical conditions have 
been linked to environmental pollutants exposure, such as lung inflammatory 
diseases (Jung et al., 2007; Lecureur et al., 2012), asthma (McGwin et al., 
2010) and cancer (Brody et al., 2007; Raaschou-Nielsen et al., 2011). 
Exposure to environmental contaminants such as polycyclic aromatic 
hydrocarbons (PAH) and halogenated aromatic hydrocarbons (HAH), 
including dioxins (Yoshioka et al., 2011), plays an important role in the 
development of several types of human cancers. PAH and HAH are wide 
spread environmental contaminants that are present in cigarette smoke, coal 
tar and automobile exhaust. The carcinogenic effects of several PAH and 
HAH are initiated after their binding and activation of the aryl hydrocarbon 
receptor (AhR) (Mandal, 2005). 
Dibenzofuran (DBF) is a ubiquitous dioxin-like compound, considered 
to be an environmental pollutant. However, little is known about its effects, 
namely on primary targets such as the lung. We have previously reported 
detrimental effects of DBF in lung mitochondria (Duarte et al., 2011) and in 
lung cells (Duarte et al., 2012). Although some studies reported that 
environmental toxicants induce mitochondrial damage (Palmeira and Madeira, 
1997; Duarte et al., 2011), more systematic studies have not yet been carried 
out in order to uncover toxic effects of some pollutants harming mitochondria 
directly. 
Mitochondria are the key organelles for energy production and many 
other cellular processes, including signaling pathways regulating several 
biologic processes in the cell. Oxidative phosphorylation (OXPHOS) in 
mitochondria produces more than 95% of a cell's energy in the form of ATP 
under normal physiological conditions and this process involves five different 
protein complexes (complex I-V). Mitochondrial respiration generates most of 
the cellular energy (ATP) and yields several intermediate compounds involved 
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in cellular metabolism. Therefore, perturbation of mitochondrial functions may 
result in severe consequences for general metabolism and all the energy 
transducing processes that require ATP. 
Besides energy production, mitochondria also participate in several 
signaling pathways regulating, for example, cell death/survival (Westermann, 
2010; Kinnally et al., 2011). An increase in mitochondrial membrane 
permeability is one of the key events in apoptotic and necrotic death, although 
the mechanisms involved are yet to be fully elucidated. It is accepted that 
mitochondrial permeability transition is caused by the permeability transition 
pore (PTP), a voltage- and Ca2+- dependent, cyclosporine A (CsA)-sensitive, 
high conductance channel, whose opening leads to permeabilization of the 
inner mitochondrial membrane (IMM) to solutes with molecular masses up to 
1.5 kDa (Rasola et al., 2010). Activation of mitochondrial permeability 
transition (MPT) is considered to be a major cause of cell death under a 
variety of pathophysiological conditions, including ischemia/reperfusion injury, 
neurodegenerative disease, traumatic brain injury (TBI), muscular dystrophy 
and drug toxicity (Kroemer et al., 2007; Millay et al., 2008; Varela et al., 2008; 
Halestrap and Pasdois, 2009; Mbye et al., 2009; Nicholls, 2009; Russmann et 
al., 2009; Varela et al., 2010). 
Despite major efforts, the molecular nature of the mPTP remains 
undefined. Earlier candidates such as the IMM adenine nucleotide 
translocase (ANT) and the outer mitochondrial membrane (OMM) voltage-
dependent anion channel (VDAC) are now considered to be regulators rather 
than constituents of the mPTP (Rasola et al., 2010), and new putative 
regulators have been proposed in the recent years. Indeed, it has been 
proposed that the mPTP is regulated by proteins that interact with the OMM 
such as hexokinase (Chiara et al., 2008; Pastorino and Hoek, 2008) and by 
ligands of the OMM translocator protein of 18 kDa, TSPO, formerly known as 
the peripheral benzodiazepine receptor (Krestinina et al., 2009; Azarashvili et 
al., 2010; Sileikytė et al., 2011). 
In the past, extensive analyses have dissected the factors that regulate 
the mPTP in situ (Bernardi et al., 2006). Nonetheless, extreme caution must 
be exerted when these data are extrapolated to mPTP modulation in the living 
cell. The continuous crosstalk between mitochondria and other cell 
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compartments suggests that several proteins can play regulatory roles on the 
pore, connecting signaling cascades known to control the apoptotic process 
with the mPTP, as this is a key switch in the cell commitment to death (Rasola 
et al., 2010). 
In this work we evaluated the toxic effects of the pollutant DBF in vitro, 
using isolated mitochondria from rat liver. We assessed mitochondrial function 
(transmembrane potential generation, oxygen consumption), mitochondrial 
susceptibility to MPT induction and permeability of mitochondrial membrane to 
protons, exposing mitochondria to the pollutant. 
 
 
4.2 – Results 
 
4.2.1 – Mitochondrial membrane potential 
 
In order to better understand the effects of the environmental pollutant 
DBF on mitochondria and its function, we assessed the mitochondrial 
transmembrane potential (ΔΨm) which, upon energization, is essential for 
mitochondrial function; this parameter reflects the differences on electric 
potential and represents the greater component of the electrochemical 
gradient of protons in the membrane, contributing to the majority of the energy 
used in the oxidative phosphorylation. We found that the ΔΨm generated by 
mitochondria isolated from rat liver was not affected by DBF exposure, 
comparing to control (Table 4.2.1; Figure 4.2.1); similarly, there were no 
differences in the depolarization induced when ADP was added to 
mitochondria (Table 4.2.1). However, some differences were found for the 
repolarization potential of mitochondria after the phosphorylative cycle, which 
is decreased in mitochondria exposed to the higher concentrations of DBF 
that were tested, 150 μM and 250 μM (Table 4.2.1). 
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Table 4.2.1 – Effects of DBF in mitochondrial membrane potential (ΔΨm) and lag 
phase. 
Mitochondria were incubated with DBF prior to succinate energization and ΔΨm was 
evaluated using a TPP+-electrode as described in Chapter 2. 
 Control 
DBF 
10 μM 
DBF 
50 μM 
DBF 
100 μM 
DBF 
150 μM 
DBF 
250 μM 
ΔΨm 
(% of control) 
100 
100.2 ± 
0.25 
100 ± 
0.42 
100.4 ± 
0.46 
99.7 ± 
0.75 
99.2 ± 
0.74 
ΔΨADP 
(% of control) 
100 
104.4 ± 
2.59 
104.7 ± 
5.08 
107.7 ± 
6.44 
103.2 ± 
1.84 
101.9 ± 
2.42 
Repolarization 
(% of control) 
100 
100.1 ± 
0.3 
99.8 ± 
0.46 
99.4 ± 
0.51 
97.8 ± 
0.75 * 
95.8 ± 
1.07 * 
Lag phase 
(% of control) 
100 
111.4 ± 
1.17 * 
122.4 ± 
6.43 * 
120.3 ± 
7.71 * 
145.0 ± 
8.15 * 
167.2 ± 
10.49 * 
Data are means ± SEM of different experiments. * indicates statistically significant difference 
versus control (P < 0.05). 
 
 
 
 
Figure 4.2.1 - Mitochondrial transmembrane potential (ΔΨm) in succinate-
energized liver mitochondria. 
Reactions were carried out using 1 mg of freshly isolated mitochondria, as described 
in Chapter 2. ΔΨm was measured using a TPP+-electrode. DBF was added prior to 
energization with succinate (3 min incubation). Data are means ± SEM of different 
experiments. Values statistically different from control: * P < 0.05. 
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We also measured the period of time during which mitochondria 
phosphorylate all the ADP that is added, known as lag phase. We found that 
the lag phase preceding repolarization was significantly increased in 
mitochondria exposed to DBF, when comparing to control (Table 4.2.1; Figure 
4.2.2), suggesting an impairment in the phosphorylative system, considering 
that the energization induced by the substrate was not impaired. Still, we 
could see that the increase in the lag phase was greater for the higher 
concentrations of DBF, showing some kind of “dose-dependent” correlation. 
 
 
 
Figure 4.2.2 – Effects of DBF in the lag phase preceding the mitochondrial 
repolarization. 
Mitochondria were incubated with DBF prior to succinate energization and ∆Ψm was 
evaluated using a TPP+-electrode as described in Chapter 2. Data are means ± SEM of 
different experiments. * indicates statistically significant difference versus control (P < 
0.05). 
 
4.2.2 – Mitochondrial oxygen consumption 
 
Oxidative phosphorylation and respiratory chain competence of 
mitochondria were investigated by following oxygen consumption upon 
exposure to DBF. The results showed an increase in the respiratory state 2 of 
mitochondria exposed to DBF (Figure 4.2.3), which could suggest an increase 
in membrane permeability to protons and consequent increase in oxygen 
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consumption in the respiratory chain. However, no differences were found 
when we tested the mitochondrial membrane permeability to protons 
assessing mitochondrial osmotic behavior in a NH4NO3 buffer (Figure 4.2.4).  
 
 
Figure 4.2.3 – Effects of DBF on mitochondrial oxygen consumption. 
State 2, state 3 and state 4 respiration in liver mitochondria, upon incubation with 
DBF, were evaluated polarographically using a Clark oxygen electrode, as described 
in Chapter 2. Data are means ± SEM of different experiments. * indicates statistically 
significant difference versus control (P < 0.05). 
 
After addition of ADP to mitochondria, we found a decrease in 
respiratory state 3 (Figure 4.2.3) oxygen consumption rate when mitochondria 
were exposed to DBF. Still, the experiments also showed that even when 
state 3 was not clearly decreased phosphorylation was taking longer when 
DBF was present, supporting the enlarged lag phase reported previously 
(Figure 4.2.2) and the idea that DBF elicits some defects in the mitochondrial 
phosphorylative system. Additionally, respiratory state 4 was clearly increased 
in mitochondria exposed to DBF (Figure 4.2.3), reflecting the impairment in 
mitochondrial function and a possible disruption of mitochondrial membrane 
impermeability after phosphorylation and consequent forced respiration. 
Consequently, both RCR and ADP/O ratios were decreased in mitochondria 
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exposed to the pollutant (Figure 4.2.5), implying an impairment in the 
oxidative phosphorylation efficiency. 
 
Figure 4.2.4 - Mitochondrial membrane permeability to protons after incubation 
with DBF. 
Reactions were carried out in a NH4NO3 buffer using 1 mg of mitochondria. Osmotic 
volume changes were evaluated using spectrophotometry (540 nm) as described in 
Chapter 2. FCCP addition is indicated by the arrow. The traces are representative of 
different experiments performed with independent mitochondrial preparations. 
 
4.2.3 – Enzymatic activities 
 
We have also tested mitochondrial Cytochrome c Oxidase (COX) 
enzymatic activity, which showed no significant differences in mitochondria 
exposed to DBF, when compared to control (Figure 4.2.6), which deals with 
the constant state 3 respiratory rates. To try to elucidate the increased lag 
phase and impairment during phosphorylation, we have also assessed 
mitochondrial ATPase activity; the results showed that DBF caused a 
decrease in the ATPase activity for all the concentrations tested (Figure 4.2.7). 
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Figure 4.2.5 – Effects of DBF in mitochondrial RCR and ADP/O ratios. 
Oxygen consumption was polarographically determined with a Clark oxygen 
electrode as described in Chapter 2. Data are means ± SEM of different 
experiments. * indicates statistically significant difference versus control (P < 0.05). 
 
 
 
 
Figure 4.2.6 - Cytochrome c Oxidase activity. 
Enzymatic activity was measured polarographically after incubation with DBF, using a 
Clark oxygen electrode as described in Chapter 2. Data is expressed in nAtoms O / 
min / mg protein. No statistically significant differences were found (P < 0.05). 
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Nevertheless, the defects in ATPase efficiency didn’t fully match the 
“dose-dependent” increase in lag phase detected in the membrane potential 
experiments, and therefore the impairment during phosphorylative cycles was 
not due only to a less active mitochondrial complex V. The decrease in the 
ATPase activity can explain the longer lag phase but does not exclude that 
DBF can act on another component of the phosphorylative system (e.g. ANT). 
 
 
 
Figure 4.2.7 – Mitochondrial ATPase activity. 
This activity was measured spectrophotometrically in mitochondria upon incubation 
with DBF, as described in Chapter 2. Data are means ± SEM of different 
experiments. * indicates statistically significant difference versus control (P < 0.05). 
 
4.2.4 – Mitochondrial swelling and MPT induction 
 
The effects of DBF on mitochondrial permeability transition (MPT) were 
assessed using light scattering to monitor mitochondrial swelling. We found 
that DBF reduced mitochondrial calcium-induced and CsA-sensitive osmotic 
swelling (Figure 4.2.8), suggesting that the pollutant can inhibit the 
permeability transition to some extent. This data pointed out to an effect of 
DBF in one particular component of the phosphorylative system that is also 
enrolled in the permeability transition, the adenine nucleotide translocase 
(ANT). 
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Figure 4.2.8 – Effects of DBF on the susceptibility to the induction of 
mitochondrial permeability transition (MPT). Mitochondrial swelling was evaluated 
spectrophotometrically (540 nm) as described in Chapter 2. MPT was induced by the 
addition of Ca2+. The traces are representative of different experiments performed 
with independent mitochondrial preparations. 
 
To test the hypothesis that DBF interacts with ANT, we first performed 
a titration with carboxyatractyloside (CAT), a highly selective inhibitor of ANT, 
cytosolic side-specific, that causes stabilization of the c conformation of ANT 
leading to mPTP opening and loss of mitochondrial membrane potential. For 
titration with CAT, after addition of succinate, mitochondria developed a 
potential of about -220 mV (negative inside). With the addition of ADP, the 
potential dropped because ATP synthase uses ΔΨm to phosphorylate ADP. 
After a short lag phase, when ADP phosphorylation takes place, the 
transmembrane potential repolarized close to the initial value. Successive 
additions of CAT aliquots before ADP addition, as indicated in Figure 4.2.9, 
progressively blocked a higher number of ANT units contributing to the 
observed decreased number of phosphorylation cycles induced by successive 
ADP additions, as well as to the observed increasing in lag phase 
corresponding to successive phosphorylation cycles. 
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Figure 4.2.9 – Mitochondrial transmembrane potential (ΔΨm) and lag phase. 
DBF was added to the reaction medium (1ml) with mitochondria (1mg) and allowed to 
incubate for 3min before the addition of succinate as substrate. Addition of ADP 
induces phosphorylation/depolarization. A titration with CAT was performed, adding 
successive amounts of 0.02 nmol, where indicated by the arrows. ADP aliquots (100 
nmol) were also added to induce depolarization. The traces represent typical direct 
recordings from independent experiments. 
 
Measuring mitochondrial membrane potential after ADP addition we 
found that, with DBF, less CAT was needed to completely abolish 
repolarization after phosphorylation (Figure 4.2.10), indicating that 
mitochondria incubated with DBF already had ANT inhibition and thus an 
impaired phosphorylative system. Furthermore, in Figure 4.2.11 we can see 
that mitochondria incubated with DBF show a higher increase in 
phosphorylative lag phase when CAT is added. Exposure to DBF is already 
causing an interference/inhibition of ANT in mitochondria, and the lag phase 
after ADP loading is already higher for DBF-exposed mitochondria, relatively 
to control. When we performed the experiments with CAT, the expected 
increase in lag phase is greater in DBF-exposed mitochondria. Moreover, for 
a little amount of CAT added to DBF-exposed mitochondria, much less than in 
control, depolarization/repolarization after ADP loading is abolished (effect 
that is also reflected on Figure 4.2.11), which is in agreement with previous 
experiments showing DBF inhibition of ANT in isolated mitochondria. 
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Figure 4.2.10 – Inhibition of mitochondrial ANT carrier by CAT. 
Mitochondrial transmembrane potential (ΔΨm) was measured with a TPP+-electrode 
as previously, and a titration with CAT was performed until no 
depolarization/repolarization was observed when ADP was added to mitochondria. 
Data are means ± SEM of different experiments. * indicates statistically significant 
difference versus control (P < 0.05). 
 
 
 
Figure 4.2.11 – Effects of DBF and CAT on mitochondrial phosphorylative lag 
phase (% of control). 
Mitochondria were incubated with DBF as described in Chapter 2. Little amounts of 
CAT were progressively added before ADP addition. The experiments were the 
same as in Figure 4.2.9. Data are means ± SEM of different experiments. * indicates 
statistically significant difference versus control (P < 0.05). 
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Using CAT also in mitochondrial swelling experiments, we could see 
that DBF prevents mitochondrial swelling that is induced by CAT (Figure 
4.2.12), and we also compared this prevention with that provided by 
bongkrekic acid (BKA); both DBF and BKA inhibit MPT induction and 
consequent mitochondrial swelling (Figure 4.2.12). 
 
 
 
 
 
Figure 4.2.12 – Effects of DBF on the susceptibility to the induction of 
mitochondrial permeability transition (MPT). 
Osmotic changes were evaluated spetcrophotometrically (540 nm) as described in 
Chapter 2. DBF, CAT (0.4 nmol), BKA (3.7 nmol) or CsA were added to 
mitochondria before the beginning of the assay. The traces are representative of 
different experiments performed with independent mitochondrial preparations. 
 
 
4.2.5 – Calcium retention capacity 
 
To further analyze MPT induction and DBF effects we tested calcium 
retention capacity in mitochondria, using the fluorescent probe Calcium-Green 
Chapter 4 – Dibenzofuran-induced mitochondrial dysfunction: interaction with ANT carrier 

5N. These experiments showed that DBF exposure induced an increase in 
the calcium retention capacity after energization, when compared to control 
(Figure 4.2.13). DBF caused a delay in calcium release from mitochondria, 
that is the consequence of mPTP opening and MPT induction, a CsA-
sensitive event (Figure 4.2.13). 
 
 
 
Figure 4.2.13 – Effects of DBF on mitochondrial calcium fluxes. 
Calcium fluxes, expressed as relative fluorescence units (RFUs), were 
fluorometrically monitored using the probe Calcium-Green-5N as described in 
Chapter 2. DBF was added to mitochondria before beginning the assay. The traces 
are representative of different experiments performed with independent 
mitochondrial preparations. 
 
Analyzing calcium retention capacity in mitochondria we confirmed that 
CAT greatly induces MPT (Figure 4.2.14); DBF exposure prevents the 
induction of MPT, even when CAT is present, and again it displays an effect 
similar to BKA, which blocks ANT in a conformation that prevents pore 
opening and MPT (Figure 4.2.14). 
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Figure 4.2.14 – Effects of DBF and ANT modulators on mitochondrial calcium 
fluxes. 
Calcium fluxes were fluorometrically monitored using the probe Calcium-Green-5N, 
as described in Chapter 2. DBF or CsA were added before the beginning of the assay. 
CAT (0.4 nmol) or BKA (3.7 nmol) were added where indicated by the arrows. The 
traces are representative of different experiments performed with independent 
mitochondrial preparations. 
 
4.2.6 – ANT immunoprecipitation 
 
Keeping in mind that, during MPT induction, permeability pore opens 
and CypD binding to ANT regulates it, we performed immunoprecipitation 
assays. Using mitochondria samples that were used in MPT induction 
experiments, we immunoprecipitated ANT and then used western blot to 
evaluate CypD present in the precipitate (thus bound previously to ANT). We 
could see that, when MPT induction is prevented, either with CsA or DBF 
exposure, the ratio CypD/ANT in the sample is decreased when compared to 
control or CAT (Figure 4.2.15), also suggesting that DBF was interacting with 
ANT and so preventing CypD binding and consequent MPT induction.  
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Figure 4.2.15 – Immunoprecipitation of ANT and CypD from mitochondrial 
extracts. 
Mitochondrial samples used in MPT experiments were collected. 
Immunoprecipitation with an antibody α-ANT was performed using agarose beads 
and western blots were performed as described in Chapter 2. Images are 
representative bands of protein content. 
 
 
4.2.7 – mPTP activation by mitochondrial outer membrane 
translocator protein (TSPO) 
In the last years, several other proteins have been reported to 
modulate mPTP opening, namely the mitochondrial outer membrane 
translocator protein of 18 kDa, TSPO, formerly known as the peripheral 
benzodiazepine receptor. We wanted to check if DBF was also interacting 
with this receptor and this way modulating MPT induction. 
We performed calcium retention capacity experiments using a ligand 
for TSPO, PK11195, which induces pore opening and consequent calcium 
release (Figure 4.2.16). However, when DBF was present, no differences 
were found in calcium retention capacity of mitochondria challenged with the 
ligand (PK11195), suggesting that DBF effects were not being exerted via 
TSPO binding (Figure 4.2.16). 
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Figure 4.2.16 – Effects of DBF and mitochondrial outer membrane translocator 
protein (TSPO) modulation on mitochondrial calcium fluxes. 
Calcium fluxes were fluorometrically monitored using the probe Calcium-Green-5N, 
as described in Chapter 2. DBF or CsA were added before the beginning of the assay. 
PK11195 (30 nmol) or CAT (0.4 nmol) were added where indicated by the arrows. 
The traces are representative of different experiments performed with independent 
mitochondrial preparations. 
 
 
4.3 – Discussion 
 
Environmental pollutants such as dioxins and furans are extremely 
toxic and related with several diseases, such as cancer. Some toxicology 
studies have addressed health effects related to exposure to chemicals, but 
few have described the molecular targets that cause toxicity (Yoshioka et al., 
2011). Therefore, clarifying the role of pollutants in some basic mechanisms 
of toxicity, such as unbalance of bioenergetics, may help to explain the 
development of some diseases related to environmental pollutants exposure. 
DBF is an aromatic ether with properties and chemical structure similar 
to dioxins, listed as a pollutant of concern due to its persistence in the 
environment, potential to bioaccumulation and toxicity to humans. Potential 
exposure to DBF may occur through inhalation and dermal contact, 
particularly at sites engaged in combustion/carbonization processes. This 
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work focused on the toxic effects of DBF directly on mitochondria, using an in 
vitro approach, given that not many studies have been conducted concerning 
mitochondrial harming by environmental pollutants. We have previously 
reported some of the effects caused by DBF, either for mitochondria isolated 
from lungs (Duarte et al., 2011) or lung cells in culture (Duarte et al., 2012). 
Mitochondria are key organelles in cellular function. Their main role is 
to generate energy (ATP) for cellular function, but they also participate in 
several other processes such as calcium homeostasis, free radicals 
generation and apoptosis (Contreras et al., 2010; Orrenius et al., 2007). The 
study of drug-induced mitochondrial toxicity may elucidate distinct 
mechanisms by which drugs interfere with energy production by the cell. 
Given the importance of mitochondria for organisms, to evaluate toxic effects 
that impair mitochondrial function is necessary when one wants to study the 
toxicity of a given compound, namely an environmental pollutant. The aim of 
this study was to evaluate if DBF is a mitochondrial toxicant through 
interference with the bioenergetic features of the mitochondria. 
The results indicate that mitochondria are targeted by DBF-induced 
toxicity. Although DBF did not affect mitochondrial capacity to generate and 
sustain membrane potential, created by the electron transport chain and used 
to drive production of ATP from ADP in the matrix, we could see a decrease in 
the mitochondrial phosphorylative efficiency elicited by DBF, which seems to 
be a critical event in DBF-induced impairment of cell function. Similar 
mitochondrial impairment had already been reported for exposure to other 
toxicants (Simões et al., 2010). Energization and phosphorylation capacities 
of mitochondria isolated from Wistar rats were investigated by following the 
transmembrane potential (ΔΨm) developed by mitochondria upon succinate 
oxidation. Although ΔΨm developed after succinate energization was not 
affected, the lag phase that occurs in the phosphorylative cycle and precedes 
repolarization was increased in mitochondria incubated with DBF when 
compared to control. This reflects an impairment in the phosphorylative 
system, which causes a delay in the restoration of membrane potential after 
conversion of ADP to ATP. When measuring oxygen consumption rate by 
mitochondria, we could detect a decrease in respiratory state 3 (active 
phosphorylation) after exposure to DBF. Additionally, an increase in 
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respiratory state 2 and state 4 with mitochondria energized with succinate 
would suggest an increase in mitochondrial membrane permeability to protons, 
consequent membrane potential dissipation and activation of respiration to 
regenerate transmembrane potential; however, no increase in permeability to 
protons was found after exposure to DBF. We could see that mitochondria 
exposed to DBF didn’t recover the state 4 respiration values after 
phosphorylation, showing that DBF affects mitochondrial integrity and 
coupling of oxidative phosphorylation. Consequently, both respiratory control 
ratio (RCR) and efficiency of ATP synthesis coupled to mitochondrial 
respiration, referred to as the ADP/O ratio, were decreased in mitochondria 
exposed to DBF when comparing to control. 
To further explore and understand the cause for the increased lag 
phases induced by DBF, showing an impairment in phosphorylative system, 
and the oxygen consumption rates, we evaluated ATPase activity, since other 
component of the phosphorylative system should be impaired, in order to 
justify the evident increase in mitochondrial lag phase during phosphorylation. 
In fact, ATPase activity was decreased in mitochondria exposed to DBF. 
Although, the defects in ATPase efficiency didn’t fully match the “dose-
dependent” increase in lag phase detected in the membrane potential 
experiments, and this effect does not exclude action at the level of other 
components of the phosphorylative system. 
Further studies were conducted in order to evaluate the mechanisms 
by which DBF affects mitochondria phosphorylative system. Having detected 
an inhibition of MPT elicited by DBF, we considered that a common player of 
both phosphorylation and MPT was a target for DBF toxicity. We performed 
experiments to evaluate MPT induction, a phenomenon that results from the 
opening of the so called mitochondrial permeability transition pore (mPTP) 
causing membrane potential disruption, matrix swelling and outer membrane 
rupture (Kinnally et al., 2011). The results showed that this toxicant prevented 
MTP induction, when compared with control mitochondria. Thus, although the 
impairment of ATP synthesis in hepatic mitochondria, data prompted us the 
idea that DBF was interacting with ANT; and so DBF was somehow mimicking 
CsA or BKA to inhibit induction of the MPT and prevent mitochondrial swelling. 
Chapter 4 – Dibenzofuran-induced mitochondrial dysfunction: interaction with ANT carrier 

With the results pointing out an interaction of DBF with ANT as the 
cause for the decreased efficiency of ATP production, we performed titrations 
with CAT to better understand DBF effects on mitochondrial transmembrane 
potential. CAT is a highly selective inhibitor of cytosolic side-specific 
mitochondrial ANT that causes stabilization of the c conformation of ANT 
leading to mPTP opening. The results showed that, in mitochondria incubated 
with DBF, less CAT was needed to completely inhibit repolarization after ADP 
addition when compared to control. On the other hand, mitochondrial lag 
phase during a phosphorylative cycle was larger when we added CAT to 
mitochondria incubated with DBF, compared to control. This showed us that, 
when exposed to DBF, mitochondria already had some ANT inhibition, 
supporting the DBF/ANT interaction and consequent impairment of the 
translocase’s function. Using CAT also in mitochondrial swelling experiments, 
we could see that DBF prevented mitochondrial swelling that is induced by 
CAT, and we also compared this prevention with that provided by BKA, 
observing that both DBF and BKA inhibit MPT induction and consequent 
mitochondrial swelling. Additional experiments were performed using the 
fluorescent probe calcium-green to assess calcium retention capacity. We 
confirmed that DBF inhibited MPT induction, not only when compared only to 
control situation but also preventing CAT effect on the MPT triggering. 
In order to elucidate the involvement of DBF in the mPTP opening and 
the role of an interaction with ANT, we performed immunoprecipitation to 
check this interaction. It is known that, during mPTP opening, CypD 
interactions with ANT promote mPTP opening and MPT induction (Rasola et 
al., 2010; Hansson et al., 2011). We could see that, in samples that were 
used in MPT induction experiments, immunoprecipitating ANT we could 
detect CypD (thus bound previously to ANT). When MPT induction was 
prevented, either with CsA or DBF exposure, the ratio CypD/ANT in the 
sample was decreased when compared to control or CAT, also supporting 
that DBF was interacting with ANT and so preventing CypD binding and MPT 
induction. Nonetheless, we also wanted to assess if DBF was interacting with 
other protein that has been reported to modulate mPTP opening, the 
mitochondrial outer membrane translocator protein of 18 kDa, TSPO, formerly 
known as the peripheral benzodiazepine receptor (Azarashvili et al., 2010; 
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Ricchelli et al., 2011; Sileikytė et al., 2011). We wanted to check if DBF was 
also interacting with this receptor and this way modulating MPT induction. We 
performed calcium retention capacity experiments using a ligand for TSPO, 
PK11195, which induces pore opening and consequent calcium release. 
However, when DBF was present, no differences were found in calcium 
retention capacity of mitochondria challenged with the ligand (PK11195), 
suggesting that DBF effects were not being exerted via TSPO binding and 
following mPTP modulation. 
In summary, this work shows that DBF impairs hepatic mitochondrial 
function. DBF toxicity is mainly related to a decrease in phosphorylative 
efficiency, shown by an increase in lag phase. Also, a possible interaction of 
DBF with ANT carrier is supported by our results and induction of 
mitochondrial permeability transition is also affected by DBF exposure. Yet, 
further studies focused on understanding the upstream molecular 
mechanisms by which metabolic pathways are deregulated are needed. 
Those may ultimately help to develop therapeutic strategies and to prevent 
diseases related to pollutants exposure. 
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5.1 - Introduction 
 
Although DBF is considered an environmental toxicant, to which 
populations are exposed mainly through inhalation, studies about pollutants-
induced toxic effects in lung function are scarce. We have studied some of the 
effects of DBF exposure in isolated mitochondria both from lung and liver, 
respectively the primary target organ and the metabolizing organ. 
Mitochondrial dynamics is clearly important in cellular homeostasis.
Mitochondria are the energy suppliers for eukaryotic cells and a proper 
mitochondrial function is therefore essential in the fulfilment of the tissues 
energy-demand. ATP synthesis occurs via electron transport and oxidative 
phosphorylation; for that reason, mitochondria are also involved in the 
production of ROS (Carlson et al., 2005). Therefore, alterations of 
mitochondrial bioenergetic features by toxicants reduce energetic charge and 
result in cell death. Previous studies have identified mitochondrial targets of 
environmental pollutants, namely ROS production and decreased ATP 
content (Senft et al., 2002a; Shertzer et al., 2006). Consequently, 
maintenance of cell function is strictly dependent on the existence of a healthy 
population of mitochondria. In this respect, mitochondrial degradation by 
autophagy (mitophagy) may play an essential role in maintaining 
mitochondrial functionality. 
Autophagy is an evolutionarily conserved subcellular degradation 
process decomposing folded proteins, protein complexes and entire 
organelles, such as aggregates of misfolded proteins or damaged 
mitochondria (Gozuacik and Kimchi, 2007). Classically considered to be a 
pathway contributing to cellular homeostasis and adaptation to stress (e.g., 
during times of starvation), the autophagic machinery is now recognized to be 
recruited during several pathogenic conditions and diseases, and during the 
execution of a caspase-independent cell death (Rubinsztein et al., 2007; 
Levine and Kroemer, 2008). 
The main objectives of this work concerned DBF effects on pulmonary 
cellular function. A human lung epithelial cell line (A549) exposed in culture to 
DBF was used to address cell death and viability, ATP content, mitochondrial 
membrane potential, oxygen consumption and ROS production, nuclear 
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morphology and autophagy induction. Clarifying the role of pollutants in some 
mechanisms of toxicity, such as unbalance of bioenergetics status or cell 
death induction, may help to explain the progressive and chronic evolution of 
lung diseases. 
 
5.2 – Results 
 
5.2.1 – Cell death / viability 
 
A549 cell viability after incubation with DBF was a basic parameter to 
assess in order to understand the toxic effects of DBF on lung cells. Cell 
viability showed not to be affected by DBF incubation (Figure 5.2.1 - A), 
indicating that the effects of this pollutant in A549 cells do not induce cell 
death, for the concentrations and exposure periods tested. We performed flow 
cytometry experiments after staining of the cells with annexin V (detecting 
cells that have expressed phosphatidylserine on the cell surface, a feature 
found in apoptosis) and Propidium Iodide (PI) (a membrane impermeant dye 
generally excluded from viable cells, that enters the necrotic cells and is 
considered therefore a marker for necrotic cell death).  
 
Figure 5.2.1 (A) – A549 cell death/viability after DBF exposure. 
A549 cells were cultured as described in Chapter 2. DBF was added for 24h or 48h 
and Annexin-PI assay was performed. Data are means ± SEM of different 
experiments. No statistically significant differences were found (P < 0.05). 
0 
20 
40 
60 
80 
100 
24h 48h 
Vi
ab
ili
ty
 ( 
%
 o
f c
ou
nt
ed
 
ce
lls
 ) 
Control 
DBF 150μM 
DBF 250μM 
Chapter 5 – Exposure to Dibenzofuran triggers autophagy in lung cells 
 
A549 cells negative staining for annexin-V and propidium iodide showed that 
DBF didn’t cause apoptosis or necrosis (respectively) in A549 cells (Fig. 5.2.1 
– A). 
A549 cells viability upon exposure to DBF was also correlated with the 
amount of LDH released into the media. DBF incubation did not increase the 
release of LDH (Fig. 5.2.1 – B), indicating that DBF exposure doesn’t cause 
significant necrotic cell death at 24h of exposure. 
 
 
 
Figure 5.2.1 (B) – Effects of DBF exposure on LDH release. 
A549 cells were cultured and treated for 24h with DBF. Samples were collected and 
assayed for LDH release into the media using spectrophotometry, as described in 
Chapter 2. No statistically significant differences were found (P < 0.05). 
 
 
5.2.2 – Nuclear morphology (apoptosis) 
 
Staining of nucleus with Hoechst 33342 was visualized in order to 
evaluate apoptosis induction in A549 cells exposed to DBF (Figure 5.2.2). 
Exposure to DBF clearly caused a decrease in cell number, which is 
consistent with data obtained with cell proliferation assays. However, there is 
no evidence of apoptotic nucleus (brightly staining condensed chromatin, 
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nuclear fragmentation or apoptotic bodies) indicating that DBF didn’t induce
apoptosis in A549 cells. 
 
 
 
Figure 5.2.2 – Fluorescence microscopy images showing A549 cells treated 
for 24h and 48h with 250 µM DBF. 
A549 cells were cultured on top of cover slips, exposed to DBF and stained with 
Hoechst 33342 as described in Chapter 2. Representative images are presented to 
show the nuclear morphology in A549 cells. Scale bar, 20 μm. 
 
 
5.2.3 – Cell proliferation 
 
Cell proliferation was assessed as another fundamental parameter to 
evaluate time- and dose-dependent effects of DBF on A549 cells. As shown in 
Figure 5.2.3, exposure of A549 cells to DBF resulted in inhibition of cell 
proliferation; this inhibition was even more accentuated at 48h. Inhibition of 
cell proliferation for 150 µM DBF was significant only for the 48h exposure 
(Figure 5.2.3). Since no cells were detached (initial indicator of acute cell 
damage), that suggested that inhibition of cell proliferation was due to a 
specific effect of DBF on cell division/cell cycle progression, rather than on 
cell viability. 
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Figure 5.2.3 - Effects of DBF on cell proliferation. 
After 24h and 48h treatment, cell proliferation was estimated spectrophotometrically 
by sulforhodamine B assay, as described in Chapter 2. Percent proliferation was 
calculated by comparing with control cell proliferation, considered as 100% at each 
time point. Data are means ± SEM of different experiments. * indicates statistically 
significant difference versus control (P < 0.05). 
 
5.2.4 – MTT reduction 
 
Cell cultures exposed to 250 µM DBF for 24 h showed a significant 
decrease in MTT reduction (Figure 5.2.4), indicating decreased mitochondrial 
activity. This effect was even more pronounced in cell cultures exposed to 
250µM DBF for 48h, and with this treatment also 150 µM DBF caused a 
decrease in MTT reduction. 
 
5.2.5 – Adenine nucleotides content 
 
Evaluation of adenine nucleotides content in A549 cells revealed that 
exposure to DBF caused a significant decrease in ATP content (Figure 5.2.5 - 
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A) relatively to control cells, with a consequent decrease in ATP/ADP ratio 
(Figure 5.2.5 - B). 

Figure 5.2.4 – Relative MTT reduction after exposure to DBF. 
After 24 and 48 hours, mitochondrial activity was measured by MTT assay, using 
spectrophotometry to measure the amount of MTT formazan, as described in 
Chapter 2. Data are means ± SEM of different experiments. * indicates statistically 
significant difference versus control (P < 0.05). 

Figure 5.2.5 (A) – ATP content in lung cells exposed to DBF. 
A549 cells were cultured, exposed to DBF for 24h and 48h and then collected to 
extract adenine nucleotides as described in Chapter 2. ATP levels were measured 
by reverse-phase HPLC. Data are means ± SEM of different experiments. * 
indicates statistically significant difference versus control (P < 0.05). 
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The decline in ATP content in A549 cells was significant for both 
concentrations of the pollutant tested (150 µM and 250 µM) but only for 48h of 
exposure. The data shows an energy deficit in lung cells exposed to DBF 
suggesting impairment in ATP production. 
 
 
Figure 5.2.5 (B) – ATP/ADP ratio in lung cells exposed to DBF. 
A549 cells were cultured, exposed to DBF for 24h and 48h and then collected to 
extract adenine nucleotides as described in Chapter 2. Data are means ± SEM of 
different experiments. * indicates statistically significant difference versus control (P 
< 0.05). 
 
 
5.2.6 – Measurement of mitochondrial membrane potential (ΔΨm) 
 
Using A549 cells incubated for 24h with DBF, we assessed 
mitochondrial membrane potential with the fluorescent dye TMRM. The 
results showed that exposure to DBF caused a decrease in mitochondrial 
potential for 24h treatment (Figure 5.2.6). The decrease in mitochondrial 
potential was elicited by exposure to 250 µM DBF and it was significantly 
lower when compared to control. 
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Figure 5.2.6 – Mitochondrial membrane potential (ΔΨm) in A549 cells exposed 
to DBF. 
Cells exposed for 24h to DBF were used to estimate mitochondrial membrane 
potential (ΔΨm) fluorometrically with the probe TMRM, as described in Chapter 2. 
Data are means ± SEM of different experiments. * indicates statistically significant 
difference versus control (P < 0.05). 
 
 
5.2.7 – Measurement of mitochondrial oxygen consumption 
 
Oxygen consumption was evaluated in A54 cells exposed to DBF for 
24h. We could see that DBF exposure caused a decrease in mitochondrial 
oxygen consumption rate (Figure 5.2.7), when compared to control. The 
decreased oxygen consumption rate indicates an impairment in mitochondrial 
function caused by exposure to DBF, showing that the pollutant can induce 
damage in lung cells at the OXPHOS level. 
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Figure 5.2.7 – Mitochondrial oxygen consumption rate in A549 cells exposed 
to DBF. 
Cells exposed for 24h to DBF were used to estimate mitochondrial oxygen 
consumption rate using fluorometry, as described in Chapter 2. Data are means ± 
SEM of different experiments. * indicates statistically significant difference versus 
control (P < 0.05). 
 
 
5.2.8 – Measurement of ROS production 
 
The evaluation of the ROS formation rate in cells exposed to DBF was 
done using a probe that is fluorescent when oxidized (H2DCF-DA), giving us 
an estimate of the ROS production in cells after 24h of exposure to DBF. 
For both concentrations tested, 150 µM and 250 µM, ROS production 
rate was decreased (Figure 5.2.8) when compared to control. Despite the 
lower rate in cells exposed to 150 µM DBF, the decreased was only 
significant in cells exposed to 250 µM DBF. 
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Figure 5.2.8 – ROS production rate in A549 cells after exposure to DBF. 
Cells were cultured and exposed to DBF for 24h, and then assayed for ROS 
production fluorometrically using the probe H2DCF-DA, as described in Chapter 2. 
Data are means ± SEM of different experiments. * indicates statistically significant 
difference versus control (P < 0.05). 
 
 
5.2.9 – LC3 distribution pattern and autophagy induction 
 
LC3 protein is mostly present in the soluble form (LC3-I) in the cytosol 
during basal physiological conditions. When autophagy is induced, LC3-I is 
processed to form LC3-II that is present in autophagosome membranes. We 
transfected A549 cells with YFP-LC3 plasmid and then exposed the cells to 
DBF (250 µM) or incubated them in starvation medium as a positive control 
for autophagy induction. 
When we analysed the intracellular distribution of YFP-LC3 in A549 
cells, we noticed that DBF exposure induced the accumulation of this marker 
of autophagy into punctuate, vesicular structures (Figure 6.2.9). On the 
contrary, control cells displayed a faint, diffuse cytoplasmic YFP-LC3 
distribution. Of note, the punctuate pattern of YFP-LC3 was similar to that 
observed in cells that underwent starvation, the prototypical inducer of 
autophagy (Figure 5.2.9). A quantitative, blind analysis of YFP-LC3 
distribution showed that DBF exposure caused a significant increase in the 
punctuate autophagy-like pattern of this fluorescent marker (Figure 5.2.9). 
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Figure 5.2.9 – Autophagy triggering in A549 cells after exposure to DBF. 
A - Cellular distribution of YFP-LC3. A549 cells were transfected with YFP-LC3 and 
exposed to 250 μM DBF for 24h, as described in Chapter 2. Representatve images 
are presented. Scale bar, 20 μm. B – Blind quantitative analysis of autophagy 
induction in A549 cells. A549 cells transfected with YFP-LC3 were inspected and 
imaged using the fluorescence microscope, as described in Chapter 2. Data is 
presented as the percentage of autophagy-positive cells in the total number of 
transfected cells counted. Values statistically different from control: * P < 0,05. 
 
5.2.10 – LC3 and p62 accumulation by western blot analysis 
 
A549 cells in culture exposed to DBF showed an increase in LC3 
content (Figure 5.2.10), a protein involved in autophagy process. Additionally, 
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after 48h incubation, DBF induced an increase in LC3-I (cytosolic) to LC3-II 
conversion, the membrane bound protein involved in autophagosome 
formation and elongation. At 24h exposure there was an increase in LC3-I 
content, although the LC3-II content didn’t change significantly when 
compared to control. During autophagic process, LC3-I is formed from newly 
synthesized LC3, followed by the conversion of a fraction of LC3-I into LC3-II. 
This way, the amount of LC3-II is correlated with the extent of 
autophagosome formation. Accordingly, DBF exposure caused an 
accumulation of processed LC3-II at 48h (Figure 5.2.10). After 24h we could 
only detect an increase in LC3-I content and we didn’t see an increase in 
LC3-II protein band, probably due to a rapid breakdown of autophagosomes 
and concomitant degradation of LC3-II.  
 
 
Figure 5.2.10 – Autophagy-related protein markers content in A549 cells 
exposed to Dibenzofuran. 
Cell lysates obtained upon exposure to Dibenzofuran were used to perform Western 
Blot experiments and evaluate protein contents. A - LC3 conversion and 
accumulation (LC3-I and LC3-II). B - p62 protein content in A549 cells exposed to 
Dibenzofuran. 
 
Furthermore, analysis of another autophagy marker such as p62 protein 
content showed that A549 cells exposed to DBF for 24h have a slight 
decrease in p62 protein content (Figure 5.2.10), indicating an increased rate 
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of degradation of this protein, and therefore an increase in autophagic 
degradation process. 
 
5.2.11 – Lysotracker accumulation 
 
A549 cells exposed to DBF showed an increased cellular staining with 
the lysosomal dye Lysotracker Red (Figure 5.2.11), which accumulation is 
proportional to lysosomal acidification and number, and has already been 
used to monitor activation of autophagy. Lysotracker accumulation 
experiments were conducted in order to evaluate the status of cellular 
components degradation by autophagic delivery to lysosomes. Exposure of 
A549 cells to DBF 250 µM caused an increase in Lysotracker staining, when 
compared to control, indicating an increase in lysosomal vacuoles (Figure 
5.2.11), and thus representing an increase in self-digestion mechanisms in 
lung cells exposed to DBF. 
 
 
 
Figure 5.2.11 – Fluorescence microscopy images showing Lysotracker 
accumulation in A549 cells. 
A549 ells were cultured in glass coverslips, exposed to DBF for 24h, and incubated 
with LysoTracker Red DND-99 (100nM, 30min) before images were taking in the 
fluorescence microscope. Representative images are presented. Scale bar, 20 μm. 
 
5.2.12 – Mitochondrial DNA copy number 
 
DBF caused an increase in autophagy in A549 cells at 24h of exposure. 
Since autophagy can be specific and eliminate organelles rather than bulk 
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cytoplasm, we evaluated mtDNA copy number in cells exposed to DBF. 
However, no differences were found for mtDNA copy number per cell (Figure 
5.2.12), indicating that at this time of exposure no mitochondria-specific 
autophagy (mitophagy) was confirmed. 
 
 
 
Figure 5.2.12 – mtDNA copy number per cell in A549 exposed to DBF. 
A549 cells were cultured and exposed to DBF for 24h. mtDNA was quantified by 
means of quantitative PCR, calculating the ratio of mitochondrial gene (cytochrome 
b) copy number to nuclear gene (pyruvate kinase) copy number and expressing it as 
the mtDNA copy number per cell. Copy numbers for each gene were calculated 
based on standard curves. Bars represent the mean ± S.E.M. for three different cell 
cultures. No statistically significant differences were found (P<0.05). 
 
 
5.3 – Discussion 
 
Exposure to dioxins and other environmental pollutants, such as fuel 
constituents and incineration products, is associated in humans with 
obstructive pulmonary disease and lung cancer (Boffetta, 2006). Dibenzofuran 
is a widespread environmental contaminant that results from chemical and 
combustion processes, and exposure to it brings out several dreadful effects. 
Although some work has been conducted on pollutants-induced liver toxicity 
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using liver cells in culture and animal models (Bunger et al., 2003; Niittynen et 
al., 2008; Weinstein et al., 2008), the evaluation of lung cell function after 
exposure to this kind of toxicants is scarce. In this study we report that there is 
both time and concentration-dependence on DBF-induced proliferative arrest 
in A549 cells, related to a drop in cellular ATP content and increased 
lysosome accumulation and self-degradation events. 
Previous studies on mitochondrial dysfunction induced by exposure to 
pollutants, such as TCDD or arsenic, have been carried out in liver 
(Mildaziene et al., 2002; Lee and Sokol, 2007), blood cells (Banerjee et al., 
2008), brain (Coburn et al., 2008), or in the lung (Duarte et al., 2011). In both 
hepatic mitochondria isolated from TCDD-treated mice and mitochondria 
incubated in vitro with TCDD, a number of functional alterations have been 
observed, including a defect in ATP synthesis and increased ROS production 
(Senft et al., 2002b; Shen et al., 2005; Shertzer et al., 2006). Reported 
experiments with lung isolated mitochondria showed that the time that elapses 
from ADP-induced depolarization until total repolarization – lag phase – was 
significantly enlarged in mitochondria exposed to DBF (Duarte et al., 2011), 
suggesting that DBF may impair mitochondrial phosphorylative efficiency. 
Additionally, Shertzer and collaborators have also shown a decreased hepatic 
ATP content related to a defect in the mitochondrial ATP synthase in rats 
treated with TCDD for 1 week. Thus, the mitochondrial phosphorylative 
system is probably a target for pollutant-induced mitochondrial dysfunction. 
In this study we evaluated cell death induced by exposure of A549 cells 
to Dibenzofuran. Previous works with A549 cells have shown that anti-cancer 
agents and toxicants from gasoline engine exhaust harm normal cell function 
(Catassi et al., 2006). These compounds have been shown to decrease cell 
viability and mitochondrial dehydrogenases activity, induce apoptotic cell 
death, increase the formation of micronucleated cells and enhance DNA 
damage, in a dose-response manner (Catassi et al., 2006; Zhang et al., 2007). 
In our study, exposure of A549 cells in culture to DBF revealed a dose- and 
time-dependent decrease in relative cell proliferation and MTT reduction, but 
no alterations in cell death/viability, assessed by staining with annexin V-PI or 
LDH release. DBF exposure did not induce apoptotic cell death; this result 
can be related to the ATP dependence of apoptosis execution, given that the 
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exposure to the pollutant caused a decrease in the ATP levels in lung cells. 
Additionally, the absence of an increase in LDH release suggested that 
inhibition of cell proliferation by DBF exposure was not due to increased 
necrotic cell death, suggesting a specific effect of DBF on cell division and/or 
the induction of self-digestion mechanisms (autophagy), that can be 
considered as a rescue mechanism from dysfunction caused by the pollutant 
in the lung cells. 
ATP content in A549 cells exposed to DBF was found to be decreased, 
and this data is in agreement with the lower mitochondrial membrane potential 
and reduced oxygen consumption observed in A549 cells exposed to 250 μM 
for 24h, suggesting an impairment of mitochondrial function. Remarkably, 
when we analysed ROS generation in lung cells incubated with DBF, we 
found a decrease in the rate of ROS formation. Some studies have reported 
that mitochondrial dysfunction/loss of mitochondrial membrane potential (Kim 
et al., 2007) and oxidative stress (Kaushik and Cuervo, 2006) induce 
autophagic mechanisms (Kaushik and Cuervo, 2006; Chen et al., 2007; Azad 
et al., 2009). In its turn, autophagy will end up removing damaged proteins 
and damaged/dysfunctional mitochondria, therefore reducing ROS levels 
(Scherz-Shouval and Elazar, 2011). 
The occurrence of increased autophagosomes in dying/dead cells in 
certain contexts led to the idea that autophagy may be a primary death 
mediator. This phenomenon was termed type-II cell death, to differentiate it 
from apoptotic (or type-I cell death) (Schweichel and Merker, 1973). Since 
increased numbers of autophagosomes can result both from increased 
autophagosome synthesis, as well as from decreased autophagosome–
lysosome fusion, cells showing type-II cell death may not always have 
increased autophagic flux. Although there is mounting evidence that this may 
be a relevant pathway in Drosophila metamorphosis (Denton et al., 2009), the 
role of autophagy as a positive mediator of cell death is unclear and not well 
understood in mammalian systems. On the other hand, many studies suggest 
that impaired autophagy sensitises cells and organisms to toxic insults 
(Takacs-Vellai et al., 2005; Levine and Yuan, 2005). One of the first studies 
that addressed this question in mammalian cells (Boya et al., 2005) reported 
that cells exhibit type-II cell death morphology when lysosome–
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autophagosome fusion is inhibited, suggesting that autophagy may be 
cytoprotective. The lysosomotropic agent hydroxychloroquine (HCQ) leads to 
the accumulation of autophagic vacuoles (AV) that triggers a pre-lethal 
program, which can be suppressed by mitochondrial membrane permeability 
inhibitors, or caspase antagonists. AV accumulation precedes ΔΨm loss, 
which marks imminent cell death and apoptosis (Boya et al., 2005). 
Consistent with these data, other group (Ravikumar et al., 2006) showed that 
genetic or chemical inhibition of autophagy sensitised cells to pro-apoptotic 
insults and that autophagy induction with rapamycin or Beclin 1 
overexpression protected cells and Drosophila from pro-apoptotic agents. 
These data suggested that the ability of autophagy to reduce the 
mitochondrial load in cells and thereby lower the amount of pro-apoptotic 
molecules (like cytochrome c) released from mitochondria after apoptotic 
insults, was an important contributor to the protective effects of autophagy 
(Moreau et al., 2010). 
An evident increase in lysosomal vacuoles in cells exposed to DBF, 
along with accumulation of LC3 in punctuate structures, suggest an increase 
in autophagosome formation in cells exposed to DBF; thus, these results put 
forward that exposure to DBF induces autophagy in A549 cells. However, the 
lack of differences in the mtDNA copy number of cells exposed to DBF does 
not permit to make an assertion about specific autophagy degrading 
mitochondria (mitophagy), at 24h of exposure to DBF. In our experimental 
settings, we found ROS generation to be decreased in lung cells after 24h of 
exposure to DBF; this is probably the consequence of a salvage mechanism 
that is triggered to prevent and/or recover from cellular damage caused by 
DBF, particularly autophagy mechanisms. 
Different autophagic pathways have been described, all sharing in 
common the import of cytoplasmic components into the lysosome. Autophagy 
induction and alterations in the autophagic-lysosomal compartment have been 
linked to neuronal death in many neurodegenerative disorders as well as in 
transmissible neuronal pathologies (Larsen and Sulzer, 2002; Qin et al., 2003; 
Webb et al., 2003; Yu et al., 2003; Mariño and López-Otín, 2004; Alirezaei et 
al., 2008). LC3-II is the only protein marker that is reliably associated with 
completed autophagosomes. In mammalian cells, the total levels of LC3 do 
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not necessarily change, as there may be increases in the conversion of LC3-I 
to LC3-II, or a decrease in LC3-II relative to LC3-I if degradation of LC3-II via 
lysosomal turnover is particularly rapid. Western blotting was used to monitor 
changes in LC3 amounts, showing an increase of LC3-I to LC3-II conversion 
in A549 cells exposed to DBF for 48h. For 24h exposure we could only see an 
increase in LC3-I content in comparison with control, although LC3-II didn’t 
change significantly; this may probably be due to the fact that, at this time, 
autophagosomal number was not yet large enough to break out the normal 
and rapid degradation, that way not being accumulated. Given that the 
amount of LC3-II is correlated with the extent of autophagosome formation, 
data shows that DBF toxic effects include triggering of autophagy in lung cells 
in culture. Additionally, we wanted to evaluate another marker that can be 
associated with autophagy induction. Thus we estimated the degradation of 
p62 protein, other established indicator of the activation of autophagy 
(Ichimura et al., 2008). We found that exposure of A549 cells to Dibenzofuran 
also caused a small decrease in p62 protein content, which is in agreement 
with the established degradation of p62 after activation of autophagy, since 
that the levels of p62 protein are regulated also by autophagy through an 
interaction of this protein with LC3 (Ichimura et al., 2008). 
In summary, our results indicate that mitochondria are probably a 
target in DBF-induced lung toxicity. A decrease in the mitochondrial 
phosphorylative efficiency elicited by Dibenzofuran, with subsequent decrease 
in ATP content, are damaging results from exposure to Dibenzofuran; also 
inhibition of lung cell proliferation and mitochondrial activity, as well as 
autophagy triggering seem to be critical events in DBF-induced impairment of 
pulmonary function. 
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Environmental pollutants such as polychlorinated dibenzo-p-dioxins 
(PCDDs) and polychlorinated dibenzofurans (PCDFs) constitute a category of 
chlorinated aromatic hydrocarbons containing 210 structurally related 
congeners (US EPA, 2004). These compounds are associated with a wide 
range of physiological and toxicological effects, many of which are mediated 
via a common underlying mechanism of action involving chemical binding to 
the aryl hydrocarbon receptor (AhR) (Goodman et al., 2010). Effects 
associated with dioxins and dioxin-like compounds (DLCs) range from 
distinctive acute effects that can be readily observed following high level 
exposures (e.g., chloracne) to more subtle effects (e.g., potential impacts on 
the levels or functioning of endogenous hormones) for which the biological 
and clinical significance may be less certain. 
In humans, exposure to nocuous agents such as PCBs, B[a]P, and 
dioxin-like compounds in cigarette smoke have the potential to induce 
inflammation or exacerbate chronic bronchitis, asthma, COPD, and lung 
cancer (Patel and Homnick, 2000; Baginski et al., 2006; Marshall and 
Kerkvliet, 2010; Chiba et al., 2012). In addition to lung and liver as primary 
target organs of toxicity, reproductive, hormonal and immunological defects 
have also been shown following exposure to different types of environmental 
pollutants (Fisher et al., 2005; van Grevenynghe et al., 2005; Kobayashi et al., 
2009; Ferecatu et al., 2010; Helgason et al., 2010; Martin and Klaassen, 
2010). Various combustion and industrial processes contribute to the 
widespread environmental contamination with Dibenzofuran (US EPA, 2004). 
These compounds also have high persistence in the environment, but 
humans can also be exposed via sources such as the diet, leading to long-
term accumulation in fatty tissues. However, the wide range of physiological 
and toxicological effects of these compounds is still uncertain, especially 
those caused by chronic exposure comparatively to distinct acute effects 
observed after high level exposures. 
Binding to AhR and related ROS generation has been suggested as 
the mechanism of action underlying the toxic and biological effects of these 
dioxins and dioxin-like compounds (Senft et al., 2002b; Chiba et al., 2011a). 
The AR/AHR nuclear translocator (ARNT) complex binds to canonical DNA 
recognition sequences found in the genes coding for many phase I and phase 
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II detoxification enzymes, such as the cytochromes P450 CYP1A1, CYP1A2, 
and CYP1B1, and initiates gene transcription (Whitlock, 1999). Besides its 
role in the regulation of drug metabolism, the AhR also has an important 
physiologic role in the control of cell-cycle progression, liver and vascular 
development, immune system function, and cell growth and differentiation 
(Fernandez-Salguero et al., 1995; Schmidt and Bradfield, 1996; Elizondo et 
al., 2000). Therefore, AhR activation has been described as necessary for the 
teratogenic, immunotoxic, carcinogenic, and biochemical effects of dioxins 
and dioxin-like compounds (Rowlands and Gustafsson, 1997), by inducing 
gene alteration, cell-cell adhesion interaction, cytokine expression, and mucin 
production, which are involved in the induction of cancer or inflammation 
(Watabe et al., 2010; Chiba et al., 2011b; Chiba et al., 2011a; Barouki et al., 
2012). 
However, the underlying mechanisms are not fully understood and 
toxic mechanisms activated by dioxins and dioxin-like compounds, 
independent of AhR activation, must be considered (Fernandez-Salguero et 
al., 1995; Hossain et al., 1998; Ahmed et al., 2005). 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) induces apoptosis in the human 
lymphoblastic T-cell line L-MAT, although these cells do not express the AhR 
(Hossain et al., 1998; Kobayashi et al., 2009). Also, previous work with Ahr 
knockout mice revealed the existence of dioxin-independent functions of Ahr, 
including developmental functions and ageing-related detoxification 
(Fernandez-Salguero et al., 1995). The relationship between these two types 
of biological actions (AhR-dependent and independent) remains unclear, 
which hampers understanding and treatment of dioxin and dioxin-like 
compounds toxicity. Recently, siRNA-mediated knockdown of the AhR in lung 
epithelial cells and fibroblasts was shown to increase sensitivity to smoke-
induced apoptosis (Rico de Souza et al., 2011). This involved mitochondrial 
dysfunction, decreased antioxidant enzymes and oxidative stress. 
Mitochondria are intracellular organelles with many cellular roles 
besides the first described energy production by oxidative phosphorylation, 
namely fatty acid β-oxidation, heat generation, ROS metabolism and cell 
death regulation (Martel et al., 2012). Mitochondria perform diverse yet 
interconnected functions, producing ATP and many biosynthetic intermediates 
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while also contributing to cellular stress responses such as autophagy and 
apoptosis. Mitochondria form a dynamic, interconnected network that is 
intimately integrated with other cellular compartments. In addition, 
mitochondrial functions extend beyond the boundaries of the cell and 
influence an organism's physiology by regulating communication between 
cells and tissues. It is therefore not surprising that mitochondrial dysfunction 
has emerged as a key factor in a myriad of diseases, including 
neurodegenerative and metabolic disorders (Nunnari and Suomalainen, 
2012). Indeed, mitochondrial dysfunction has been associated with a series of 
human diseases such as cancer, cardiopathies, nonalcoholic fatty liver 
diseases, neurodegenerative diseases, aging and cell dysfunction triggered 
by exposure to xenobiotics (Wallace, 1999; Kroemer et al., 2007; Martel et al., 
2012). Decreased mitochondrial efficiency leads to metabolic impairment 
characterized by decreased ATP synthesis capacity, enhanced ROS 
production due to electron leak from the respiratory chain, as well as 
morphological alterations of mitochondrial network. Mitochondria also 
contribute to cellular stress responses such as autophagy and apoptosis, via 
mitochondrial membrane permeabilization (MMP) and release of proapoptotic 
factors contained in the intermembrane space to the cytosol (Eisenberg-
Lerner et al., 2009; Okamoto and Kondo-Okamoto, 2012). Multiple lines of 
evidence indicate that mitochondrial ROS also influence homeostatic 
signaling pathways to control cell proliferation and differentiation and to 
contribute to adaptive stress signaling pathways, such as hypoxia (Hamanaka 
and Chandel, 2010). 
Mitochondrial dysfunction induced by exposure to pollutants, such as 
TCDD or arsenic has been shown in liver (Mildaziene et al., 2002; Lee and 
Sokol, 2007), blood cells (Banerjee et al., 2008) and in brain (Coburn et al., 
2008). In both hepatic mitochondria isolated from TCDD-treated mice and 
mitochondria incubated in vitro with TCDD, a number of functional alterations 
have been observed, including a defect in ATP synthesis and increased ROS 
production (Senft et al., 2002a; Shen et al., 2005; Shertzer et al., 2006; Kopf 
and Walker, 2010). TCDD decreases hepatic ATP levels through changes in 
mitochondrial F0F1-ATP synthase and ubiquinone and generates 
mitochondrial oxidative DNA damage, which is exacerbated by increasing 
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mitochondrial glutathione redox state and by inner membrane 
hyperpolarization. These mitochondrial effects of TCDD are also associated 
with altered expression of nuclear encoded mitochondrial genes (Forgacs et 
al., 2010), as well as apoptosis induction involving calcium/calmodulin 
signaling (Kobayashi et al., 2009). In primary hepatocytes, TCDD has been 
shown to induce an oxidative stress response involving mitochondrial 
dysfunction (Aly and Domènech, 2009), and in mice exposure to TCDD would 
caused a loss in mitochondrial membrane potential mediated by AhR-
dependent production of ROS (Fisher et al., 2005). 
Experiments with isolated mitochondria from lungs showed that the 
generation of mitochondrial membrane potential was not compromised by 
exposure to DBF, neither was mitochondrial oxygen consumption (Chapter 3). 
Nevertheless, the time that elapses from ADP-induced depolarization until 
total repolarization – lag phase – was significantly enlarged in mitochondria 
exposed to DBF, suggesting that DBF may impair the mitochondrial 
phosphorylative system. Additionally, Shertzer and collaborators have also 
shown a decrease in hepatic ATP levels related to a defect in the 
mitochondrial ATP synthase in rats treated with TCDD for 1 week (Shertzer et 
al., 2006). Mitochondrial ATPase (ATPsynthase) activity, one of the 
components of the mitochondrial phosphorylative sub-system, was then 
evaluated through phosphate (Pi) production from ATP hydrolysis (Chapter 3). 
Interestingly, no significant differences were found between lung mitochondria 
incubated with DBF and control, indicating that other components of the 
phosphorylative system are being affected by DBF and then causing the 
impairment on ATP synthesis.  In isolated liver mitochondria, DBF also did not 
affect mitochondrial capacity to generate and sustain membrane potential, 
created by the electron transport chain and used to drive production of ATP 
from ADP in the matrix (Chapter 4). However, similarly to the effects on lung 
mitochondria, DBF decreased mitochondrial phosphorylative efficiency 
(increased lag phase), thus impairing ATP synthesis. This was also reflected 
by the decrease in respiratory state 3 (active phosphorylation) after exposure 
to DBF. Hence, in liver mitochondria, DBF exposure decreased ATPase 
efficiency, while not excluding action at the level of other components of the 
phosphorylative system (Chapter 4). Titrations with CAT showed that, in 
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mitochondria incubated with DBF, less CAT was needed to completely inhibit 
repolarization after ADP addition when compared to control. Also, the lag 
phase in DBF-exposed mitochondria during a phosphorylative cycle was 
larger in the presence of CAT, comparatively to control. This suggested that 
DBF inhibits ANT activity (Chapter 4), at least in isolated mitochondria. 
Increases in mitochondrial permeability are also manifestations of 
mitochondrial dysfunction and are associated with induction of apoptotic and 
necrotic death (Kroemer et al., 2007; Millay et al., 2008; Varela et al., 2008; 
Halestrap and Pasdois, 2009; Mbye et al., 2009; Nicholls, 2009; Russmann et 
al., 2009; Varela et al., 2010). Mitochondrial permeability transition is caused 
by the mitochondrial permeability transition pore (mPTP), a voltage- and Ca2+- 
dependent, cyclosporine A (CsA)-sensitive, high conductance channel 
(Rasola et al., 2010). This causes cell death by uncoupling oxidative 
phosphorylation, inducing mitochondrial swelling and collapsing mitochondrial 
membrane potential, thus blocking cellular ATP formation. Such defective 
mitochondria have the potential to further damage the population of healthy 
mitochondria, by exposure to accelerated ROS generation and increased 
calcium concentrations. MPT induction is associated with pathological 
conditions and is triggered by high Ca2+, oxidative stress, ATP depletion, high 
inorganic phosphate and mitochondrial depolarization. In both lung (Chapter 
3) and liver mitochondria (Chapter 4), exposure to DBF inhibited calcium-
induced mitochondrial swelling, cytochrome c release and calcium-induced 
mitochondrial calcium efflux sensitive to CsA. DBF also prevented 
mitochondrial swelling induced by CAT in liver mitochondria (Chapter 4). 
Taking also into account the suggested inhibition of the ANT activity, based 
on the lag phase experiments, DBF inhibitory effect on the MPT is probably 
dependent on the ANT. CAT induces MPT induction by facilitating changes in 
the conformational state of the ANT, stabilizing the “c” conformation where the 
nucleotide binding site faces the cytoplasmic side of the membrane (Zoratti 
and Szabò, 1995). The calcium-dependency of the MPT suggested that there 
might be a calcium trigger site exposed on the ANT associated with the “c” 
conformation (Halestrap and Brenner, 2003). The requirement for the ANT in 
MPT induction was questioned when liver mitochondria of mice genetically 
modified to lack the two major isoforms of ANT (ANT1 and ANT2) still 
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exhibited CsA-sensitive MPT (Kokoszka et al., 2004). However, ANT-deficient 
mitochondria require much higher calcium concentrations to open the 
permeability pore, suggesting if not a physical at least a regulatory role for the 
ANT in MPT induction, sensitizing to adenine nucleotides and ANT ligands 
(Kokoszka et al., 2004; Baines and Molkentin, 2009). Early on, it was 
demonstrated that ANT binds cyclophilin D (CypD) in a CsA-sensitive manner 
and that role of CypD in mPTP formation was to induce a conformational 
change in the ANT (Crompton et al., 1998; Woodfield et al., 1998; Rasola et 
al., 2010; Hansson et al., 2011). CypD was detected by immunoprecipitating 
the ANT after calcium-induced mitochondrial swelling (thus bound previously 
to ANT) (Chapter 4). When MPT induction was prevented, either with CsA or 
DBF exposure, the ratio CypD/ANT in the samples was decreased when 
compared to control or CAT, also supporting that DBF interacts with the ANT 
and somehow prevents CypD binding and MPT induction (Chapter 4). It has 
been described that the MPT can also operate in a more “limited size” or “low 
conductance” mode, which allows passage of only small ions across the inner 
mitochondrial membrane (Novgorodov and Gudz, 1996; Ichas and Mazat, 
1998). Because opening of the low conductance mPTP does not allow 
passage of large molecules, but does allow the passage of small ions, 
mitochondrial ion gradients and energy production are affected. As such, it is 
thought that the low conductance MPT functions not to induce cell death but 
to aid in the fine regulation of cell metabolism (Ichas and Mazat, 1998). The 
low-conductance state also allows fine dissipation of mitochondrial membrane 
potential, preventing mitochondrial ROS generation due to mitochondrial 
hyperpolarization. 
Studies with lung epithelial A549 cells exposed to DBF showed that 
DBF exposure decreases ATP content, thus inhibiting cell proliferation, 
without inducing necrotic or apoptotic cell death (Chapter 5). The decreased 
mitochondrial activity was associated with a reduced rate of oxygen 
consumption and decreased ROS generation, which could be explained by 
increased autophagy and mitochondria removal. It is currently known that 
autophagy might mediate cytoprotective effects; the mechanisms include the 
ability of autophagy to buffer against starvation-induced stress, protect against 
apoptotic insults and clear mitochondria, aggregate-prone proteins and 
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pathogens (Moreau et al., 2010). These effects are pertinent to the roles of 
autophagy in normal human physiology, including the early neonatal period 
and ageing, as well as a variety of diseases, including cancer, 
neurodegenerative conditions and infectious diseases (Moreau et al., 2010). 
Concerning DBF exposure of A549 lung cells, autophagy will end up removing 
damaged proteins and dysfunctional mitochondria, therefore reducing ROS 
levels (Chapter 5) and preventing the extension of the initial damage induced 
by DBF. The same rescue mechanism has already been reported by other 
authors (Scherz-Shouval and Elazar, 2011). The mechanisms whereby 
autophagy mediates its cytoprotective effects are still the subject of active 
investigation by a number of laboratories. It is likely that these may vary 
according to the stress that the relevant cells and organisms are exposed to, 
and the cell types involved (Moreau et al., 2010). 
Controversy exists as to whether autophagy promotes or prevents cell 
death (Hait et al., 2006; Levine and Kroemer, 2008). Autophagy removes 
damaged mitochondria that would otherwise activate caspases and apoptosis, 
suggesting that autophagy should be protective. Also, disruption of 
autophagic processing and/or lysosomal function promotes caspase-
dependent cell death, as well as excessive and dysregulated autophagy may 
promote cell death (Narendra et al., 2008; Narendra et al., 2010; Kim and 
Lemasters, 2011; Green et al., 2011; Michel et al., 2012; Mai et al., 2012). 
Compromised mitochondrial function and autophagic overload have been 
described for several pathologies. Compromising mitochondrial function with 
the antiretroviral drug efavirenz induces cell survival-promoting autophagy 
(Apostolova et al., 2011). Increased autophagy contributes to COPD 
pathogenesis by promoting epithelial cell death (Ryter and Choi, 2010) and 
exposure to cigarette smoke extract induces ER stress and autophagy in 
human umbilical vein endothelial cells (HUVECs) (Csordas et al., 2011). 
In summary, this work aimed to evaluate the effects that are elicited by 
Dibenzofuran exposure. Since mitochondria are key players in cellular 
life/death regulation, besides being its primary energy supplier, isolated 
mitochondria were used as models. In vitro exposure to the toxicant caused 
mitochondrial impairment, mainly at the phosphorylative system level but also 
deregulation of mitochondrial permeability transition (which is one of the main 
Chapter 6 – General discussion 
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mechanisms involved in cell death regulation, calcium homeostasis and global 
mitochondrial and cellular fitness). Both mitochondria from the lung (primary 
exposure source for gaseous toxicants like DBF) and the liver (the organ that 
most accumulates and metabolizes xenobiotics) were affected by DBF, which 
exerted its deleterious effects at least in part by interacting with the 
mitochondrial ANT carrier. Also A549 lung cells were exposed to DBF and 
showed impaired function. DBF caused a decrease in cellular proliferation, 
mitochondrial potential and cellular energy levels (reduced ATP), and the 
harmful effects of the toxicant trigger a rescue mechanism that involves 
autophagy induction after DBF exposure. The main toxic effects of DBF are 
depicted in Figure 6.1. 
 
 
 
Figure 6.1 – Scheme illustrating the main effects of DBF exposure. 
DBF affects mitochondrial function, impairing phosphorylative efficiency and 
interfering with MPT induction. These effects are related to an interaction with the 
ANT carrier. Mitochondrial dysfunction can help to explain cellular damage. At least 
in lung cells, DBF exposure triggers autophagy as a rescue mechanism to block the 
progression of the damage, and therefore improve cellular function, by mitigating the 
origin of the damage (dysfunctional mitochondria and ROS production). 
Chapter 6 – General discussion 
 
 
Clarifying some of the molecular mechanisms that motivate 
environmental pollutants-induced damage, may help to develop better and 
more effective strategies to ameliorate health condition that is continuously 
threatened by today’s continuously increasing environmental pollution. 
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Bibliography

Bibliography 
 
Abramov, A. Y., Gegg, M., Grünewald, A., Wood, N. W., Klein, C. and Schapira, A. 
H. V. (2011). Bioenergetic Consequences of PINK1 Mutations in Parkinson 
Disease. PLoS ONE 6, e25622. 
Ahmed, S., Shibazaki, M., Takeuchi, T. and Kikuchi, H. (2005). Protein kinase 
Ctheta activity is involved in the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced signal 
transduction pathway leading to apoptosis in L-MAT, a human lymphoblastic T-cell 
line. FEBS J 272, 903–915. 
Alexander, C., Votruba, M., Pesch, U. E., Thiselton, D. L., Mayer, S., Moore, A., 
Rodriguez, M., Kellner, U., Leo-Kottler, B., Auburger, G., et al. (2000). OPA1, 
encoding a dynamin-related GTPase, is mutated in autosomal dominant optic 
atrophy linked to chromosome 3q28. Nat Genet 26, 211–215. 
Alirezaei, M., Kiosses, W. B., Flynn, C. T., Brady, N. R. and Fox, H. S. (2008). 
Disruption of neuronal autophagy by infected microglia results in 
neurodegeneration. PLoS ONE 3, e2906. 
Aly, H. A. A. and Domènech, O. (2009). Cytotoxicity and mitochondrial dysfunction of 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in isolated rat hepatocytes. Toxicol Lett 
191, 79–87. 
Aoki, Y. (2001). Polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins, and 
polychlorinated dibenzofurans as endocrine disrupters--what we have learned from 
Yusho disease. Environ Res 86, 2–11. 
Apostolova, N., Gomez-Sucerquia, L. J., Gortat, A., Blas-Garcia, A. and 
Esplugues, J. V. (2011). Compromising mitochondrial function with the 
antiretroviral drug efavirenz induces cell survival-promoting autophagy. Hepatology 
54, 1009–1019. 
Argaud, L., Gateau-Roesch, O., Raisky, O., Loufouat, J., Robert, D. and Ovize, M. 
(2005). Postconditioning inhibits mitochondrial permeability transition. Circulation 
111, 194–197. 
Aristizábal, B., Cobo, M., Hoyos, A., Montes de Correa, C., Abalos, M., Martínez, 
K., Abad, E. and Rivera, J. (2008). Baseline levels of dioxin and furan emissions 
from waste thermal treatment in Colombia. CHEMOSPHERE 73, S171–5. 
Ashford, T. and Porter, K. (1962). Cytoplasmic components in hepatic cell lysosomes. 
J Cell Biol 12, 198–202. 
Attardi, G. and Schatz, G. (1988). Biogenesis of mitochondria. Annu. Rev. Cell Biol. 4, 
289–333. 
Azad, M. B., Chen, Y. and Gibson, S. B. (2009). Regulation of autophagy by reactive 
oxygen species (ROS): implications for cancer progression and treatment. Antioxid 
Redox Signal 11, 777–790. 
Azarashvili, T., Stricker, R. and Reiser, G. (2010). The mitochondria permeability 
transition pore complex in the brain with interacting proteins - promising targets for 
protection in neurodegenerative diseases. Biological Chemistry 391, 619–629. 
Azoulay-Zohar, H., Israelson, A., Abu-Hamad, S. and Shoshan-Barmatz, V. (2004). 
In self-defence: hexokinase promotes voltage-dependent anion channel closure 
and prevents mitochondria-mediated apoptotic cell death. Biochem J 377, 347–
Bibliography 

355. 
Azzolin, L., Stockum, von, S., Basso, E., Petronilli, V., Forte, M. A. and Bernardi, 
P. (2010). The mitochondrial permeability transition from yeast to mammals. FEBS 
Lett 584, 2504–2509. 
Bae, Y. S., Oh, H., Rhee, S. G. and Yoo, Y. D. (2011). Regulation of reactive oxygen 
species generation in cell signaling. Mol. Cells 32, 491–509. 
Baginski, T. K., Dabbagh, K., Satjawatcharaphong, C. and Swinney, D. C. (2006). 
Cigarette smoke synergistically enhances respiratory mucin induction by 
proinflammatory stimuli. Am J Respir Cell Mol Biol 35, 165–174. 
Baines, C. P. (2009). The molecular composition of the mitochondrial permeability 
transition pore. J Mol Cell Cardiol 46, 850–857. 
Baines, C. P. and Molkentin, J. D. (2009). Adenine nucleotide translocase-1 induces 
cardiomyocyte death through upregulation of the pro-apoptotic protein Bax. J Mol 
Cell Cardiol 46, 969–977. 
Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. 
A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005). 
Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition 
in cell death. Nature 434, 658–662. 
Baines, C. P., Kaiser, R. A., Sheiko, T., Craigen, W. J. and Molkentin, J. D. (2007). 
Voltage-dependent anion channels are dispensable for mitochondrial-dependent 
cell death. Nat Cell Biol 9, 550–555. 
Baines, C. P., Song, C.-X., Zheng, Y.-T., Wang, G.-W., Zhang, J., Wang, O.-L., Guo, 
Y., Bolli, R., Cardwell, E. M. and Ping, P. (2003). Protein kinase Cepsilon 
interacts with and inhibits the permeability transition pore in cardiac mitochondria. 
Circ Res 92, 873–880. 
Bakeeva, L. E., Chentsov YuS and Skulachev, V. P. (1978). Mitochondrial 
framework (reticulum mitochondriale) in rat diaphragm muscle. Biochim Biophys 
Acta 501, 349–369. 
Bakke, B., Stewart, P. A. and Waters, M. A. (2007). Uses of and exposure to 
trichloroethylene in U.S. industry: a systematic literature review. J Occup Environ 
Hyg 4, 375–390. 
Banerjee, N., Banerjee, M., Ganguly, S., Bandyopadhyay, S., Das, J. K., 
Bandyopadhay, A., Chatterjee, M. and Giri, A. K. (2008). Arsenic-induced 
mitochondrial instability leading to programmed cell death in the exposed 
individuals. Toxicology 246, 101–111. 
Barouki, R., Aggerbeck, M., Aggerbeck, L. and Coumoul, X. (2012). The aryl 
hydrocarbon receptor system. Drug Metabol Drug Interact 27, 3–8. 
Basso, E., Fante, L., Fowlkes, J., Petronilli, V., Forte, M. A. and Bernardi, P. 
(2005). Properties of the permeability transition pore in mitochondria devoid of 
Cyclophilin D. J Biol Chem 280, 18558–18561. 
Basso, E., Petronilli, V., Forte, M. A. and Bernardi, P. (2008). Phosphate is essential 
for inhibition of the mitochondrial permeability transition pore by cyclosporin A and 
Bibliography 
 
by cyclophilin D ablation. J Biol Chem 283, 26307–26311. 
Bauer, M. K., Schubert, A., Rocks, O. and Grimm, S. (1999). Adenine nucleotide 
translocase-1, a component of the permeability transition pore, can dominantly 
induce apoptosis. J Cell Biol 147, 1493–1502. 
Bayir, H. and Kagan, V. E. (2008). Bench-to-bedside review: Mitochondrial injury, 
oxidative stress and apoptosis--there is nothing more practical than a good theory. 
Crit Care 12, 206. 
Bereiter-Hahn, J. and Vöth, M. (1994). Dynamics of mitochondria in living cells: shape 
changes, dislocations, fusion, and fission of mitochondria. Microsc. Res. Tech. 27, 
198–219. 
Bernales, S., McDonald, K. L. and Walter, P. (2006). Autophagy counterbalances 
endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol 
4, e423. 
Bernardi, P. (1992). Modulation of the mitochondrial cyclosporin A-sensitive 
permeability transition pore by the proton electrochemical gradient. Evidence that 
the pore can be opened by membrane depolarization. J Biol Chem 267, 8834–
8839. 
Bernardi, P. (1999). Mitochondrial transport of cations: channels, exchangers, and 
permeability transition. Physiol Rev 79, 1127–1155. 
Bernardi, P. and Stockum, von, S. (2012). The permeability transition pore as a 
Ca(2+) release channel: New answers to an old question. Cell Calcium. 
Bernardi, P., Broekemeier, K. M. and Pfeiffer, D. R. (1994). Recent progress on 
regulation of the mitochondrial permeability transition pore; a cyclosporin-sensitive 
pore in the inner mitochondrial membrane. J Bioenerg Biomembr 26, 509–517. 
Bernardi, P., Krauskopf, A., Basso, E., Petronilli, V., Blachly-Dyson, E., Blalchy-
Dyson, E., Di Lisa, F. and Forte, M. A. (2006). The mitochondrial permeability 
transition from in vitro artifact to disease target. FEBS J 273, 2077–2099. 
Bernardi, P., Petronilli, V., Di Lisa, F. and Forte, M. (2001). A mitochondrial 
perspective on cell death. Trends Biochem Sci 26, 112–117. 
Bernardi, P., Vassanelli, S., Veronese, P., Colonna, R., Szabò, I. and Zoratti, M. 
(1992). Modulation of the mitochondrial permeability transition pore. Effect of 
protons and divalent cations. J Biol Chem 267, 2934–2939. 
Billet, S., Abbas, I., Le Goff, J., Verdin, A., André, V., Lafargue, P.-E., Hachimi, A., 
Cazier, F., Sichel, F., Shirali, P., et al. (2008). Genotoxic potential of Polycyclic 
Aromatic Hydrocarbons-coated onto airborne Particulate Matter (PM 2.5) in human 
lung epithelial A549 cells. Cancer Lett 270, 144–155. 
Blair, A. and Freeman, L. B. (2006). Lung cancer among nonsmokers. Epidemiology 
17, 601–603. 
Boffetta, P. (2006). Human cancer from environmental pollutants: the epidemiological 
evidence. Mutat Res 608, 157–162. 
Bolaños-Meade, J., Zhou, L., Hoke, A., Corse, A., Vogelsang, G. and Wagner, K. 
Bibliography 

R. (2005). Hydroxychloroquine causes severe vacuolar myopathy in a patient with 
chronic graft-versus-host disease. Am. J. Hematol. 78, 306–309. 
Boya, P., González-Polo, R.-A., Casares, N., Perfettini, J.-L., Dessen, P., 
Larochette, N., Métivier, D., Meley, D., Souquere, S., Yoshimori, T., et al. 
(2005). Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25, 1025–
1040. 
Brautigan, D., Ferguson-Miller, S. and Margoliash, E. (1978). Mitochondrial 
cytochrome c: preparation and activity of native and chemically modified 
cytochromes c. Meth Enzymol 53, 128–164. 
Brdiczka, D., Beutner, G., Rück, A., Dolder, M. and Wallimann, T. (1998). The 
molecular structure of mitochondrial contact sites. Their role in regulation of energy 
metabolism and permeability transition. Biofactors 8, 235–242. 
Brody, J. G., Moysich, K. B., Humblet, O., Attfield, K. R., Beehler, G. P. and Rudel, 
R. A. (2007). Environmental pollutants and breast cancer: epidemiologic studies. 
Cancer 109, 2667–2711. 
Broekemeier, K. M. and Pfeiffer, D. R. (1989). Cyclosporin A-sensitive and 
insensitive mechanisms produce the permeability transition in mitochondria. 
Biochem Biophys Res Commun 163, 561–566. 
Broekemeier, K. M., Carpenter-Deyo, L., Reed, D. J. and Pfeiffer, D. R. (1992). 
Cyclosporin A protects hepatocytes subjected to high Ca2+ and oxidative stress. 
FEBS Lett 304, 192–194. 
Brunekreef, B. and Forsberg, B. (2005). Epidemiological evidence of effects of 
coarse airborne particles on health. Eur Respir J 26, 309–318. 
Bunger, M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C. and 
Bradfield, C. A. (2003). Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity 
and abnormal liver development in mice carrying a mutation in the nuclear 
localization sequence of the aryl hydrocarbon receptor. J Biol Chem 278, 17767–
17774. 
Carlson, D. E., Pumplin, D. W., Ghavam, S., Fiedler, S. M., Chiu, W. C. and Scalea, 
T. M. (2005). ATP accelerates respiration of mitochondria from rat lung and 
suppresses their release of hydrogen peroxide. J Bioenerg Biomembr 37, 327–
338. 
Catassi, A., Cesario, A., Arzani, D., Menichini, P., Alama, A., Bruzzo, C., 
Imperatori, A., Rotolo, N., Granone, P. and Russo, P. (2006). Characterization 
of apoptosis induced by marine natural products in non small cell lung cancer A549 
cells. Cell Mol Life Sci 63, 2377–2386. 
Cave, M., Appana, S., Patel, M., Falkner, K. C., McClain, C. J. and Brock, G. (2010). 
Polychlorinated biphenyls, lead, and mercury are associated with liver disease in 
American adults: NHANES 2003-2004. Environ Health Perspect 118, 1735–1742. 
Cecconi, F. and Levine, B. (2008). The role of autophagy in mammalian 
development: cell makeover rather than cell death. Dev Cell 15, 344–357. 
Chance, B. and Williams, G. (1956). The respiratory chain and oxidative 
phosphorylation. Adv Enzymol Relat Subj Biochem 17, 65–134. 
Bibliography 
 
Chang, H. J., Wang, S., Li, H. W., Lin, K. H., Chao, C. C. and Lai, Y. C. (2010). 
Polychlorinated dibenzo-p-dioxins and dibenzofuran contents in fish and sediment 
near a pentachlorophenol contaminated site. J Environ Sci Health A Tox Hazard 
Subst Environ Eng 45, 923–931. 
Chen, H. and Chan, D. C. (2009). Mitochondrial dynamics--fusion, fission, movement, 
and mitophagy--in neurodegenerative diseases. Human Molecular Genetics 18, 
R169–76. 
Chen, H. and Chan, D. C. (2010). Physiological functions of mitochondrial fusion. Ann 
N Y Acad Sci 1201, 21–25. 
Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E. and Chan, D. C. 
(2003). Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and 
are essential for embryonic development. J Cell Biol 160, 189–200. 
Chen, K., Pociask, D. A., McAleer, J. P., Chan, Y. R., Alcorn, J. F., Kreindler, J. L., 
Keyser, M. R., Shapiro, S. D., Houghton, A. M., Kolls, J. K., et al. (2011). IL-
17RA is required for CCL2 expression, macrophage recruitment, and emphysema 
in response to cigarette smoke. PLoS ONE 6, e20333. 
Chen, Y. and Klionsky, D. J. (2011). The regulation of autophagy - unanswered 
questions. Journal of Cell Science 124, 161–170. 
Chen, Y., McMillan-Ward, E., Kong, J., Israels, S. J. and Gibson, S. B. (2007). 
Mitochondrial electron-transport-chain inhibitors of complexes I and II induce 
autophagic cell death mediated by reactive oxygen species. Journal of Cell 
Science 120, 4155–4166. 
Cheng, Z., Tseng, Y. and White, M. F. (2010). Insulin signaling meets mitochondria in 
metabolism. Trends Endocrinol Metab 21, 589–598. 
Cheon, H., Woo, Y.-S., Lee, J. Y., Kim, H. S., Kim, H. J., Cho, S., Won, N. H. and 
Sohn, J. (2007). Signaling pathway for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced 
TNF-alpha production in differentiated THP-1 human macrophages. Exp Mol Med 
39, 524–534. 
Chevrollier, A., Loiseau, D., Chabi, B., Renier, G., Douay, O., Malthièry, Y. and 
Stepien, G. (2005). ANT2 isoform required for cancer cell glycolysis. J Bioenerg 
Biomembr 37, 307–316. 
Chiara, F., Castellaro, D., Marin, O., Petronilli, V., Brusilow, W. S., Juhaszova, M., 
Sollott, S. J., Forte, M., Bernardi, P. and Rasola, A. (2008). Hexokinase II 
detachment from mitochondria triggers apoptosis through the permeability 
transition pore independent of voltage-dependent anion channels. PLoS ONE 3, 
e1852. 
Chiba, T., Chihara, J. and Furue, M. (2012). Role of the Arylhydrocarbon Receptor 
(AhR) in the Pathology of Asthma and COPD. J Allergy (Cairo) 2012, 372384. 
Chiba, T., Uchi, H., Tsuji, G., Gondo, H., Moroi, Y. and Furue, M. (2011a). 
Arylhydrocarbon receptor (AhR) activation in airway epithelial cells induces 
MUC5AC via reactive oxygen species (ROS) production. Pulm Pharmacol Ther 24, 
133–140. 
Chiba, T., Uchi, H., Yasukawa, F. and Furue, M. (2011b). Role of the 
Bibliography 

arylhydrocarbon receptor in lung disease. Int. Arch. Allergy Immunol. 155 Suppl 1, 
129–134. 
Chinopoulos, C. and Adam-Vizi, V. (2012). Modulation of the mitochondrial 
permeability transition by cyclophilin D: moving closer to F(0)-F(1) ATP synthase? 
Mitochondrion 12, 41–45. 
Chomyn, A. and Attardi, G. (2003). MtDNA mutations in aging and apoptosis. 
Biochem Biophys Res Commun 304, 519–529. 
Clark, G. C., Taylor, M. J., Tritscher, A. M. and Lucier, G. W. (1991). Tumor necrosis 
factor involvement in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated endotoxin 
hypersensitivity in C57BL/6J mice congenic at the Ah locus. Toxicol Appl 
Pharmacol 111, 422–431. 
Coburn, C. G., Currás-Collazo, M. C. and Kodavanti, P. R. S. (2008). In vitro effects 
of environmentally relevant polybrominated diphenyl ether (PBDE) congeners on 
calcium buffering mechanisms in rat brain. Neurochem Res 33, 355–364. 
Cohen, A. J., Ross Anderson, H., Ostro, B., Pandey, K. D., Krzyzanowski, M., 
Künzli, N., Gutschmidt, K., Pope, A., Romieu, I., Samet, J. M., et al. (2005). The 
global burden of disease due to outdoor air pollution. Journal of Toxicology and 
Environmental Health Part A 68, 1301–1307. 
Contreras, L., Drago, I., Zampese, E. and Pozzan, T. (2010). Mitochondria: the 
calcium connection. Biochim Biophys Acta 1797, 607–618. 
Couraud, S., Zalcman, G., Milleron, B., Morin, F. and Souquet, P.-J. (2012). Lung 
cancer in never smokers--a review. Eur J Cancer 48, 1299–1311. 
Crighton, D., Wilkinson, S., O'Prey, J., Syed, N., Smith, P., Harrison, P. R., Gasco, 
M., Garrone, O., Crook, T. and Ryan, K. M. (2006). DRAM, a p53-induced 
modulator of autophagy, is critical for apoptosis. Cell 126, 121–134. 
Crompton, M., Barksby, E., Johnson, N. and Capano, M. (2002). Mitochondrial 
intermembrane junctional complexes and their involvement in cell death. Biochimie 
84, 143–152. 
Crompton, M., Virji, S. and Ward, J. M. (1998). Cyclophilin-D binds strongly to 
complexes of the voltage-dependent anion channel and the adenine nucleotide 
translocase to form the permeability transition pore. Eur J Biochem 258, 729–735. 
Csordas, A., Kreutmayer, S., Ploner, C., Braun, P. R., Karlas, A., Backovic, A., 
Wick, G. and Bernhard, D. (2011). Cigarette smoke extract induces prolonged 
endoplasmic reticulum stress and autophagic cell death in human umbilical vein 
endothelial cells. Cardiovasc Res 92, 141–148. 
Davis, J. W., Burdick, A. D., Lauer, F. T. and Burchiel, S. W. (2003). The aryl 
hydrocarbon receptor antagonist, 3“methoxy-4”nitroflavone, attenuates 2,3,7,8-
tetrachlorodibenzo-p-dioxin-dependent regulation of growth factor signaling and 
apoptosis in the MCF-10A cell line. Toxicol Appl Pharmacol 188, 42–49. 
de Duve, C. (1963). The lysosome. Sci. Am. 208, 64–72. 
de Duve, C. and Wattiaux, R. (1966). Functions of lysosome. Annu. Rev. Physiol. 28, 
435–492. 
Bibliography 
 
Delettre, C., Lenaers, G., Griffoin, J. M., Gigarel, N., Lorenzo, C., Belenguer, P., 
Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., et al. (2000). Nuclear 
gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in 
dominant optic atrophy. Nat Genet 26, 207–210. 
Denton, D., Shravage, B., Simin, R., Mills, K., Berry, D. L., Baehrecke, E. H. and 
Kumar, S. (2009). Autophagy, not apoptosis, is essential for midgut cell death in 
Drosophila. Curr Biol 19, 1741–1746. 
Detmer, S. A. and Chan, D. C. (2007). Functions and dysfunctions of mitochondrial 
dynamics. Nat Rev Mol Cell Biol 8, 870–879. 
Di Lisa, F. and Bernardi, P. (2006). Mitochondria and ischemia-reperfusion injury of 
the heart: fixing a hole. Cardiovasc Res 70, 191–199. 
Di Lisa, F. and Bernardi, P. (2009). A CaPful of mechanisms regulating the 
mitochondrial permeability transition. J Mol Cell Cardiol 46, 775–780. 
Di Lisa, F. and Ziegler, M. (2001). Pathophysiological relevance of mitochondria in 
NAD(+) metabolism. FEBS Lett 492, 4–8. 
Di Lisa, F., Canton, M., Menabò, R., Kaludercic, N. and Bernardi, P. (2007). 
Mitochondria and cardioprotection. Heart Fail Rev 12, 249–260. 
Di Lisa, F., Menabò, R., Canton, M., Barile, M. and Bernardi, P. (2001). Opening of 
the mitochondrial permeability transition pore causes depletion of mitochondrial 
and cytosolic NAD+ and is a causative event in the death of myocytes in 
postischemic reperfusion of the heart. J Biol Chem 276, 2571–2575. 
Doczi, J., Turiák, L., Vajda, S., Mándi, M., Töröcsik, B., Gerencser, A. A., Kiss, G., 
Konràd, C., Adam-Vizi, V. and Chinopoulos, C. (2011). Complex contribution of 
cyclophilin D to Ca2+-induced permeability transition in brain mitochondria, with 
relation to the bioenergetic state. J Biol Chem 286, 6345–6353. 
Doll, R. and Hill, A. (1950). Smoking and carcinoma of the lung; preliminary report. Br 
Med J 2, 739–748. 
Du, C., Fang, M., Li, Y., Li, L. and Wang, X. (2000). Smac, a mitochondrial protein 
that promotes cytochrome c-dependent caspase activation by eliminating IAP 
inhibition. Cell 102, 33–42. 
Duarte, F. V., Simões, A. M., Teodoro, J. S., Rolo, A. P. and Palmeira, C. M. (2011). 
Exposure to dibenzofuran affects lung mitochondrial function in vitro. Toxicology 
mechanisms and methods 21, 571–576. 
Duarte, F. V., Teodoro, J. S., Rolo, A. P. and Palmeira, C. M. (2012). Exposure to 
dibenzofuran triggers autophagy in lung cells. Toxicol Lett 209, 35–42. 
Duchen, M. R. (2004a). Roles of mitochondria in health and disease. Diabetes 53 
Suppl 1, S96–102. 
Duchen, M. R. (2004b). Mitochondria in health and disease: perspectives on a new 
mitochondrial biology. Mol Aspects Med 25, 365–451. 
Ehrenberg, B., Montana, V., Wei, M. D., Wuskell, J. P. and Loew, L. M. (1988). 
Membrane potential can be determined in individual cells from the nernstian 
Bibliography 

distribution of cationic dyes. Biophys J 53, 785–794. 
Eisenberg-Lerner, A., Bialik, S., Simon, H.-U. and Kimchi, A. (2009). Life and death 
partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 
16, 966–975. 
Elizondo, G., Fernandez-Salguero, P., Sheikh, M. S., Kim, G. Y., Fornace, A. J., 
Lee, K. S. and Gonzalez, F. J. (2000). Altered cell cycle control at the G(2)/M 
phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol Pharmacol 57, 
1056–1063. 
Elmore, S. P., Qian, T., Grissom, S. F. and Lemasters, J. J. (2001). The 
mitochondrial permeability transition initiates autophagy in rat hepatocytes. The 
FASEB Journal 15, 2286–2287. 
Elrod, J. W., Wong, R., Mishra, S., Vagnozzi, R. J., Sakthievel, B., Goonasekera, S. 
A., Karch, J., Gabel, S., Farber, J., Force, T., et al. (2010). Cyclophilin D controls 
mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and 
propensity for heart failure in mice. J Clin Invest 120, 3680–3687. 
Estabrook, R. (1967). Mitochondrial respiratory control and the polarographic 
measurement of ADP/O ratios. Methods Enzymol 10, 41–47. 
Fader, C. M. and Colombo, M. I. (2009). Autophagy and multivesicular bodies: two 
closely related partners. Cell Death Differ 16, 70–78. 
Feng, Z., Zhang, H., Levine, A. J. and Jin, S. (2005). The coordinate regulation of the 
p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 102, 8204–8209. 
Ferecatu, I., Borot, M.-C., Bossard, C., Leroux, M., Boggetto, N., Marano, F., 
Baeza-Squiban, A. and Andreau, K. (2010). Polycyclic aromatic hydrocarbon 
components contribute to the mitochondria-antiapoptotic effect of fine particulate 
matter on human bronchial epithelial cells via the aryl hydrocarbon receptor. 
Particle and Fibre Toxicology 7, 18. 
Ferlay, J., Shin, H.-R., Bray, F., Forman, D., Mathers, C. and Parkin, D. M. (2010). 
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 
127, 2893–2917. 
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, 
S., Nebert, D. W., Rudikoff, S., Ward, J. M. and Gonzalez, F. J. (1995). Immune 
system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah 
receptor. Science 268, 722–726. 
Fimia, G. M., Stoykova, A., Romagnoli, A., Giunta, L., Di Bartolomeo, S., Nardacci, 
R., Corazzari, M., Fuoco, C., Ucar, A., Schwartz, P., et al. (2007). Ambra1 
regulates autophagy and development of the nervous system. Nature 447, 1121–
1125. 
Fisher, M. T., Nagarkatti, M. and Nagarkatti, P. S. (2005). Aryl hydrocarbon receptor-
dependent induction of loss of mitochondrial membrane potential in epididydimal 
spermatozoa by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Lett 157, 99–
107. 
Forgacs, A. L., Burgoon, L. D., Lynn, S. G., LaPres, J. J. and Zacharewski, T. 
(2010). Effects of TCDD on the expression of nuclear encoded mitochondrial 
Bibliography 
 
genes. Toxicol Appl Pharmacol 246, 58–65. 
Gendy, El, M. A. M., Soshilov, A. A., Denison, M. S. and El-Kadi, A. O. S. (2012). 
Transcriptional and posttranslational inhibition of dioxin-mediated induction of 
CYP1A1 by harmine and harmol. Toxicol Lett 208, 51–61. 
Gentner, N. J. and Weber, L. P. (2010). Intranasal benzo[a]pyrene alters circadian 
blood pressure patterns and causes lung inflammation in rats. Arch Toxicol. 
Giorgi, C., Agnoletto, C., Bononi, A., Bonora, M., De Marchi, E., Marchi, S., 
Missiroli, S., Patergnani, S., Poletti, F., Rimessi, A., et al. (2012). Mitochondrial 
calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion 
12, 77–85. 
Giorgio, V., Soriano, M. E., Basso, E., Bisetto, E., Lippe, G., Forte, M. A. and 
Bernardi, P. (2010). Cyclophilin D in mitochondrial pathophysiology. Biochim 
Biophys Acta 1797, 1113–1118. 
Gomes, A. P., Duarte, F. V., Nunes, P., Hubbard, B. P., Teodoro, J. S., Varela, A. 
T., Jones, J. G., Sinclair, D. A., Palmeira, C. M. and Rolo, A. P. (2012). 
Berberine protects against high fat diet-induced dysfunction in muscle mitochondria 
by inducing SIRT1-dependent mitochondrial biogenesis. Biochim Biophys Acta 
1822, 185–195. 
Gomez, L., Li, B., Mewton, N., Sanchez, I., Piot, C., Elbaz, M. and Ovize, M. (2009). 
Inhibition of mitochondrial permeability transition pore opening: translation to 
patients. Cardiovasc Res 83, 226–233. 
Goodman, J. E., Kerper, L. E., Boyce, C. P., Prueitt, R. L. and Rhomberg, L. R. 
(2010). Weight-of-evidence analysis of human exposures to dioxins and dioxin-like 
compounds and associations with thyroid hormone levels during early 
development. Regul Toxicol Pharmacol 58, 79–99. 
Gornall, A., Bardawill, C. and David, M. (1949). Determination of serum proteins by 
means of the biuret reaction. J Biol Chem 177, 751–766. 
Gozuacik, D. and Kimchi, A. (2006). DAPk protein family and cancer. Autophagy 2, 
74–79. 
Gozuacik, D. and Kimchi, A. (2007). Autophagy and cell death.pp. 217–245. Current 
Topics in Developmental Biology. 
Green, D. R. and Kroemer, G. (2004). The pathophysiology of mitochondrial cell 
death. Science 305, 626–629. 
Green, D. R., Galluzzi, L. and Kroemer, G. (2011). Mitochondria and the autophagy-
inflammation-cell death axis in organismal aging. Science 333, 1109–1112. 
Griffiths, E. J. and Halestrap, A. P. (1995). Mitochondrial non-specific pores remain 
closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307 ( Pt 
1), 93–98. 
Gunter, T. E. and Pfeiffer, D. R. (1990). Mechanisms by which mitochondria transport 
calcium. Am J Physiol 258, C755–86. 
Hailey, D. W., Rambold, A. S., Satpute-Krishnan, P., Mitra, K., Sougrat, R., Kim, P. 
Bibliography 

K. and Lippincott-Schwartz, J. (2010). Mitochondria supply membranes for 
autophagosome biogenesis during starvation. Cell 141, 656–667. 
Hait, W. N., Jin, S. and Yang, J.-M. (2006). A matter of life or death (or both): 
understanding autophagy in cancer. Clin Cancer Res 12, 1961–1965. 
Halappanavar, S., Wu, D., Williams, A., Kuo, B., Godschalk, R. W., Van Schooten, 
F. J. and Yauk, C. L. (2011). Pulmonary gene and microRNA expression changes 
in mice exposed to benzo(a)pyrene by oral gavage. Toxicology 285, 133–141. 
Halestrap, A. P. (2009). What is the mitochondrial permeability transition pore? J Mol 
Cell Cardiol 46, 821–831. 
Halestrap, A. P. and Brenner, C. (2003). The adenine nucleotide translocase: a 
central component of the mitochondrial permeability transition pore and key player 
in cell death. Curr Med Chem 10, 1507–1525. 
Halestrap, A. P. and Davidson, A. M. (1990). Inhibition of Ca2(+)-induced large-
amplitude swelling of liver and heart mitochondria by cyclosporin is probably 
caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans 
isomerase and preventing it interacting with the adenine nucleotide translocase. 
Biochem J 268, 153–160. 
Halestrap, A. P. and Pasdois, P. (2009). The role of the mitochondrial permeability 
transition pore in heart disease. Biochim Biophys Acta 1787, 1402–1415. 
Halestrap, A. P., Clarke, S. J. and Javadov, S. A. (2004). Mitochondrial permeability 
transition pore opening during myocardial reperfusion--a target for cardioprotection. 
Cardiovasc Res 61, 372–385. 
Halestrap, A. P., Clarke, S. J. and Khaliulin, I. (2007). The role of mitochondria in 
protection of the heart by preconditioning. Biochim Biophys Acta 1767, 1007–1031. 
Hamanaka, R. B. and Chandel, N. S. (2010). Mitochondrial reactive oxygen species 
regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci 35, 
505–513. 
Hansson, M. J., Morota, S., Chen, L., Matsuyama, N., Suzuki, Y., Nakajima, S., 
Tanoue, T., Omi, A., Shibasaki, F., Shimazu, M., et al. (2011). Cyclophilin D-
sensitive mitochondrial permeability transition in adult human brain and liver 
mitochondria. J. Neurotrauma 28, 143–153. 
Hausenloy, D. J. and Yellon, D. M. (2003). The mitochondrial permeability transition 
pore: its fundamental role in mediating cell death during ischaemia and 
reperfusion. J Mol Cell Cardiol 35, 339–341. 
Hausenloy, D. J., Yellon, D. M., Mani-Babu, S. and Duchen, M. R. (2004). 
Preconditioning protects by inhibiting the mitochondrial permeability transition. Am 
J Physiol Heart Circ Physiol 287, H841–9. 
Haynes, C. M. and Ron, D. (2010). The mitochondrial UPR - protecting organelle 
protein homeostasis. Journal of Cell Science 123, 3849–3855. 
Helgason, L. B., Verreault, J., Braune, B. M., Borgå, K., Primicerio, R., Jenssen, B. 
M. and Gabrielsen, G. W. (2010). Relationship between persistent halogenated 
organic contaminants and TCDD-toxic equivalents on EROD activity and retinoid 
Bibliography 
 
and thyroid hormone status in northern fulmars. Sci Total Environ 408, 6117–6123. 
Hengartner, M. O. (2000). The biochemistry of apoptosis. Nature 407, 770–776. 
Hombach-Klonisch, S., Pocar, P., Kauffold, J. and Klonisch, T. (2006). Dioxin 
exerts anti-estrogenic actions in a novel dioxin-responsive telomerase-
immortalized epithelial cell line of the porcine oviduct (TERT-OPEC). Toxicol Sci 
90, 519–528. 
Hossain, A., Tsuchiya, S., Minegishi, M., Osada, M., Ikawa, S., Tezuka, F. A., Kaji, 
M., Konno, T., Watanabe, M. and Kikuchi, H. (1998). The Ah receptor is not 
involved in 2,3,7,8-tetrachlorodibenzo- p-dioxin-mediated apoptosis in human 
leukemic T cell lines. J Biol Chem 273, 19853–19858. 
Hu, C., Jiang, L., Geng, C., Zhang, X., Cao, J. and Zhong, L. (2008). Possible 
involvement of oxidative stress in trichloroethylene-induced genotoxicity in human 
HepG2 cells. Mutat Res 652, 88–94. 
Hu, M.-T., Chen, S.-J., Huang, K.-L., Lin, Y.-C., Chang-Chien, G.-P. and Tsai, J.-H. 
(2009). Characterization of polychlorinated dibenzo-p-dioxin/dibenzofuran 
emissions from joss paper burned in a furnace with air pollution control devices. 
Science of the Total Environment, The 407, 3290–3294. 
Ichas, F. and Mazat, J. P. (1998). From calcium signaling to cell death: two 
conformations for the mitochondrial permeability transition pore. Switching from 
low- to high-conductance state. Biochim Biophys Acta 1366, 33–50. 
Ichimura, Y., Kumanomidou, T., Sou, Y.-S., Mizushima, T., Ezaki, J., Ueno, T., 
Kominami, E., Yamane, T., Tanaka, K. and Komatsu, M. (2008). Structural basis 
for sorting mechanism of p62 in selective autophagy. J Biol Chem 283, 22847–
22857. 
Iida, A., Emi, M., Matsuoka, R., Hiratsuka, E., Okui, K., Ohashi, H., Inazawa, J., 
Fukushima, Y., Imai, T. and Nakamura, Y. (2000). Identification of a gene 
disrupted by inv(11)(q13.5;q25) in a patient with left-right axis malformation. Hum. 
Genet. 106, 277–287. 
Iida, T., Todaka, T., Hirakawa, H., Hori, T., Tobiishi, K., Matsueda, T., Watanabe, S. 
and Yamada, T. (2007). Concentration and distribution of dioxins and related 
compounds in human tissues. CHEMOSPHERE 67, S263–71. 
Ishida, T., Hirono, Y., Yoshikawa, K., Hutei, Y., Miyagawa, M., Sakaguchi, I., 
Pinkerton, K. E. and Takeuchi, M. (2009). Inhibition of immunological function 
mediated DNA damage of alveolar macrophages caused by cigarette smoke in 
mice. Inhal Toxicol 21, 1229–1235. 
James, D. I., Parone, P. A., Mattenberger, Y. and Martinou, J.-C. (2003). hFis1, a 
novel component of the mammalian mitochondrial fission machinery. J Biol Chem 
278, 36373–36379. 
Javadov, S., Hunter, J. C., Barreto-Torres, G. and Parodi-Rullan, R. (2011). 
Targeting the mitochondrial permeability transition: cardiac ischemia-reperfusion 
versus carcinogenesis. Cell. Physiol. Biochem. 27, 179–190. 
Javadov, S., Rajapurohitam, V., Kilić, A., Zeidan, A., Choi, A. and Karmazyn, M. 
(2009). Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent 
Bibliography 

attenuation of mitochondrial dysfunction. J Mol Cell Cardiol 46, 998–1007. 
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E. and Forman, D. (2011). 
Global cancer statistics. CA Cancer J Clin 61, 69–90. 
Jobe, S. M., Wilson, K. M., Leo, L., Raimondi, A., Molkentin, J. D., Lentz, S. R. and 
Di Paola, J. (2008). Critical role for the mitochondrial permeability transition pore 
and cyclophilin D in platelet activation and thrombosis. Blood 111, 1257–1265. 
Jules, G. E., Pratap, S., Ramesh, A. and Hood, D. B. (2012). In utero exposure to 
benzo(a)pyrene predisposes offspring to cardiovascular dysfunction in later-life. 
Toxicology. 
Jung, W.-W., Kim, E.-M., Lee, E.-H., Yun, H.-J., Ju, H.-R., Jeong, M.-J., Hwang, K. 
W., Sul, D. and Kang, H.-S. (2007). Formaldehyde exposure induces airway 
inflammation by increasing eosinophil infiltrations through the regulation of reactive 
oxygen species production. Environ. Toxicol. Pharmacol. 24, 174–182. 
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y. and 
Yoshimori, T. (2004). LC3, GABARAP and GATE16 localize to autophagosomal 
membrane depending on form-II formation. Journal of Cell Science 117, 2805–
2812. 
Kamimoto, T., Shoji, S., Hidvegi, T., Mizushima, N., Umebayashi, K., Perlmutter, 
D. H. and Yoshimori, T. (2006). Intracellular inclusions containing mutant alpha1-
antitrypsin Z are propagated in the absence of autophagic activity. J Biol Chem 
281, 4467–4476. 
Kamo, N., Muratsugu, M., Hongoh, R. and Kobatake, Y. (1979). Membrane potential 
of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium 
and relationship between proton electrochemical potential and phosphorylation 
potential in steady state. J. Membr. Biol. 49, 105–121. 
Katanoda, K., Sobue, T., Satoh, H., Tajima, K., Suzuki, T., Nakatsuka, H., 
Takezaki, T., Nakayama, T., Nitta, H., Tanabe, K., et al. (2011). An association 
between long-term exposure to ambient air pollution and mortality from lung cancer 
and respiratory diseases in Japan. J Epidemiol 21, 132–143. 
Kaushik, S. and Cuervo, A. M. (2006). Autophagy as a cell-repair mechanism: 
activation of chaperone-mediated autophagy during oxidative stress. Mol Aspects 
Med 27, 444–454. 
Khuder, S. A. (2001). Effect of cigarette smoking on major histological types of lung 
cancer: a meta-analysis. Lung Cancer 31, 139–148. 
Kim, I. and Lemasters, J. J. (2011). Mitochondrial degradation by autophagy 
(mitophagy) in GFP-LC3 transgenic hepatocytes during nutrient deprivation. AJP: 
Cell Physiology 300, C308–17. 
Kim, I., Rodriguez-Enriquez, S. and Lemasters, J. J. (2007). Selective degradation 
of mitochondria by mitophagy.pp. 245–253. 
Kinnally, K. W., Peixoto, P. M., Ryu, S.-Y. and Dejean, L. M. (2011). Is mPTP the 
gatekeeper for necrosis, apoptosis, or both? Biochim Biophys Acta 1813, 616–622. 
Klingenberg, M. (2008). The ADP and ATP transport in mitochondria and its carrier. 
Bibliography 
 
Biochim Biophys Acta 1778, 1978–2021. 
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. 
S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008). 
Guidelines for the use and interpretation of assays for monitoring autophagy in 
higher eukaryotes. Autophagy 4, 151–175. 
Kobayashi, D., Ahmed, S., Ishida, M., Kasai, S. and Kikuchi, H. (2009). 
Calcium/calmodulin signaling elicits release of cytochrome c during 2,3,7,8-
tetrachlorodibenzo-p-dioxin-induced apoptosis in the human lymphoblastic T-cell 
line, L-MAT. Toxicology 258, 25–32. 
Kokoszka, J. E., Waymire, K. G., Levy, S. E., Sligh, J. E., Cai, J., Jones, D. P., 
MacGregor, G. R. and Wallace, D. C. (2004). The ADP/ATP translocator is not 
essential for the mitochondrial permeability transition pore. Nature 427, 461–465. 
Komatsu, M. and Ichimura, Y. (2010). Selective autophagy regulates various cellular 
functions. Genes Cells 15, 923–933. 
Konràd, C., Kiss, G., Töröcsik, B., Lábár, J. L., Gerencser, A. A., Mándi, M., Adam-
Vizi, V. and Chinopoulos, C. (2011). A distinct sequence in the adenine 
nucleotide translocase from Artemia franciscana embryos is associated with 
insensitivity to bongkrekate and atypical effects of adenine nucleotides on Ca2+ 
uptake and sequestration. FEBS J 278, 822–836. 
Kopf, P. G. and Walker, M. K. (2010). 2,3,7,8-tetrachlorodibenzo-p-dioxin increases 
reactive oxygen species production in human endothelial cells via induction of 
cytochrome P4501A1. Toxicol Appl Pharmacol 245, 91–99. 
Koshiba, T., Detmer, S. A., Kaiser, J. T., Chen, H., McCaffery, J. M. and Chan, D. 
C. (2004). Structural basis of mitochondrial tethering by mitofusin complexes. 
Science 305, 858–862. 
Krauskopf, A., Eriksson, O., Craigen, W. J., Forte, M. A. and Bernardi, P. (2006). 
Properties of the permeability transition in VDAC1(-/-) mitochondria. Biochim 
Biophys Acta 1757, 590–595. 
Krestinina, O. V., Grachev, D. E., Odinokova, I. V., Reiser, G., Evtodienko, Y. V. 
and Azarashvili, T. S. (2009). Effect of peripheral benzodiazepine receptor 
(PBR/TSPO) ligands on opening of Ca2+-induced pore and phosphorylation of 3.5-
kDa polypeptide in rat brain mitochondria. Biochemistry Mosc. 74, 421–429. 
Krishnan, K. J., Greaves, L. C., Reeve, A. K. and Turnbull, D. (2007). The ageing 
mitochondrial genome. Nucleic Acids Research 35, 7399–7405. 
Kroemer, G., Galluzzi, L. and Brenner, C. (2007). Mitochondrial membrane 
permeabilization in cell death. Physiol Rev 87, 99–163. 
Kroemer, G., Zamzami, N. and Susin, S. A. (1997). Mitochondrial control of 
apoptosis. Immunol. Today 18, 44–51. 
Kushnareva, Y. and Newmeyer, D. D. (2010). Bioenergetics and cell death. Ann N Y 
Acad Sci 1201, 50–57. 
Landes, T., Leroy, I., Bertholet, A., Diot, A., Khosrobakhsh, F., Daloyau, M., 
Davezac, N., Miquel, M.-C., Courilleau, D., Guillou, E., et al. (2010). OPA1 
Bibliography 

(dys)functions. Semin Cell Dev Biol 21, 593–598. 
Larsen, K. E. and Sulzer, D. (2002). Autophagy in neurons: a review. Histol. 
Histopathol. 17, 897–908. 
Larsson, N.-G. (2010). Somatic mitochondrial DNA mutations in mammalian aging. 
Annu. Rev. Biochem. 79, 683–706. 
Lecureur, V., Arzel, M., Ameziane, S., Houlbert, N., Le Vee, M., Jouneau, S. and 
Fardel, O. (2012). MAPK- and PKC/CREB-dependent induction of interleukin-11 
by the environmental contaminant formaldehyde in human bronchial epithelial 
cells. Toxicology 292, 13–22. 
Lee, A. C., Xu, X. and Colombini, M. (1996). The role of pyridine dinucleotides in 
regulating the permeability of the mitochondrial outer membrane. J Biol Chem 271, 
26724–26731. 
Lee, J., Giordano, S. and Zhang, J. (2012). Autophagy, mitochondria and oxidative 
stress: cross-talk and redox signalling. Biochem J 441, 523–540. 
Lee, W. S. and Sokol, R. J. (2007). Liver disease in mitochondrial disorders. Semin. 
Liver Dis. 27, 259–273. 
Lehmann, I., Rehwagen, M., Diez, U., Seiffart, A., Rolle-Kampczyk, U., Richter, M., 
Wetzig, H., Borte, M., Herbarth, O.Leipzig Allergy Risk Children Study (2001). 
Enhanced in vivo IgE production and T cell polarization toward the type 2 
phenotype in association with indoor exposure to VOC: results of the LARS study. 
Int J Hyg Environ Health 204, 211–221. 
Lehmann, I., Röder-Stolinski, C., Nieber, K. and Fischäder, G. (2008). In vitro 
models for the assessment of inflammatory and immuno-modulatory effects of the 
volatile organic compound chlorobenzene. Exp. Toxicol. Pathol. 60, 185–193. 
Lehmann, I., Thoelke, A., Weiss, M., Schlink, U., Schulz, R., Diez, U., Sierig, G., 
Emmrich, F., Jacob, B., Belcredi, P., et al. (2002). T cell reactivity in neonates 
from an East and a West German city--results of the LISA study. Allergy 57, 129–
136. 
Lemasters, J. J. (2005). Selective mitochondrial autophagy, or mitophagy, as a 
targeted defense against oxidative stress, mitochondrial dysfunction, and aging. 
Rejuvenation Res 8, 3–5. 
Lemasters, J. J., Qian, T., He, L., Kim, J.-S., Elmore, S. P., Cascio, W. E. and 
Brenner, D. A. (2002). Role of mitochondrial inner membrane permeabilization in 
necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal 4, 769–781. 
Lemasters, J. J., Theruvath, T. P., Zhong, Z. and Nieminen, A.-L. (2009). 
Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys 
Acta 1787, 1395–1401. 
Lenaz, G. (2012). Mitochondria and reactive oxygen species. Which role in physiology 
and pathology? Adv. Exp. Med. Biol. 942, 93–136. 
Leung, A. W. C. and Halestrap, A. P. (2008). Recent progress in elucidating the 
molecular mechanism of the mitochondrial permeability transition pore. Biochim 
Biophys Acta 1777, 946–952. 
Bibliography 
 
Leung, A. W. C., Varanyuwatana, P. and Halestrap, A. P. (2008). The mitochondrial 
phosphate carrier interacts with cyclophilin D and may play a key role in the 
permeability transition. J Biol Chem 283, 26312–26323. 
Levine, B. and Kroemer, G. (2008). Autophagy in the pathogenesis of disease. Cell 
132, 27–42. 
Levine, B. and Yuan, J. (2005). Autophagy in cell death: an innocent convict? Journal 
of Clinical Investigation 115, 2679–2688. 
Li, L. Y., Luo, X. and Wang, X. (2001). Endonuclease G is an apoptotic DNase when 
released from mitochondria. Nature 412, 95–99. 
Li, X.-D., Yan, M., Chen, T., Lu, S.-Y., Yan, J.-H. and Cen, K.-F. (2010). Levels of 
PCDD/Fs in soil in the vicinity of a medical waste incinerator in China: the temporal 
variation during 2007-2009. Journal of Hazardous Materials 179, 783–789. 
Lin, D.-T. and Lechleiter, J. D. (2002). Mitochondrial targeted cyclophilin D protects 
cells from cell death by peptidyl prolyl isomerization. J Biol Chem 277, 31134–
31141. 
Liu, X., Kim, C. N., Yang, J., Jemmerson, R. and Wang, X. (1996). Induction of 
apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. 
Cell 86, 147–157. 
Liu, X., Weaver, D., Shirihai, O. and Hajnóczky, G. (2009). Mitochondrial “kiss-and-
run”: interplay between mitochondrial motility and fusion-fission dynamics. EMBO J 
28, 3074–3089. 
Luce, K., Weil, A. C. and Osiewacz, H. D. (2010). Mitochondrial protein quality control 
systems in aging and disease. Adv. Exp. Med. Biol. 694, 108–125. 
Luvisetto, S., Basso, E., Petronilli, V., Bernardi, P. and Forte, M. (2008). 
Enhancement of anxiety, facilitation of avoidance behavior, and occurrence of 
adult-onset obesity in mice lacking mitochondrial cyclophilin D. Neuroscience 155, 
585–596. 
Madeira, V. M. (1975). A rapid and ultrasensitive method to measure Ca++ 
movements across biological membranes. Biochem Biophys Res Commun 64, 
870–876. 
Madeira, V. M., Antunes-Madeira, M. C. and Carvalho, A. P. (1974). Activation 
energies of the ATPase activity of sarcoplasmic reticulum. Biochem Biophys Res 
Commun 58, 897–904. 
Mai, S., Muster, B., Bereiter-Hahn, J. and Jendrach, M. (2012). Autophagy proteins 
LC3B, ATG5 and ATG12 participate in quality control after mitochondrial damage 
and influence lifespan. Autophagy 8, 47–62. 
Maiuri, M. C., Zalckvar, E., Kimchi, A. and Kroemer, G. (2007). Self-eating and self-
killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8, 741–
752. 
Mandal, P. K. (2005). Dioxin: a review of its environmental effects and its aryl 
hydrocarbon receptor biology. J. Comp. Physiol. B, Biochem. Syst. Environ. 
Physiol. 175, 221–230. 
Bibliography 

Mariño, G. and López-Otín, C. (2004). Autophagy: molecular mechanisms, 
physiological functions and relevance in human pathology. Cell Mol Life Sci 61, 
1439–1454. 
Marshall, N. B. and Kerkvliet, N. I. (2010). Dioxin and immune regulation: emerging 
role of aryl hydrocarbon receptor in the generation of regulatory T cells. Ann N Y 
Acad Sci 1183, 25–37. 
Martel, C., Huynh, L. H., Garnier, A., Ventura-Clapier, R. and Brenner, C. (2012). 
Inhibition of the Mitochondrial Permeability Transition for Cytoprotection: Direct 
versus Indirect Mechanisms. Biochem Res Int 2012, 213403. 
Martin, L. and Klaassen, C. D. (2010). Differential effects of polychlorinated biphenyl 
congeners on serum thyroid hormone levels in rats. Toxicological Sciences 117, 
36–44. 
Martinelli, N., Girelli, D., Cigolini, D., Sandri, M., Ricci, G., Rocca, G. and Olivieri, 
O. (2012). Access rate to the emergency department for venous thromboembolism 
in relationship with coarse and fine particulate matter air pollution. PLoS ONE 7, 
e34831. 
Martinez-Vicente, M. and Cuervo, A. M. (2007). Autophagy and neurodegeneration: 
when the cleaning crew goes on strike. Lancet Neurol 6, 352–361. 
Masini, A., Ceccarelli-Stanzani, D. and Muscatello, U. (1984). An investigation on 
the effect of oligomycin on state-4 respiration in isolated rat-liver mitochondria. 
Biochim Biophys Acta 767, 130–137. 
Mathew, R., Karantza-Wadsworth, V. and White, E. (2007). Role of autophagy in 
cancer. Nat Rev Cancer 7, 961–967. 
Matsumoto, Y., Ide, F., Kishi, R., Akutagawa, T., Sakai, S., Nakamura, M., 
Ishikawa, T., Fujii-Kuriyama, Y. and Nakatsuru, Y. (2007). Aryl hydrocarbon 
receptor plays a significant role in mediating airborne particulate-induced 
carcinogenesis in mice. Environ Sci Technol 41, 3775–3780. 
Mbye, L. H. A. N., Singh, I. N., Carrico, K. M., Saatman, K. E. and Hall, E. D. (2009). 
Comparative neuroprotective effects of cyclosporin A and NIM811, a 
nonimmunosuppressive cyclosporin A analog, following traumatic brain injury. J. 
Cereb. Blood Flow Metab. 29, 87–97. 
McCommis, K. S. and Baines, C. P. (2012). The role of VDAC in cell death: Friend or 
foe? Biochim Biophys Acta 1818, 1444–1450. 
McGregor, D. B., Partensky, C., Wilbourn, J. and Rice, J. M. (1998). An IARC 
evaluation of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans 
as risk factors in human carcinogenesis. Environ Health Perspect 106 Suppl 2, 
755–760. 
McGwin, G., Lienert, J. and Kennedy, J. I. (2010). Formaldehyde exposure and 
asthma in children: a systematic review. Environ Health Perspect 118, 313–317. 
Meeusen, S., McCaffery, J. M. and Nunnari, J. (2004). Mitochondrial fusion 
intermediates revealed in vitro. Science 305, 1747–1752. 
Meier, J.-M., Urban, P. and Goy, J.-J. (2005). Postconditioning inhibits mitochondrial 
Bibliography 
 
permeability transition. Future Cardiol 1, 457–460. 
Mennear, J. H. and Lee, C. C. (1994). Polybrominated dibenzo-p-dioxins and 
dibenzofurans: literature review and health assessment. Environ Health Perspect 
102 Suppl 1, 265–274. 
Michel, S., Wanet, A., De Pauw, A., Rommelaere, G., Arnould, T. and Renard, P. 
(2012). Crosstalk between mitochondrial (dys)function and mitochondrial 
abundance. J. Cell. Physiol. 227, 2297–2310. 
Mildaziene, V., Nauciene, Z., Baniene, R., Demin, O. and Krab, K. (2002). Analysis 
of effects of 2,2“,5,5-”tetrachlorobiphenyl on the flux control in oxidative 
phosphorylation system in rat liver mitochondria. Mol Biol Rep 29, 35–40. 
Millay, D. P., Sargent, M. A., Osinska, H., Baines, C. P., Barton, E. R., Vuagniaux, 
G., Sweeney, H. L., Robbins, J. and Molkentin, J. D. (2008). Genetic and 
pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular 
dystrophy. Nat Med 14, 442–447. 
Mimura, J. and Fujii-Kuriyama, Y. (2003). Functional role of AhR in the expression of 
toxic effects by TCDD. Biochim Biophys Acta 1619, 263–268. 
Min, L., Fulton, D. B. and Andreotti, A. H. (2005). A case study of proline 
isomerization in cell signaling. Front Biosci 10, 385–397. 
Minelli, C., Wei, I., Sagoo, G., Jarvis, D., Shaheen, S. and Burney, P. (2011). 
Interactive effects of antioxidant genes and air pollution on respiratory function and 
airway disease: a HuGE review. American Journal of Epidemiology 173, 603–620. 
Mizushima, N., Levine, B., Cuervo, A. M. and Klionsky, D. J. (2008). Autophagy 
fights disease through cellular self-digestion. Nature 451, 1069–1075. 
Moreau, K., Luo, S. and Rubinsztein, D. C. (2010). Cytoprotective roles for 
autophagy. Curr Opin Cell Biol 22, 206–211. 
Mögel, I., Baumann, S., Böhme, A., Kohajda, T., Bergen, von, M., Simon, J.-C. and 
Lehmann, I. (2011). The aromatic volatile organic compounds toluene, benzene 
and styrene induce COX-2 and prostaglandins in human lung epithelial cells via 
oxidative stress and p38 MAPK activation. Toxicology 289, 28–37. 
Murphy, E. and Steenbergen, C. (2008). Mechanisms underlying acute protection 
from cardiac ischemia-reperfusion injury. Physiol Rev 88, 581–609. 
Murphy, M. P. (2009). How mitochondria produce reactive oxygen species. Biochem J 
417, 1–13. 
Nadal, M., Domingo, J. L., García, F. and Schuhmacher, M. (2009). Levels of 
PCDD/F in adipose tissue on non-occupationally exposed subjects living near a 
hazardous waste incinerator in Catalonia, Spain. CHEMOSPHERE 74, 1471–1476. 
Nakagawa, T., Shimizu, S., Watanabe, T., Yamaguchi, O., Otsu, K., Yamagata, H., 
Inohara, H., Kubo, T. and Tsujimoto, Y. (2005). Cyclophilin D-dependent 
mitochondrial permeability transition regulates some necrotic but not apoptotic cell 
death. Nature 434, 652–658. 
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., 
Bibliography 

Cookson, M. R. and Youle, R. J. (2010). PINK1 is selectively stabilized on 
impaired mitochondria to activate Parkin. PLoS Biol 8, e1000298. 
Narendra, D., Tanaka, A., Suen, D.-F. and Youle, R. J. (2008). Parkin is recruited 
selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183, 
795–803. 
Nemmar, A., Zia, S., Subramaniyan, D., Fahim, M. A. and Ali, B. H. (2011). 
Exacerbation of thrombotic events by diesel exhaust particle in mouse model of 
hypertension. Toxicology 285, 39–45. 
Nicholls, D. G. (2009). Mitochondrial calcium function and dysfunction in the central 
nervous system. Biochim Biophys Acta 1787, 1416–1424. 
Niittynen, M., Tuomisto, J. T. and Pohjanvirta, R. (2008). Effect of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) on heme oxygenase-1, biliverdin IXalpha 
reductase and delta-aminolevulinic acid synthetase 1 in rats with wild-type or 
variant AH receptor. Toxicology 250, 132–142. 
Nishino, I. (2006). Autophagic vacuolar myopathy. Semin Pediatr Neurol 13, 90–95. 
Novgorodov, S. A. and Gudz, T. I. (1996). Permeability transition pore of the inner 
mitochondrial membrane can operate in two open states with different selectivities. 
J Bioenerg Biomembr 28, 139–146. 
Nunnari, J. and Suomalainen, A. (2012). Mitochondria: in sickness and in health. Cell 
148, 1145–1159. 
Oda, K., Matsuoka, Y., Funahashi, A. and Kitano, H. (2005). A comprehensive 
pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 1, 
2005.0010. 
Oettinghaus, B., Licci, M., Scorrano, L. and Frank, S. (2011). Less than perfect 
divorces: dysregulated mitochondrial fission and neurodegeneration. Acta 
Neuropathol. 
Okamoto, K. and Kondo-Okamoto, N. (2012). Mitochondria and autophagy: Critical 
interplay between the two homeostats. Biochim Biophys Acta 1820, 595–600. 
Okamoto, K., Kondo-Okamoto, N. and Ohsumi, Y. (2009). A landmark protein 
essential for mitophagy: Atg32 recruits the autophagic machinery to mitochondria. 
Autophagy 5, 1203–1205. 
Olichon, A., Baricault, L., Gas, N., Guillou, E., Valette, A., Belenguer, P. and 
Lenaers, G. (2003). Loss of OPA1 perturbates the mitochondrial inner membrane 
structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 
278, 7743–7746. 
Orrenius, S., Gogvadze, V. and Zhivotovsky, B. (2007). Mitochondrial oxidative 
stress: implications for cell death. Annu Rev Pharmacol Toxicol 47, 143–183. 
Palmeira, C. M. and Madeira, V. M. (1997). Mercuric chloride toxicity in rat liver 
mitochondria and isolated hepatocytes. Environ. Toxicol. Pharmacol. 3, 229–235. 
Palmeira, C. M. and Wallace, K. B. (1997). Benzoquinone inhibits the voltage-
dependent induction of the mitochondrial permeability transition caused by redox-
Bibliography 
 
cycling naphthoquinones. Toxicol Appl Pharmacol 143, 338–347. 
Palmeira, C. M., Moreno, A. J. and Madeira, V. M. (1994). Interactions of herbicides 
2,4-D and dinoseb with liver mitochondrial bioenergetics. Toxicol Appl Pharmacol 
127, 50–57. 
Palmeira, C. M., Rolo, A. P., Berthiaume, J., Bjork, J. A. and Wallace, K. B. (2007). 
Hyperglycemia decreases mitochondrial function: the regulatory role of 
mitochondrial biogenesis. Toxicol Appl Pharmacol 225, 214–220. 
Pantucharoensri, S., Boontee, P., Likhitsan, P., Padungtod, C. and 
Prasartsansoui, S. (2004). Generalized eruption accompanied by hepatitis in two 
Thai metal cleaners exposed to trichloroethylene. Ind Health 42, 385–388. 
Parkin, D. M., Bray, F., Ferlay, J. and Pisani, P. (2005). Global cancer statistics, 
2002. CA Cancer J Clin 55, 74–108. 
Pasdois, P., Parker, J. E., Griffiths, E. J. and Halestrap, A. P. (2011). The role of 
oxidized cytochrome c in regulating mitochondrial reactive oxygen species 
production and its perturbation in ischaemia. Biochem J 436, 493–505. 
Pastorino, J. G. and Hoek, J. B. (2003). Hexokinase II: the integration of energy 
metabolism and control of apoptosis. Curr Med Chem 10, 1535–1551. 
Pastorino, J. G. and Hoek, J. B. (2008). Regulation of hexokinase binding to VDAC. J 
Bioenerg Biomembr 40, 171–182. 
Patel, D. R. and Homnick, D. N. (2000). Pulmonary effects of smoking. Adolesc Med 
11, 567–576. 
Pedersen, P. L., Mathupala, S., Rempel, A., Geschwind, J. F. and Ko, Y. H. (2002). 
Mitochondrial bound type II hexokinase: a key player in the growth and survival of 
many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys 
Acta 1555, 14–20. 
Pedraza-Chaverri, J., Barrera, D., Medina-Campos, O. N., Carvajal, R. C., 
Hernández-Pando, R., Macías-Ruvalcaba, N. A., Maldonado, P. D., Salcedo, M. 
I., Tapia, E., Saldívar, L., et al. (2005). Time course study of oxidative and 
nitrosative stress and antioxidant enzymes in K2Cr2O7-induced nephrotoxicity. 
BMC Nephrol 6, 4. 
Pelucchi, C., Negri, E., Gallus, S., Boffetta, P., Tramacere, I. and La Vecchia, C. 
(2009). Long-term particulate matter exposure and mortality: a review of European 
epidemiological studies. BMC Public Health 9, 453. 
Peralta, S., Wang, X. and Moraes, C. T. (2011). Mitochondrial transcription: Lessons 
from mouse models. Biochim Biophys Acta. 
Perez, L., Rapp, R. and Künzli, N. (2010). The Year of the Lung: outdoor air pollution 
and lung health. Swiss Med Wkly 140, w13129. 
Perier, C. and Vila, M. (2012). Mitochondrial biology and Parkinson's disease. Cold 
Spring Harb Perspect Med 2, a009332. 
Perlmutter, D. H. (2006). The role of autophagy in alpha-1-antitrypsin deficiency: a 
specific cellular response in genetic diseases associated with aggregation-prone 
Bibliography 

proteins. Autophagy 2, 258–263. 
Petronilli, V., Miotto, G., Canton, M., Brini, M., Colonna, R., Bernardi, P. and Di 
Lisa, F. (1999). Transient and long-lasting openings of the mitochondrial 
permeability transition pore can be monitored directly in intact cells by changes in 
mitochondrial calcein fluorescence. Biophys J 76, 725–734. 
Pfeiffer, D. R. and Tchen, T. T. (1975). The activation of adrenal cortex mitochondrial 
malic enzyme by Ca2+ and Mg2+. Biochemistry 14, 89–96. 
Piot, C., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Elbelghiti, R., 
Cung, T. T., Bonnefoy, E., Angoulvant, D., et al. (2008). Effect of cyclosporine 
on reperfusion injury in acute myocardial infarction. N. Engl. J. Med. 359, 473–481. 
Polster, B. M. and Fiskum, G. (2004). Mitochondrial mechanisms of neural cell 
apoptosis. J Neurochem 90, 1281–1289. 
Prüss-Ustün, A., Vickers, C., Haefliger, P. and Bertollini, R. (2011). Knowns and 
unknowns on burden of disease due to chemicals: a systematic review. 
Environmental Health 10, 9. 
Puppala, D., Lee, H., Kim, K. B. and Swanson, H. I. (2008). Development of an aryl 
hydrocarbon receptor antagonist using the proteolysis-targeting chimeric molecules 
approach: a potential tool for chemoprevention. Mol Pharmacol 73, 1064–1071. 
Purdue, M. P., Bakke, B., Stewart, P., De Roos, A. J., Schenk, M., Lynch, C. F., 
Bernstein, L., Morton, L. M., Cerhan, J. R., Severson, R. K., et al. (2011). A 
case-control study of occupational exposure to trichloroethylene and non-Hodgkin 
lymphoma. Environ Health Perspect 119, 232–238. 
Qin, Z.-H., Wang, Y., Kegel, K. B., Kazantsev, A., Apostol, B. L., Thompson, L. M., 
Yoder, J., Aronin, N. and DiFiglia, M. (2003). Autophagy regulates the 
processing of amino terminal huntingtin fragments. Human Molecular Genetics 12, 
3231–3244. 
Raaschou-Nielsen, O., Andersen, Z., Hvidberg, M., Jensen, S. S., Ketzel, M., 
Sørensen, M., Loft, S., Overvad, K. and Tjønneland, A. (2011). Lung Cancer 
Incidence and Long-Term Exposure to Air Pollution from Traffic. Environ Health 
Perspect. 
Rasola, A., Sciacovelli, M., Chiara, F., Pantic, B., Brusilow, W. S. and Bernardi, P. 
(2010a). Activation of mitochondrial ERK protects cancer cells from death through 
inhibition of the permeability transition. Proc Natl Acad Sci USA 107, 726–731. 
Rasola, A., Sciacovelli, M., Pantic, B. and Bernardi, P. (2010b). Signal transduction 
to the permeability transition pore. FEBS Lett 584, 1989–1996. 
Ravikumar, B., Acevedo-Arozena, A., Imarisio, S., Berger, Z., Vacher, C., O'Kane, 
C. J., Brown, S. D. M. and Rubinsztein, D. C. (2005). Dynein mutations impair 
autophagic clearance of aggregate-prone proteins. Nat Genet 37, 771–776. 
Ravikumar, B., Berger, Z., Vacher, C., O'Kane, C. J. and Rubinsztein, D. C. (2006). 
Rapamycin pre-treatment protects against apoptosis. Human Molecular Genetics 
15, 1209–1216. 
Ravikumar, B., Duden, R. and Rubinsztein, D. C. (2002). Aggregate-prone proteins 
Bibliography 
 
with polyglutamine and polyalanine expansions are degraded by autophagy. 
Human Molecular Genetics 11, 1107–1117. 
Reddy, P. H., Reddy, T. P., Manczak, M., Calkins, M. J., Shirendeb, U. and Mao, P. 
(2011). Dynamin-related protein 1 and mitochondrial fragmentation in 
neurodegenerative diseases. Brain Res Rev 67, 103–118. 
Ricchelli, F., Sileikytė, J. and Bernardi, P. (2011). Shedding light on the 
mitochondrial permeability transition. Biochim Biophys Acta 1807, 482–490. 
Rico de Souza, A., Zago, M., Pollock, S. J., Sime, P. J., Phipps, R. P. and Baglole, 
C. J. (2011). Genetic ablation of the aryl hydrocarbon receptor causes cigarette 
smoke-induced mitochondrial dysfunction and apoptosis. J Biol Chem 286, 43214–
43228. 
Rizzuto, R., Bernardi, P. and Pozzan, T. (2000). Mitochondria as all-round players of 
the calcium game. J Physiol (Lond) 529 Pt 1, 37–47. 
Rolo, A. P. and Palmeira, C. M. (2006). Diabetes and mitochondrial function: role of 
hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212, 167–178. 
Rolo, A. P., Gomes, A. P. and Palmeira, C. M. (2011). Regulation of mitochondrial 
biogenesis in metabolic syndrome. Curr Drug Targets 12, 872–878. 
Rolo, A. P., Palmeira, C. M. and Wallace, K. B. (2003). Mitochondrially mediated 
synergistic cell killing by bile acids. Biochim Biophys Acta 1637, 127–132. 
Rolo, A. P., Teodoro, J. S., Peralta, C., Roselló-Catafau, J. and Palmeira, C. M. 
(2009). Prevention of I/R injury in fatty livers by ischemic preconditioning is 
associated with increased mitochondrial tolerance: the key role of ATPsynthase 
and mitochondrial permeability transition. Transpl. Int. 22, 1081–1090. 
Rostovtseva, T. K., Komarov, A., Bezrukov, S. M. and Colombini, M. (2002). 
Dynamics of nucleotides in VDAC channels: structure-specific noise generation. 
Biophys J 82, 193–205. 
Rostovtseva, T. K., Tan, W. and Colombini, M. (2005). On the role of VDAC in 
apoptosis: fact and fiction. J Bioenerg Biomembr 37, 129–142. 
Roupé, K. M., Nybo, M., Sjöbring, U., Alberius, P., Schmidtchen, A. and Sørensen, 
O. E. (2010). Injury is a major inducer of epidermal innate immune responses 
during wound healing. J. Invest. Dermatol. 130, 1167–1177. 
Rowlands, J. C. and Gustafsson, J. A. (1997). Aryl hydrocarbon receptor-mediated 
signal transduction. Critical Reviews in Toxicology 27, 109–134. 
Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O. and Klionsky, D. J. (2007). 
Potential therapeutic applications of autophagy. Nat Rev Drug Discov 6, 304–312. 
Russmann, S., Kullak-Ublick, G. A. and Grattagliano, I. (2009). Current concepts of 
mechanisms in drug-induced hepatotoxicity. Curr Med Chem 16, 3041–3053. 
Ryter, S. W. and Choi, A. M. K. (2010). Autophagy in the lung. Proc Am Thorac Soc 
7, 13–21. 
Safe, S. (1990). Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), 
Bibliography 

dibenzofurans (PCDFs), and related compounds: environmental and mechanistic 
considerations which support the development of toxic equivalency factors (TEFs). 
Critical Reviews in Toxicology 21, 51–88. 
Sakai, Y., Oku, M., van der Klei, I. J. and Kiel, J. A. K. W. (2006). Pexophagy: 
autophagic degradation of peroxisomes. Biochim Biophys Acta 1763, 1767–1775. 
Salnikow, K. and Zhitkovich, A. (2008). Genetic and epigenetic mechanisms in metal 
carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res 
Toxicol 21, 28–44. 
Scagliotti, G. V., Longo, M. and Novello, S. (2009). Nonsmall cell lung cancer in 
never smokers. Curr Opin Oncol 21, 99–104. 
Scarpulla, R. C. (2008). Transcriptional paradigms in mammalian mitochondrial 
biogenesis and function. Physiol Rev 88, 611–638. 
Schapira, A. H. V. (2006). Mitochondrial disease. Lancet 368, 70–82. 
Schapira, A. H. V. and Gegg, M. (2011). Mitochondrial contribution to Parkinson's 
disease pathogenesis. Parkinsons Dis 2011, 159160. 
Scherz-Shouval, R. and Elazar, Z. (2011). Regulation of autophagy by ROS: 
physiology and pathology. Trends Biochem Sci 36, 30–38. 
Schinzel, A. C., Takeuchi, O., Huang, Z., Fisher, J. K., Zhou, Z., Rubens, J., Hetz, 
C., Danial, N. N., Moskowitz, M. A. and Korsmeyer, S. J. (2005). Cyclophilin D is 
a component of mitochondrial permeability transition and mediates neuronal cell 
death after focal cerebral ischemia. Proc Natl Acad Sci USA 102, 12005–12010. 
Schmidt, J. V. and Bradfield, C. A. (1996). Ah receptor signaling pathways. Annu 
Rev Cell Dev Biol 12, 55–89. 
Schweichel, J. U. and Merker, H. J. (1973). The morphology of various types of cell 
death in prenatal tissues. Teratology 7, 253–266. 
Scorrano, L. (2009). Opening the doors to cytochrome c: changes in mitochondrial 
shape and apoptosis. Int J Biochem Cell Biol 41, 1875–1883. 
Senft, A. P., Dalton, T. P., Nebert, D. W., Genter, M. B., Hutchinson, R. J. and 
Shertzer, H. G. (2002a). Dioxin increases reactive oxygen production in mouse 
liver mitochondria. Toxicol Appl Pharmacol 178, 15–21. 
Senft, A. P., Dalton, T. P., Nebert, D. W., Genter, M. B., Puga, A., Hutchinson, R. 
J., Kerzee, J. K., Uno, S. and Shertzer, H. G. (2002b). Mitochondrial reactive 
oxygen production is dependent on the aromatic hydrocarbon receptor. Free Radic 
Biol Med 33, 1268–1278. 
Sewall, C. H., Clark, G. C. and Lucier, G. W. (1995). TCDD reduces rat hepatic 
epidermal growth factor receptor: comparison of binding, immunodetection, and 
autophosphorylation. Toxicol Appl Pharmacol 132, 263–272. 
Shacka, J. J., Roth, K. A. and Zhang, J. (2008). The autophagy-lysosomal 
degradation pathway: role in neurodegenerative disease and therapy. Front Biosci 
13, 718–736. 
Bibliography 
 
Shah, P. P., Saurabh, K., Pant, M. C., Mathur, N. and Parmar, D. (2009). Evidence 
for increased cytochrome P450 1A1 expression in blood lymphocytes of lung 
cancer patients. Mutat Res 670, 74–78. 
Shen, D., Dalton, T. P., Nebert, D. W. and Shertzer, H. G. (2005). Glutathione redox 
state regulates mitochondrial reactive oxygen production. J Biol Chem 280, 25305–
25312. 
Shertzer, H. G., Genter, M. B., Shen, D., Nebert, D. W., Chen, Y. and Dalton, T. P. 
(2006). TCDD decreases ATP levels and increases reactive oxygen production 
through changes in mitochondrial F(0)F(1)-ATP synthase and ubiquinone. Toxicol 
Appl Pharmacol 217, 363–374. 
Shibata, M., Lu, T., Furuya, T., Degterev, A., Mizushima, N., Yoshimori, T., 
MacDonald, M., Yankner, B. and Yuan, J. (2006). Regulation of intracellular 
accumulation of mutant Huntingtin by Beclin 1. J Biol Chem 281, 14474–14485. 
Shimada, T. and Fujii-Kuriyama, Y. (2004). Metabolic activation of polycyclic 
aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer 
Science 95, 1–6. 
Shimizu, S., Matsuoka, Y., Shinohara, Y., Yoneda, Y. and Tsujimoto, Y. (2001). 
Essential role of voltage-dependent anion channel in various forms of apoptosis in 
mammalian cells. J Cell Biol 152, 237–250. 
Shoubridge, E. A. (2001). Nuclear genetic defects of oxidative phosphorylation. 
Human Molecular Genetics 10, 2277–2284. 
Sileikytė, J., Petronilli, V., Zulian, A., Dabbeni-Sala, F., Tognon, G., Nikolov, P., 
Bernardi, P. and Ricchelli, F. (2011). Regulation of the inner membrane 
mitochondrial permeability transition by the outer membrane translocator protein 
(peripheral benzodiazepine receptor). J Biol Chem 286, 1046–1053. 
Simões, A. M., Duarte, F. V., Teodoro, J. S., Rolo, A. P. and Palmeira, C. M. (2010). 
Exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and tetraethyl lead affects lung 
mitochondria bioenergetics. Toxicology mechanisms and methods 20, 1–6. 
Singh, P., Suman, S., Chandna, S. and Das, T. K. (2009). Possible role of amyloid-
beta, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial 
dysfunction of Alzheimer's disease. Bioinformation 3, 440–445. 
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., 
Warren, J. T., Bokesch, H., Kenney, S. and Boyd, M. R. (1990). New 
colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82, 
1107–1112. 
Slattery, M. L., Samowtiz, W., Ma, K., Murtaugh, M., Sweeney, C., Levin, T. R. and 
Neuhausen, S. (2004). CYP1A1, cigarette smoking, and colon and rectal cancer. 
American Journal of Epidemiology 160, 842–852. 
Smeitink, J. A., Zeviani, M., Turnbull, D. M. and Jacobs, H. T. (2006). Mitochondrial 
medicine: a metabolic perspective on the pathology of oxidative phosphorylation 
disorders. Cell Metab 3, 9–13. 
Smirnova, E., Shurland, D. L., Ryazantsev, S. N. and van der Bliek, A. M. (1998). A 
human dynamin-related protein controls the distribution of mitochondria. J Cell Biol 
Bibliography 

143, 351–358. 
Soudani, N., Ben Amara, I., Sefi, M., Boudawara, T. and Zeghal, N. (2011). Effects 
of selenium on chromium (VI)-induced hepatotoxicity in adult rats. Exp. Toxicol. 
Pathol. 63, 541–548. 
Stocchi, V., Cucchiarini, L., Magnani, M., Chiarantini, L., Palma, P. and 
Crescentini, G. (1985). Simultaneous extraction and reverse-phase high-
performance liquid chromatographic determination of adenine and pyridine 
nucleotides in human red blood cells. Anal Biochem 146, 118–124. 
Su, K. G., Banker, G., Bourdette, D. and Forte, M. (2009). Axonal degeneration in 
multiple sclerosis: The mitochondrial hypothesis. Curr Neurol Neurosci 9, 411–417. 
Su, T.-C., Chen, S.-Y. and Chan, C.-C. (2011). Progress of ambient air pollution and 
cardiovascular disease research in Asia. Prog Cardiovasc Dis 53, 369–378. 
Sun, Q., Hong, X. and Wold, L. E. (2010). Cardiovascular effects of ambient 
particulate air pollution exposure. Circulation 121, 2755–2765. 
Sun, S., Schiller, J. H. and Gazdar, A. F. (2007). Lung cancer in never smokers--a 
different disease. Nat Rev Cancer 7, 778–790. 
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., 
Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999). Molecular 
characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441–446. 
Sutter, C. H., Yin, H., Li, Y., Mammen, J. S., Bodreddigari, S., Stevens, G., Cole, J. 
A. and Sutter, T. R. (2009). EGF receptor signaling blocks aryl hydrocarbon 
receptor-mediated transcription and cell differentiation in human epidermal 
keratinocytes. Proc Natl Acad Sci USA 106, 4266–4271. 
Tabrez, S. and Ahmad, M. (2009). Toxicity, biomarkers, genotoxicity, and 
carcinogenicity of trichloroethylene and its metabolites: a review. J Environ Sci 
Health C Environ Carcinog Ecotoxicol Rev 27, 178–196. 
Takacs-Vellai, K., Vellai, T., Puoti, A., Passannante, M., Wicky, C., Streit, A., 
Kovács, A. L. and Müller, F. (2005). Inactivation of the autophagy gene bec-1 
triggers apoptotic cell death in C. elegans. Curr Biol 15, 1513–1517. 
Tanida, I., Ueno, T. and Kominami, E. (2004). LC3 conjugation system in mammalian 
autophagy. Int J Biochem Cell Biol 36, 2503–2518. 
Tanida, I., Ueno, T. and Kominami, E. (2008). LC3 and Autophagy. Methods Mol Biol 
445, 77–88. 
Tatsuta, T. and Langer, T. (2008). Quality control of mitochondria: protection against 
neurodegeneration and ageing. EMBO J 27, 306–314. 
Teodoro, J. S., Simões, A. M., Duarte, F. V., Rolo, A. P., Murdoch, R. C., Hussain, 
S. M. and Palmeira, C. M. (2011). Assessment of the toxicity of silver 
nanoparticles in vitro: a mitochondrial perspective. Toxicol In Vitro 25, 664–670. 
Terman, A. and Brunk, U. T. (2005). Autophagy in cardiac myocyte homeostasis, 
aging, and pathology. Cardiovasc Res 68, 355–365. 
Bibliography 
 
Thiele, D. L., Eigenbrodt, E. H. and Ware, A. J. (1982). Cirrhosis after repeated 
trichloroethylene and 1,1,1-trichloroethane exposure. Gastroenterology 83, 926–
929. 
Thornberry, N. A. and Lazebnik, Y. (1998). Caspases: enemies within. Science 281, 
1312–1316. 
Thun, M. J., Henley, S. J., Burns, D., Jemal, A., Shanks, T. G. and Calle, E. E. 
(2006). Lung cancer death rates in lifelong nonsmokers. JNCI Journal of the 
National Cancer Institute 98, 691–699. 
Toyooka, T. and Ibuki, Y. (2009). Cigarette sidestream smoke induces 
phosphorylated histone H2AX. Mutat Res 676, 34–40. 
Tritscher, A. M., Mahler, J., Portier, C. J., Lucier, G. W. and Walker, N. J. (2000). 
Induction of lung lesions in female rats following chronic exposure to 2,3,7,8-
tetrachlorodibenzo-p-dioxin. Toxicol Pathol 28, 761–769. 
Turner, N. and Heilbronn, L. K. (2008). Is mitochondrial dysfunction a cause of insulin 
resistance? Trends Endocrinol Metab 19, 324–330. 
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., 
Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008). Fission and selective 
fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 
27, 433–446. 
Valavanidis, A., Vlahogianni, T., Dassenakis, M. and Scoullos, M. (2006). 
Molecular biomarkers of oxidative stress in aquatic organisms in relation to toxic 
environmental pollutants. Ecotoxicol. Environ. Saf. 64, 178–189. 
van Grevenynghe, J., Bernard, M., Langouet, S., Le Berre, C., Fest, T. and Fardel, 
O. (2005). Human CD34-positive hematopoietic stem cells constitute targets for 
carcinogenic polycyclic aromatic hydrocarbons. J Pharmacol Exp Ther 314, 693–
702. 
van Loo, G., Schotte, P., van Gurp, M., Demol, H., Hoorelbeke, B., Gevaert, K., 
Rodriguez, I., Ruiz-Carrillo, A., Vandekerckhove, J., Declercq, W., et al. (2001). 
Endonuclease G: a mitochondrial protein released in apoptosis and involved in 
caspase-independent DNA degradation. Cell Death Differ 8, 1136–1142. 
Varela, A. T., Gomes, A. P., Simões, A. M., Teodoro, J. S., Duarte, F. V., Rolo, A. P. 
and Palmeira, C. M. (2008). Indirubin-3'-oxime impairs mitochondrial oxidative 
phosphorylation and prevents mitochondrial permeability transition induction. 
Toxicol Appl Pharmacol 233, 179–185. 
Varela, A. T., Simões, A. M., Teodoro, J. S., Duarte, F. V., Gomes, A. P., Palmeira, 
C. M. and Rolo, A. P. (2010). Indirubin-3'-oxime prevents hepatic I/R damage by 
inhibiting GSK-3beta and mitochondrial permeability transition. Mitochondrion 10, 
456–463. 
Vassalli, P. (1992). The pathophysiology of tumor necrosis factors. Annu. Rev. 
Immunol. 10, 411–452. 
Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., 
Moritz, R. L., Simpson, R. J. and Vaux, D. L. (2000). Identification of DIABLO, a 
mammalian protein that promotes apoptosis by binding to and antagonizing IAP 
Bibliography 

proteins. Cell 102, 43–53. 
Wallace, D. C. (1999). Mitochondrial diseases in man and mouse. Science 283, 1482–
1488. 
Wallace, D. C. (2005). The mitochondrial genome in human adaptive radiation and 
disease: on the road to therapeutics and performance enhancement. Gene 354, 
169–180. 
Wang, C.-Y. and Zhao, Z.-B. (2012). Somatic mtDNA mutations in lung tissues of 
pesticide-exposed fruit growers. Toxicology 291, 51–55. 
Wang, P. and Heitman, J. (2005). The cyclophilins. Genome Biol. 6, 226. 
Watabe, Y., Nazuka, N., Tezuka, M. and Shimba, S. (2010). Aryl hydrocarbon 
receptor functions as a potent coactivator of E2F1-dependent trascription activity. 
Biol Pharm Bull 33, 389–397. 
Waterham, H. R., Koster, J., van Roermund, C. W. T., Mooyer, P. A. W., Wanders, 
R. J. A. and Leonard, J. V. (2007). A lethal defect of mitochondrial and 
peroxisomal fission. N. Engl. J. Med. 356, 1736–1741. 
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N. and Rubinsztein, D. C. 
(2003). Alpha-Synuclein is degraded by both autophagy and the proteasome. J 
Biol Chem 278, 25009–25013. 
Weinstein, D. A., Gogal, R. M., Mustafa, A., Prater, M. R. and Holladay, S. D. 
(2008). Mid-gestation exposure of C57BL/6 mice to 2,3,7,8-tetrachlorodibenzo-p-
dioxin causes postnatal morphologic changes in the spleen and liver. Toxicol 
Pathol 36, 705–713. 
West, A. P., Shadel, G. S. and Ghosh, S. (2011). Mitochondria in innate immune 
responses. Nat Rev Immunol 11, 389–402. 
Westermann, B. (2010). Mitochondrial fusion and fission in cell life and death. Nat Rev 
Mol Cell Biol 11, 872–884. 
Whitlock, J. P. (1999). Induction of cytochrome P4501A1. Annu Rev Pharmacol 
Toxicol 39, 103–125. 
Wojtczak, L., Zaluska, H., Wroniszewska, A. and Wojtczak, A. B. (1972). Assay for 
the intactness of the outer membrane in isolated mitochondria. Acta Biochim Pol 
19, 227–234. 
Woodfield, K., Rück, A., Brdiczka, D. and Halestrap, A. P. (1998). Direct 
demonstration of a specific interaction between cyclophilin-D and the adenine 
nucleotide translocase confirms their role in the mitochondrial permeability 
transition. Biochem J 336 ( Pt 2), 287–290. 
Wu, Y.-T., Wu, S.-B., Lee, W.-Y. and Wei, Y.-H. (2010). Mitochondrial respiratory 
dysfunction-elicited oxidative stress and posttranslational protein modification in 
mitochondrial diseases. Ann N Y Acad Sci 1201, 147–156. 
Yang, C.-Y., Huang, T.-S., Lin, K.-C., Kuo, P., Tsai, P.-C. and Guo, Y. L. (2011). 
Menstrual effects among women exposed to polychlorinated biphenyls and 
dibenzofurans. Environ Res 111, 288–294. 
Bibliography 
 
Yang, C.-Y., Wang, Y.-J., Chen, P.-C., Tsai, S.-J. and Guo, Y. L. (2008). Exposure to 
a mixture of polychlorinated biphenyls and polychlorinated dibenzofurans resulted 
in a prolonged time to pregnancy in women. Environ Health Perspect 116, 599–
604. 
Yang, X., Jiang, Y., Li, J., Hong, W.-X., Wu, D., Huang, X., Huang, H., Zhou, L., 
Yang, L., Yuan, J., et al. (2012). Lentivirus-mediated silencing of I2PP2A through 
RNA interference attenuates trichloroethylene-induced cytotoxicity in human 
hepatic L-02 cells. Toxicol Lett 209, 232–238. 
Yarden, Y. and Schlessinger, J. (1987). Epidermal growth factor induces rapid, 
reversible aggregation of the purified epidermal growth factor receptor. 
Biochemistry 26, 1443–1451. 
Yorimitsu, T. and Klionsky, D. J. (2007). Eating the endoplasmic reticulum: quality 
control by autophagy. Trends Cell Biol 17, 279–285. 
Yoshioka, W., Peterson, R. E. and Tohyama, C. (2011). Molecular targets that link 
dioxin exposure to toxicity phenotypes. J. Steroid Biochem. Mol. Biol. 127, 96–101. 
Yu, L.-Y., Jokitalo, E., Sun, Y.-F., Mehlen, P., Lindholm, D., Saarma, M. and 
Arumae, U. (2003). GDNF-deprived sympathetic neurons die via a novel 
nonmitochondrial pathway. J Cell Biol 163, 987–997. 
Yue, Z., Horton, A., Bravin, M., DeJager, P. L., Selimi, F. and Heintz, N. (2002). A 
novel protein complex linking the delta 2 glutamate receptor and autophagy: 
implications for neurodegeneration in lurcher mice. Neuron 35, 921–933. 
Yue, Z., Jin, S., Yang, C., Levine, A. J. and Heintz, N. (2003). Beclin 1, an autophagy 
gene essential for early embryonic development, is a haploinsufficient tumor 
suppressor. Proc Natl Acad Sci USA 100, 15077–15082. 
Zangar, R. C., Davydov, D. R. and Verma, S. (2004). Mechanisms that regulate 
production of reactive oxygen species by cytochrome P450. Toxicol Appl 
Pharmacol 199, 316–331. 
Zhang, Y. and Chan, D. C. (2007). Structural basis for recruitment of mitochondrial 
fission complexes by Fis1. Proc Natl Acad Sci USA 104, 18526–18530. 
Zhang, Y., Qi, H., Taylor, R., Xu, W., Liu, L. F. and Jin, S. (2007a). The role of 
autophagy in mitochondria maintenance: characterization of mitochondrial 
functions in autophagy-deficient S. cerevisiae strains. Autophagy 3, 337–346. 
Zhang, Z., Che, W., Liang, Y., Wu, M., Li, N., Shu, Y., Liu, F. and Wu, D. (2007b). 
Comparison of cytotoxicity and genotoxicity induced by the extracts of methanol 
and gasoline engine exhausts. Toxicol In Vitro 21, 1058–1065. 
Zheng, Y. T., Shahnazari, S., Brech, A., Lamark, T., Johansen, T. and Brumell, J. 
H. (2009). The adaptor protein p62/SQSTM1 targets invading bacteria to the 
autophagy pathway. J Immunol 183, 5909–5916. 
Zheng, Y., Shi, Y., Tian, C., Jiang, C., Jin, H., Chen, J., Almasan, A., Tang, H. and 
Chen, Q. (2004). Essential role of the voltage-dependent anion channel (VDAC) in 
mitochondrial permeability transition pore opening and cytochrome c release 
induced by arsenic trioxide. Oncogene 23, 1239–1247. 
Bibliography 

Zoratti, M. and Szabò, I. (1995). The mitochondrial permeability transition. Biochim 
Biophys Acta 1241, 139–176. 
Zorov, D. B., Juhaszova, M., Yaniv, Y., Nuss, H. B., Wang, S. and Sollott, S. J. 
(2009). Regulation and pharmacology of the mitochondrial permeability transition 
pore. Cardiovasc Res 83, 213–225. 
Zou, H., Henzel, W. J., Liu, X., Lutschg, A. and Wang, X. (1997). Apaf-1, a human 
protein homologous to C. elegans CED-4, participates in cytochrome c-dependent 
activation of caspase-3. Cell 90, 405–413. 
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., 
Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004). 
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth 
neuropathy type 2A. Nat Genet 36, 449–451. 

• US EPA, 2004. Exposure and Human Health Reassessment of 2,3,7,8-
Tetrachlorodibenzo-p-dioxin (TCDD) and Related Compounds, National Academy 
of Sciences (NAS) Review Draft. EPA/600/P-00/001Cb. Available from: 
http://www.epa.gov/ncea/pdfs/dioxin/nas-review. 
 
